List of Predicted Activities
No - number of activity
Active compounds - number of active compounds
IAP - Invariant accuracy of prediction
This is Activities List for PASS Online
No | Activity Type | Active compounds | IAP |
1 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase inhibitor | 6 | 0.9555 |
2 | (R)-3-amino-2-methylpropionate-pyruvate transaminase inhibitor | 24 | 0.9969 |
3 | (R)-6-hydroxynicotine oxidase inhibitor | 3 | 0.9296 |
4 | (R)-aminopropanol dehydrogenase inhibitor | 10 | 0.9906 |
5 | (R)-limonene 6-monooxygenase inhibitor | 3 | 0.9969 |
6 | (R)-Pantolactone dehydrogenase (flavin) inhibitor | 8 | 0.8724 |
7 | (R,R)-butanediol dehydrogenase inhibitor | 3 | 0.9947 |
8 | (S)-2-hydroxy-acid oxidase inhibitor | 28 | 0.9258 |
9 | (S)-2-Methylmalate dehydratase inhibitor | 4 | 0.9965 |
10 | (S)-3-amino-2-methylpropionate transaminase inhibitor | 8 | 0.9543 |
11 | (S)-3-hydroxyacid ester dehydrogenase inhibitor | 3 | 0.9908 |
12 | (S)-6-hydroxynicotine oxidase inhibitor | 4 | 0.9526 |
13 | (S)-carnitine 3-dehydrogenase inhibitor | 7 | 0.9877 |
14 | (S)-methylmalonyl-CoA hydrolase inhibitor | 8 | 1.0000 |
15 | [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)] kinase inhibitor | 34 | 0.9919 |
16 | [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase inhibitor | 12 | 0.9998 |
17 | [acetyl-CoA carboxylase] kinase inhibitor | 6 | 0.9955 |
18 | [acyl-carrier-protein] S-acetyltransferase inhibitor | 7 | 0.9562 |
19 | [acyl-carrier-protein] S-malonyltransferase inhibitor | 10 | 0.9873 |
20 | [citrate-(pro-3S)-lyase] thiolesterase inhibitor | 4 | 0.9992 |
21 | [glutamate-ammonia-ligase] adenylyltransferase inhibitor | 13 | 0.9971 |
22 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase inhibitor | 11 | 0.9555 |
23 | [hydroxymethylglutaryl-CoA reductase (NADPH)]-phosphatase inhibitor | 8 | 0.9981 |
24 | [Isocitrate dehydrogenase (NADP+)] kinase inhibitor | 9 | 0.9979 |
25 | [myelin basic protein]-arginine N-methyltransferase inhibitor | 3 | 0.9841 |
26 | [phosphorylase] phosphatase inhibitor | 14 | 0.9449 |
27 | [protein-PII] uridylyltransferase inhibitor | 27 | 0.9973 |
28 | [Skp1-protein]-hydroxyproline N-acetylglucosaminyltransferase inhibitor | 5 | 0.9974 |
29 | 1,2-alpha-L-fucosidase inhibitor | 5 | 0.9483 |
30 | 1,3-Beta-glucan synthase inhibitor | 3 | 0.9992 |
31 | 1,4-Alpha-glucan branching enzyme inhibitor | 4 | 0.9592 |
32 | 1,4-Lactonase inhibitor | 4 | 0.8081 |
33 | 1,5-Anhydro-D-fructose reductase inhibitor | 9 | 0.9925 |
34 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 1737 | 0.9921 |
35 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 253 | 0.9977 |
36 | 11-Beta-hydroxysteroid dehydrogenase inhibitor | 1789 | 0.9917 |
37 | 11-Cis-retinyl-palmitate hydrolase inhibitor | 4 | 0.9960 |
38 | 12-Lipoxygenase inhibitor | 86 | 0.9768 |
39 | 15-Hydroxyprostaglandin-D dehydrogenase (NADP+) inhibitor | 8 | 0.9686 |
40 | 15-Lipoxygenase inhibitor | 269 | 0.9827 |
41 | 17-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 49 | 0.9816 |
42 | 17-Beta-hydroxysteroid dehydrogenase 5 inhibitor | 6 | 1.0000 |
43 | 1-Acylglycerol-3-phosphate O-acyltransferase inhibitor | 45 | 0.8821 |
44 | 1-Alkyl-2-acetylglycerol O-acyltransferase inhibitor | 3 | 0.9979 |
45 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 441 | 0.9926 |
46 | 1-Alkylglycerophosphocholine O-acetyltransferase inhibitor | 24 | 0.9261 |
47 | 1-Aminocyclopropane-1-carboxylate deaminase inhibitor | 11 | 0.9876 |
48 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 12 | 0.9982 |
49 | 1-Phosphofructokinase inhibitor | 9 | 0.9905 |
50 | 1-Pyrroline-5-carboxylate dehydrogenase inhibitor | 24 | 0.9895 |
51 | 2-(acetamidomethylene)succinate hydrolase inhibitor | 11 | 0.9991 |
52 | 2,2-Dialkylglycine decarboxylase (pyruvate) inhibitor | 7 | 0.9888 |
53 | 2,3,4,5-Tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase inhibitor | 5 | 0.9715 |
54 | 2,3-Dihydroxyindole 2,3-dioxygenase inhibitor | 4 | 0.9852 |
55 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 142 | 0.9882 |
56 | 2,4-Diaminopentanoate dehydrogenase inhibitor | 3 | 0.9896 |
57 | 2,4-Dichlorophenol 6-monooxygenase inhibitor | 9 | 0.9714 |
58 | 2,5-Dihydroxypyridine 5,6-dioxygenase inhibitor | 7 | 0.9896 |
59 | 2,6-Dihydroxypyridine 3-monooxygenase inhibitor | 3 | 0.9829 |
60 | 27-Hydroxycholesterol 7alpha-monooxygenase inhibitor | 6 | 0.8289 |
61 | 2-Acylglycerol O-acyltransferase inhibitor | 18 | 0.9388 |
62 | 2-Amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase inhibitor | 4 | 0.9987 |
63 | 2-Aminoadipate transaminase inhibitor | 6 | 0.9850 |
64 | 2-Aminoethylphosphonate-pyruvate transaminase inhibitor | 9 | 0.9906 |
65 | 2-Aminohexano-6-lactam racemase inhibitor | 19 | 0.9847 |
66 | 2-Aminohexanoate transaminase inhibitor | 3 | 1.0000 |
67 | 2-Dehydro-3-deoxy-L-arabinonate dehydratase inhibitor | 4 | 0.9936 |
68 | 2-Dehydro-3-deoxy-phosphogluconate aldolase inhibitor | 6 | 0.9916 |
69 | 2-Dehydropantoate 2-reductase inhibitor | 7 | 0.8106 |
70 | 2-Dehydropantoate aldolase inhibitor | 3 | 0.9918 |
71 | 2-Dehydropantolactone reductase (A-specific) inhibitor | 10 | 0.9909 |
72 | 2-Enoate reductase inhibitor | 10 | 0.9618 |
73 | 2-Ethylmalate synthase inhibitor | 3 | 0.9996 |
74 | 2-Haloacid dehalogenase (configuration-inverting) inhibitor | 6 | 0.9858 |
75 | 2-Haloacid dehalogenase inhibitor | 3 | 0.9735 |
76 | 2-Hydroxy-3-oxoadipate synthase inhibitor | 3 | 0.9827 |
77 | 2-Hydroxy-3-oxopropionate reductase inhibitor | 5 | 0.9904 |
78 | 2-Hydroxyacylsphingosine 1-beta-galactosyltransferase inhibitor | 3 | 1.0000 |
79 | 2-Hydroxymuconate-semialdehyde hydrolase inhibitor | 7 | 0.9331 |
80 | 2-Hydroxyquinoline 8-monooxygenase inhibitor | 6 | 0.8414 |
81 | 2-Isopropylmalate synthase inhibitor | 15 | 0.9984 |
82 | 2-Methylacyl-CoA dehydrogenase inhibitor | 7 | 0.9850 |
83 | 2-Methyl-branched-chain-enoyl-CoA reductase inhibitor | 5 | 0.9799 |
84 | 2-Methylcitrate dehydratase inhibitor | 4 | 0.9963 |
85 | 2-Methylcitrate synthase inhibitor | 3 | 0.9781 |
86 | 2-Methyleneglutarate mutase inhibitor | 9 | 0.9916 |
87 | 2-Nitrophenol 2-monooxygenase inhibitor | 3 | 0.9904 |
88 | 2-Nitropropane dioxygenase inhibitor | 21 | 0.9676 |
89 | 2-Oxoaldehyde dehydrogenase (NAD+) inhibitor | 12 | 0.9910 |
90 | 2-Oxoaldehyde dehydrogenase (NADP+) inhibitor | 3 | 0.9851 |
91 | 2-Oxoglutarate decarboxylase inhibitor | 8 | 0.9824 |
92 | 2-Oxoisovalerate dehydrogenase (acylating) inhibitor | 4 | 0.9923 |
93 | 2-Pyrocatechuate decarboxylase inhibitor | 20 | 0.9919 |
94 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 97 | 0.9997 |
95 | 3'(2'),5'-Bisphosphate nucleotidase inhibitor | 4 | 0.9967 |
96 | 3(or 17)alpha-hydroxysteroid dehydrogenase inhibitor | 9 | 0.9927 |
97 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 63 | 0.9772 |
98 | 3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase inhibitor | 4 | 0.9857 |
99 | 3,4-Dihydroxyphenylacetate 2,3-dioxygenase inhibitor | 12 | 0.9960 |
100 | 3-Alpha-hydroxysteroid dehydrogenase (B-specific) inhibitor | 7 | 0.9734 |
101 | 3-Aminobutyryl-CoA ammonia-lyase inhibitor | 3 | 0.9936 |
102 | 3-Carboxyethylcatechol 2,3-dioxygenase inhibitor | 4 | 0.9889 |
103 | 3-Chloro-D-alanine dehydrochlorinase inhibitor | 4 | 0.9878 |
104 | 3C-like protease (Human coronavirus) inhibitor | 29 | 0.8891 |
105 | 3-Cyanoalanine hydratase inhibitor | 4 | 0.8386 |
106 | 3-Dehydroquinate dehydratase inhibitor | 14 | 0.9940 |
107 | 3-Dehydroquinate synthase inhibitor | 16 | 0.9948 |
108 | 3'-Demethylstaurosporine O-methyltransferase inhibitor | 4 | 0.9694 |
109 | 3-Demethylubiquinone-9 3-O-methyltransferase inhibitor | 3 | 0.9861 |
110 | 3-Deoxy-7-phosphoheptulonate synthase inhibitor | 48 | 0.9917 |
111 | 3-Deoxy-8-phosphooctulonate synthase inhibitor | 8 | 0.9948 |
112 | 3-Galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase inhibitor | 3 | 0.9936 |
113 | 3-Hydroxy-4-oxoquinoline 2,4-dioxygenase inhibitor | 6 | 0.9808 |
114 | 3-Hydroxyacyl-CoA dehydrogenase inhibitor | 6 | 0.9908 |
115 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 14 | 0.9456 |
116 | 3-Hydroxyanthranilate oxidase inhibitor | 13 | 0.9804 |
117 | 3-Hydroxybenzoate 4-monooxygenase inhibitor | 7 | 0.9809 |
118 | 3-Hydroxybenzoate 6-monooxygenase inhibitor | 5 | 0.8427 |
119 | 3-Hydroxybutyrate dehydrogenase inhibitor | 25 | 0.9900 |
120 | 3-Hydroxybutyryl-CoA dehydrogenase inhibitor | 3 | 0.9896 |
121 | 3-Hydroxydecanoyl-[acyl-carrier-protein] dehydratase inhibitor | 9 | 0.9895 |
122 | 3-Hydroxyisobutyryl-CoA hydrolase inhibitor | 7 | 1.0000 |
123 | 3-Hydroxyphenylacetate 6-hydroxylase inhibitor | 4 | 0.9906 |
124 | 3-Isopropylmalate dehydratase inhibitor | 8 | 0.9862 |
125 | 3-Isopropylmalate dehydrogenase inhibitor | 7 | 0.9956 |
126 | 3-Ketovalidoxylamine C-N-lyase inhibitor | 4 | 0.9849 |
127 | 3-Mercaptopyruvate sulfurtransferase inhibitor | 9 | 0.9997 |
128 | 3-Methyl-2-oxobutanoate dehydrogenase (lipoamide) inhibitor | 15 | 0.9953 |
129 | 3-Methyl-2-oxobutanoate hydroxymethyltransferase inhibitor | 8 | 0.9816 |
130 | 3-Methylbutanal reductase inhibitor | 9 | 0.8575 |
131 | 3'-Nucleotidase inhibitor | 8 | 0.9780 |
132 | 3-Oxoacid CoA-transferase inhibitor | 26 | 0.9933 |
133 | 3-Oxoacyl-[acyl-carrier-protein] synthase II inhibitor | 9 | 0.9838 |
134 | 3-Oxoacyl-[acyl-carrier-protein] synthase III inhibitor | 32 | 0.9806 |
135 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 54 | 0.9835 |
136 | 3-Oxoadipate enol-lactonase inhibitor | 3 | 0.9928 |
137 | 3-Oxosteroid 1-dehydrogenase inhibitor | 6 | 0.9944 |
138 | 3-Phosphoshikimate 1-carboxyvinyltransferase inhibitor | 41 | 0.9971 |
139 | 3-Phytase inhibitor | 9 | 0.8882 |
140 | 4,5-Dihydroxyphthalate decarboxylase inhibitor | 16 | 0.9304 |
141 | 4a-Hydroxytetrahydrobiopterin dehydratase inhibitor | 3 | 0.9983 |
142 | 4-Alpha-glucanotransferase inhibitor | 8 | 0.9915 |
143 | 4-Carboxymethyl-4-methylbutenolide mutase inhibitor | 9 | 0.9946 |
144 | 4-Chlorobenzoyl-CoA dehalogenase inhibitor | 7 | 0.9771 |
145 | 4-Chlorophenylacetate 3,4-dioxygenase inhibitor | 4 | 0.9876 |
146 | 4-Coumarate-CoA ligase inhibitor | 8 | 0.8520 |
147 | 4-Hydroxy-2-oxoglutarate aldolase inhibitor | 17 | 0.9946 |
148 | 4-Hydroxy-4-methyl-2-oxoglutarate aldolase inhibitor | 11 | 0.9954 |
149 | 4-Hydroxybenzoate 1-hydroxylase inhibitor | 3 | 0.9995 |
150 | 4-Hydroxybenzoate 3-monooxygenase [NAD(P)H] inhibitor | 6 | 0.9998 |
151 | 4-Hydroxybenzoate 3-monooxygenase inhibitor | 28 | 0.9858 |
152 | 4-Hydroxybenzoate decarboxylase inhibitor | 7 | 0.9973 |
153 | 4-Hydroxybenzoate nonaprenyltransferase inhibitor | 15 | 0.9661 |
154 | 4-Hydroxybenzoate-CoA ligase inhibitor | 4 | 0.9980 |
155 | 4-Hydroxyglutamate transaminase inhibitor | 4 | 0.9857 |
156 | 4-Hydroxymandelate oxidase inhibitor | 10 | 0.9266 |
157 | 4-Hydroxyphenylacetate 1-monooxygenase inhibitor | 4 | 0.9998 |
158 | 4-Hydroxyphenylacetate 3-monooxygenase inhibitor | 8 | 0.8789 |
159 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 22 | 0.9950 |
160 | 4-Hydroxyproline epimerase inhibitor | 8 | 0.8755 |
161 | 4-Methoxybenzoate monooxygenase (O-demethylating) inhibitor | 19 | 0.8921 |
162 | 4-Nitrophenol 2-monooxygenase inhibitor | 6 | 0.8201 |
163 | 4-Nitrophenylphosphatase inhibitor | 47 | 0.8961 |
164 | 4-Phytase inhibitor | 13 | 0.9856 |
165 | 4-Pyridoxolactonase inhibitor | 6 | 0.9941 |
166 | 5 Hydroxytryptamine 1 agonist | 1903 | 0.9865 |
167 | 5 Hydroxytryptamine 1 antagonist | 4787 | 0.9821 |
168 | 5 Hydroxytryptamine 1A agonist | 1131 | 0.9884 |
169 | 5 Hydroxytryptamine 1A antagonist | 3853 | 0.9851 |
170 | 5 Hydroxytryptamine 1B agonist | 65 | 0.9897 |
171 | 5 Hydroxytryptamine 1B antagonist | 1027 | 0.9860 |
172 | 5 Hydroxytryptamine 1D agonist | 695 | 0.9955 |
173 | 5 Hydroxytryptamine 1D antagonist | 1072 | 0.9853 |
174 | 5 Hydroxytryptamine 1E antagonist | 33 | 0.9108 |
175 | 5 Hydroxytryptamine 1F agonist | 115 | 0.9993 |
176 | 5 Hydroxytryptamine 1F antagonist | 216 | 0.9899 |
177 | 5 Hydroxytryptamine 2 agonist | 479 | 0.9912 |
178 | 5 Hydroxytryptamine 2 antagonist | 4227 | 0.9738 |
179 | 5 Hydroxytryptamine 2A agonist | 59 | 0.9501 |
180 | 5 Hydroxytryptamine 2A antagonist | 2961 | 0.9809 |
181 | 5 Hydroxytryptamine 2B agonist | 9 | 0.9469 |
182 | 5 Hydroxytryptamine 2B antagonist | 861 | 0.9782 |
183 | 5 Hydroxytryptamine 2C agonist | 415 | 0.9951 |
184 | 5 Hydroxytryptamine 2C antagonist | 1781 | 0.9847 |
185 | 5 Hydroxytryptamine 3 agonist | 73 | 0.9691 |
186 | 5 Hydroxytryptamine 3 antagonist | 1679 | 0.9888 |
187 | 5 Hydroxytryptamine 3A antagonist | 254 | 0.9771 |
188 | 5 Hydroxytryptamine 4 agonist | 343 | 0.9945 |
189 | 5 Hydroxytryptamine 4 antagonist | 571 | 0.9945 |
190 | 5 Hydroxytryptamine 4A antagonist | 7 | 0.9353 |
191 | 5 Hydroxytryptamine 4B antagonist | 6 | 0.9994 |
192 | 5 Hydroxytryptamine 4C antagonist | 4 | 0.9777 |
193 | 5 Hydroxytryptamine 4D antagonist | 4 | 0.9777 |
194 | 5 Hydroxytryptamine 4E antagonist | 27 | 0.9951 |
195 | 5 Hydroxytryptamine 5 antagonist | 126 | 0.9836 |
196 | 5 Hydroxytryptamine 5A antagonist | 124 | 0.9851 |
197 | 5 Hydroxytryptamine 6 agonist | 29 | 0.9919 |
198 | 5 Hydroxytryptamine 6 antagonist | 764 | 0.9914 |
199 | 5 Hydroxytryptamine 7 agonist | 8 | 0.9261 |
200 | 5 Hydroxytryptamine 7 antagonist | 560 | 0.9838 |
201 | 5 Hydroxytryptamine 7L antagonist | 5 | 0.9513 |
202 | 5 Hydroxytryptamine 7S antagonist | 5 | 0.9462 |
203 | 5 Hydroxytryptamine agonist | 2906 | 0.9786 |
204 | 5 Hydroxytryptamine antagonist | 10856 | 0.9662 |
205 | 5 Hydroxytryptamine release inhibitor | 33 | 0.8710 |
206 | 5 Hydroxytryptamine release stimulant | 17 | 0.9117 |
207 | 5 Hydroxytryptamine uptake inhibitor | 4311 | 0.9852 |
208 | 5 Hydroxytryptamine uptake stimulant | 5 | 0.8135 |
209 | 5 Lipoxygenase activating protein inhibitor | 144 | 0.9996 |
210 | 5-Alpha-reductase 1 inhibitor | 467 | 0.9963 |
211 | 5-Alpha-reductase 2 inhibitor | 509 | 0.9934 |
212 | 5-Alpha-reductase inhibitor | 1463 | 0.9941 |
213 | 5-Aminolevulinate synthase inhibitor | 25 | 0.9788 |
214 | 5-Aminovalerate transaminase inhibitor | 7 | 0.9965 |
215 | 5-Formyltetrahydrofolate cyclo-ligase inhibitor | 11 | 0.9297 |
216 | 5-Guanidino-2-oxopentanoate decarboxylase inhibitor | 8 | 0.9999 |
217 | 5-Hydroxypentanoate CoA-transferase inhibitor | 4 | 0.9998 |
218 | 5-Lipoxygenase inhibitor | 1998 | 0.9832 |
219 | 5-Methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase inhibitor | 4 | 0.9959 |
220 | 5'-Nucleotidase inhibitor | 45 | 0.9944 |
221 | 5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase inhibitor | 3 | 0.8822 |
222 | 5-Oxoprolinase (ATP-hydrolysing) inhibitor | 8 | 0.9958 |
223 | 6,7-Dihydropteridine reductase inhibitor | 47 | 0.9746 |
224 | 6-Carboxyhexanoate-CoA ligase inhibitor | 3 | 0.9894 |
225 | 6-Methylsalicylate decarboxylase inhibitor | 8 | 0.9891 |
226 | 6-Phospho-beta-glucosidase inhibitor | 8 | 0.9979 |
227 | 6-Phosphofructo-2-kinase inhibitor | 11 | 0.9935 |
228 | 6-Pyruvoyltetrahydropterin synthase inhibitor | 4 | 0.9873 |
229 | 8-Amino-7-oxononanoate synthase inhibitor | 15 | 0.9759 |
230 | 8-oxodGTPase stimulant | 12 | 0.9998 |
231 | ABCA1 expression enhancer | 211 | 0.9777 |
232 | Abl kinase inhibitor | 604 | 0.9708 |
233 | Abortion inducer | 38 | 0.9493 |
234 | Acaricide | 42 | 0.9447 |
235 | Acetate kinase inhibitor | 11 | 0.9080 |
236 | Acetate-CoA ligase inhibitor | 23 | 0.9869 |
237 | Acetoacetate decarboxylase inhibitor | 8 | 0.9924 |
238 | Acetoacetyl-CoA reductase inhibitor | 10 | 0.9980 |
239 | Acetoin dehydrogenase inhibitor | 15 | 0.9858 |
240 | Acetolactate decarboxylase inhibitor | 15 | 0.9828 |
241 | Acetolactate synthase inhibitor | 20 | 0.9840 |
242 | Acetylcholine agonist | 2053 | 0.9739 |
243 | Acetylcholine antagonist | 3940 | 0.9725 |
244 | Acetylcholine M1 receptor agonist | 1014 | 0.9922 |
245 | Acetylcholine M1 receptor antagonist | 1263 | 0.9878 |
246 | Acetylcholine M2 receptor agonist | 39 | 0.9710 |
247 | Acetylcholine M2 receptor antagonist | 1374 | 0.9887 |
248 | Acetylcholine M3 receptor agonist | 16 | 0.9963 |
249 | Acetylcholine M3 receptor antagonist | 1397 | 0.9863 |
250 | Acetylcholine M4 receptor agonist | 57 | 0.9949 |
251 | Acetylcholine M4 receptor antagonist | 706 | 0.9885 |
252 | Acetylcholine M5 receptor antagonist | 591 | 0.9895 |
253 | Acetylcholine muscarinic agonist | 1216 | 0.9883 |
254 | Acetylcholine muscarinic antagonist | 3051 | 0.9786 |
255 | Acetylcholine neuromuscular blocking agent | 18 | 0.8275 |
256 | Acetylcholine nicotinic agonist | 802 | 0.9784 |
257 | Acetylcholine nicotinic antagonist | 947 | 0.9789 |
258 | Acetylcholine release stimulant | 146 | 0.9625 |
259 | Acetylcholinesterase stimulant | 6 | 0.9999 |
260 | Acetyl-CoA C-acyltransferase inhibitor | 10 | 0.9641 |
261 | Acetyl-CoA carboxylase 1 inhibitor | 96 | 0.9920 |
262 | Acetyl-CoA carboxylase 2 inhibitor | 260 | 1.0000 |
263 | Acetyl-CoA carboxylase inhibitor | 279 | 0.9918 |
264 | Acetyl-CoA transferase 1 inhibitor | 602 | 0.9897 |
265 | Acetyl-CoA transferase 2 inhibitor | 226 | 0.9797 |
266 | Acetyl-CoA transferase inhibitor | 1569 | 0.9888 |
267 | Acetylenecarboxylate hydratase inhibitor | 3 | 0.9889 |
268 | Acetylesterase inhibitor | 6 | 0.8663 |
269 | Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase inhibitor | 6 | 0.8268 |
270 | Acetylornithine deacetylase inhibitor | 4 | 0.9849 |
271 | Acetylserotonin O-methyltransferase inhibitor | 11 | 0.9115 |
272 | Acetylspermidine deacetylase inhibitor | 16 | 0.9512 |
273 | Acid phosphatase 1 inhibitor | 5 | 1.0000 |
274 | Acid phosphatase inhibitor | 43 | 0.9551 |
275 | Acidifying agent gastric | 6 | 0.9981 |
276 | Acidifying agent non gastric | 7 | 0.9552 |
277 | Acidosis | 130 | 0.8121 |
278 | Acidosis, lactic | 9 | 0.8839 |
279 | Acidosis, metabolic | 45 | 0.8461 |
280 | Acid-sensing ion channel blocker | 6 | 0.8824 |
281 | ACK1 kinase inhibitor | 9 | 0.9333 |
282 | Acneiform eruption | 3 | 0.9468 |
283 | Aconitate decarboxylase inhibitor | 4 | 0.9960 |
284 | Aconitate hydratase inhibitor | 22 | 0.9919 |
285 | Acrocylindropepsin inhibitor | 3 | 0.8770 |
286 | Acrosin inhibitor | 20 | 0.9651 |
287 | Actin depolymerization stimulant | 8 | 0.9984 |
288 | Actin polymerization inhibitor | 5 | 1.0000 |
289 | Activin receptor-like kinase 4 inhibitor | 23 | 0.9998 |
290 | Acute neurologic disorders treatment | 1183 | 0.8103 |
291 | Acylaminoacyl-peptidase inhibitor | 25 | 0.9633 |
292 | Acylcarnitine hydrolase inhibitor | 3 | 0.9187 |
293 | Acyl-CoA dehydrogenase (NADP+) inhibitor | 19 | 0.9895 |
294 | Acyl-CoA dehydrogenase inhibitor | 15 | 0.9935 |
295 | Acyl-CoA hydrolase inhibitor | 44 | 0.9787 |
296 | Acyl-CoA oxidase inhibitor | 11 | 0.9143 |
297 | Acylglycerone-phosphate reductase inhibitor | 6 | 0.9857 |
298 | Acyl-lysine deacylase inhibitor | 3 | 0.9942 |
299 | Acyloxyacyl hydrolase inhibitor | 15 | 0.9862 |
300 | Acylphosphatase inhibitor | 13 | 0.9791 |
301 | ADAM inhibitor | 54 | 0.9970 |
302 | ADAM10 endopeptidase inhibitor | 125 | 0.9866 |
303 | Adamalysin inhibitor | 8 | 0.9967 |
304 | Adenine deaminase inhibitor | 10 | 0.9877 |
305 | Adenine nucleotide translocase inhibitor | 23 | 0.9632 |
306 | Adenine nucleotide translocator 1 inhibitor | 3 | 1.0000 |
307 | Adenine phosphoribosyltransferase inhibitor | 23 | 0.9948 |
308 | Adenomatous polyposis treatment | 10 | 0.9408 |
309 | Adenosine A1 receptor agonist | 273 | 0.9990 |
310 | Adenosine A1 receptor agonist enhancer | 10 | 1.0000 |
311 | Adenosine A1 receptor antagonist | 2623 | 0.9888 |
312 | Adenosine A2 receptor agonist | 239 | 0.9989 |
313 | Adenosine A2 receptor antagonist | 2819 | 0.9896 |
314 | Adenosine A2a receptor agonist | 216 | 0.9991 |
315 | Adenosine A2a receptor antagonist | 2091 | 0.9897 |
316 | Adenosine A2b receptor agonist | 17 | 0.9989 |
317 | Adenosine A2b receptor antagonist | 852 | 0.9931 |
318 | Adenosine A3 receptor agonist | 88 | 0.9980 |
319 | Adenosine A3 receptor antagonist | 1365 | 0.9803 |
320 | Adenosine deaminase inhibitor | 165 | 0.9838 |
321 | Adenosine kinase inhibitor | 334 | 0.9959 |
322 | Adenosine receptor agonist | 614 | 0.9947 |
323 | Adenosine receptor antagonist | 4310 | 0.9828 |
324 | Adenosine regulator | 3 | 0.9014 |
325 | Adenosine uptake inhibitor | 55 | 0.9995 |
326 | Adenosylhomocysteine nucleosidase inhibitor | 57 | 0.9999 |
327 | Adenosylmethionine cyclotransferase inhibitor | 12 | 0.9996 |
328 | Adenosylmethionine-8-amino-7-oxononanoate transaminase inhibitor | 12 | 0.9865 |
329 | Adenylate cyclase I inhibitor | 54 | 0.9969 |
330 | Adenylate cyclase I stimulant | 43 | 1.0000 |
331 | Adenylate cyclase inhibitor | 174 | 0.9497 |
332 | Adenylate cyclase stimulant | 89 | 0.9372 |
333 | Adenylate cyclase V inhibitor | 36 | 0.9598 |
334 | Adenylate kinase inhibitor | 23 | 0.9355 |
335 | Adenylosuccinate lyase inhibitor | 29 | 0.9961 |
336 | Adenylosuccinate synthase inhibitor | 60 | 0.9916 |
337 | Adenylyl-sulfate kinase inhibitor | 20 | 0.9723 |
338 | Adenylyl-sulfate reductase inhibitor | 5 | 0.8988 |
339 | Adenylylsulphatase inhibitor | 17 | 0.9808 |
340 | ADP-ribose diphosphatase inhibitor | 7 | 0.9978 |
341 | ADP-ribosylarginine hydrolase inhibitor | 6 | 0.9241 |
342 | ADP-thymidine kinase inhibitor | 5 | 0.9523 |
343 | Adrenal cortex hypoplasia | 3 | 0.9249 |
344 | Adrenaline agonist | 2055 | 0.9787 |
345 | Adrenaline antagonist | 6430 | 0.9718 |
346 | Adrenaline release stimulant | 8 | 0.9338 |
347 | Adrenaline uptake inhibitor | 2366 | 0.9878 |
348 | Adrenergic | 4509 | 0.9763 |
349 | Adrenergic, ophthalmic | 9 | 0.9917 |
350 | Aerobactin synthase inhibitor | 3 | 0.9912 |
351 | Agaritine gamma-glutamyltransferase inhibitor | 11 | 0.9903 |
352 | Age-related macular degeneration treatment | 51 | 0.8810 |
353 | Aggrecanase 1 inhibitor | 48 | 0.9768 |
354 | Aggrecanase 2 inhibitor | 117 | 0.9941 |
355 | Aggrecanase inhibitor | 310 | 0.9948 |
356 | Agmatinase inhibitor | 7 | 0.9243 |
357 | Agranulocytosis | 408 | 0.8408 |
358 | AgrC-1 protein inhibitor | 4 | 1.0000 |
359 | AgrC-2 protein inhibitor | 4 | 1.0000 |
360 | AICAR transformylase inhibitor | 39 | 0.9618 |
361 | Akathisia | 84 | 0.8463 |
362 | Alanine carboxypeptidase inhibitor | 10 | 0.9941 |
363 | Alanine dehydrogenase inhibitor | 27 | 0.9892 |
364 | Alanine racemase inhibitor | 12 | 0.9843 |
365 | Alanine transaminase inhibitor | 18 | 0.9862 |
366 | Alanine-tRNA ligase inhibitor | 6 | 0.9698 |
367 | Albendazole monooxygenase inhibitor | 3 | 0.9698 |
368 | Alcohol dehydrogenase (acceptor) inhibitor | 11 | 0.8721 |
369 | Alcohol dehydrogenase (NADP+) inhibitor | 45 | 0.9587 |
370 | Alcohol dehydrogenase [NAD(P)+] inhibitor | 16 | 0.9279 |
371 | Alcohol dehydrogenase alpha inhibitor | 12 | 1.0000 |
372 | Alcohol dehydrogenase beta 1 inhibitor | 7 | 1.0000 |
373 | Alcohol dehydrogenase beta inhibitor | 7 | 1.0000 |
374 | Alcohol dehydrogenase gamma 2 inhibitor | 6 | 0.9999 |
375 | Alcohol dehydrogenase gamma inhibitor | 6 | 0.9999 |
376 | Alcohol dehydrogenase I inhibitor | 14 | 1.0000 |
377 | Alcohol dehydrogenase inhibitor | 119 | 0.9569 |
378 | Alcohol dehydrogenase substrate | 71 | 0.9547 |
379 | Alcohol O-acetyltransferase inhibitor | 9 | 0.9079 |
380 | Alcohol oxidase inhibitor | 17 | 0.9888 |
381 | Aldehyde dehydrogenase (NAD+) inhibitor | 38 | 0.9602 |
382 | Aldehyde dehydrogenase (NADP+) inhibitor | 17 | 0.9668 |
383 | Aldehyde dehydrogenase (pyrroloquinoline-quinone) inhibitor | 7 | 0.8766 |
384 | Aldehyde dehydrogenase [NAD(P)+] inhibitor | 5 | 0.9924 |
385 | Aldehyde dehydrogenase 1 substrate | 8 | 0.9989 |
386 | Aldehyde dehydrogenase 1A2 inhibitor | 30 | 0.9946 |
387 | Aldehyde dehydrogenase 2 substrate | 6 | 0.8550 |
388 | Aldehyde dehydrogenase 3 substrate | 5 | 0.9987 |
389 | Aldehyde dehydrogenase inhibitor | 114 | 0.9600 |
390 | Aldehyde dehydrogenase substrate | 55 | 0.9595 |
391 | Aldehyde ferredoxin oxidoreductase inhibitor | 5 | 0.9886 |
392 | Aldehyde oxidase inhibitor | 27 | 0.8903 |
393 | Aldehyde oxidase substrate | 51 | 0.9422 |
394 | Aldose 1-epimerase inhibitor | 31 | 0.9932 |
395 | Aldose reductase 2 inhibitor | 88 | 0.9956 |
396 | Aldose reductase inhibitor | 803 | 0.9861 |
397 | Aldose reductase substrate | 11 | 0.9636 |
398 | Aldosterone antagonist | 58 | 0.8716 |
399 | ALK inhibitor | 121 | 0.9636 |
400 | Alkaline phosphatase inhibitor | 336 | 0.9569 |
401 | Alkanal monooxygenase (FMN-linked) inhibitor | 27 | 0.9583 |
402 | Alkane 1-monooxygenase inhibitor | 4 | 0.9508 |
403 | Alkene monooxygenase inhibitor | 3 | 0.9908 |
404 | Alkenylglycerophosphocholine hydrolase inhibitor | 5 | 0.9109 |
405 | Alkenylglycerophosphoethanolamine hydrolase inhibitor | 6 | 0.9306 |
406 | Alkylacetylglycerophosphatase inhibitor | 4 | 0.8816 |
407 | Alkylator | 562 | 0.9471 |
408 | Alkylglycerone-phosphate synthase inhibitor | 6 | 0.9804 |
409 | Alkylglycerophosphoethanolamine phosphodiesterase inhibitor | 5 | 0.9726 |
410 | Allantoate deiminase inhibitor | 3 | 0.9931 |
411 | Allantoicase inhibitor | 9 | 0.9897 |
412 | Allantoin racemase inhibitor | 4 | 0.9903 |
413 | Allantoinase inhibitor | 4 | 0.9927 |
414 | Allergic contact dermatitis | 93 | 0.8449 |
415 | Allergic dermatitis | 73 | 0.8531 |
416 | Allergic rhinitis treatment | 409 | 0.9643 |
417 | Allophanate hydrolase inhibitor | 5 | 0.9864 |
418 | All-trans-retinyl-palmitate hydrolase inhibitor | 4 | 0.9450 |
419 | Allyl-alcohol dehydrogenase inhibitor | 6 | 0.9827 |
420 | Alopecia treatment | 6 | 0.8647 |
421 | Alpha 1 adrenoreceptor agonist | 78 | 0.9922 |
422 | Alpha 1 adrenoreceptor antagonist | 3876 | 0.9781 |
423 | Alpha 1a adrenoreceptor agonist | 48 | 0.9997 |
424 | Alpha 1a adrenoreceptor antagonist | 3142 | 0.9824 |
425 | Alpha 1b adrenoreceptor antagonist | 1331 | 0.9832 |
426 | Alpha 1d adrenoreceptor antagonist | 1512 | 0.9854 |
427 | Alpha 1L adrenoreceptor agonist | 3 | 0.9933 |
428 | Alpha 1L adrenoreceptor antagonist | 11 | 0.9722 |
429 | Alpha 2 adrenoreceptor agonist | 337 | 0.9871 |
430 | Alpha 2 adrenoreceptor antagonist | 1608 | 0.9802 |
431 | Alpha 2a adrenoreceptor antagonist | 629 | 0.9809 |
432 | Alpha 2b adrenoreceptor agonist | 45 | 0.9992 |
433 | Alpha 2b adrenoreceptor antagonist | 420 | 0.9749 |
434 | Alpha 2c adrenoreceptor agonist | 45 | 0.9996 |
435 | Alpha 2c adrenoreceptor antagonist | 497 | 0.9778 |
436 | Alpha 2d adrenoreceptor agonist | 44 | 0.9984 |
437 | Alpha 2d adrenoreceptor antagonist | 94 | 0.9881 |
438 | Alpha 3 adrenoreceptor agonist | 5 | 0.9935 |
439 | Alpha adrenoreceptor agonist | 496 | 0.9798 |
440 | Alpha adrenoreceptor antagonist | 5126 | 0.9709 |
441 | Alpha galactosidase inhibitor | 16 | 0.9996 |
442 | Alpha glucosidase I inhibitor | 5 | 0.9999 |
443 | Alpha glucosidase II inhibitor | 8 | 1.0000 |
444 | Alpha glucosidase inhibitor | 115 | 0.9797 |
445 | Alpha,alpha-phosphotrehalase inhibitor | 5 | 0.9931 |
446 | Alpha,alpha-trehalase inhibitor | 20 | 0.9858 |
447 | Alpha,alpha-trehalose phosphorylase (configuration-retaining) inhibitor | 11 | 0.9946 |
448 | Alpha,alpha-trehalose phosphorylase inhibitor | 4 | 0.9986 |
449 | Alpha,alpha-trehalose-phosphate synthase (UDP-forming) inhibitor | 14 | 0.9690 |
450 | Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitor | 11 | 0.9985 |
451 | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitor | 3 | 0.9964 |
452 | Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase inhibitor | 4 | 0.9599 |
453 | Alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase inhibitor | 5 | 0.9913 |
454 | Alpha-amino-acid esterase inhibitor | 4 | 0.9991 |
455 | Alpha-amylase inhibitor | 28 | 0.9486 |
456 | Alpha-glucuronidase inhibitor | 4 | 0.9788 |
457 | Alpha-L-fucosidase inhibitor | 44 | 0.9906 |
458 | Alpha-L-rhamnosidase inhibitor | 11 | 0.9937 |
459 | Alpha-mannosidase inhibitor | 59 | 0.9852 |
460 | Alpha-Methylacyl-CoA racemase inhibitor | 8 | 0.9811 |
461 | Alpha-N-acetylgalactosaminidase inhibitor | 3 | 0.9947 |
462 | Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase inhibitor | 17 | 0.9957 |
463 | Alpha-N-acetylglucosaminidase inhibitor | 4 | 0.9797 |
464 | Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase inhibitor | 15 | 0.9973 |
465 | Alpha-N-arabinofuranosidase inhibitor | 9 | 0.9832 |
466 | Alpha-pinene-oxide decyclase inhibitor | 8 | 0.9879 |
467 | Alternansucrase inhibitor | 4 | 0.9976 |
468 | Altronate dehydratase inhibitor | 7 | 0.9989 |
469 | Alzheimer's disease treatment | 2493 | 0.8918 |
470 | Amidase inhibitor | 124 | 0.9737 |
471 | Amidophosphoribosyltransferase inhibitor | 25 | 0.9973 |
472 | Amiloride-sensitive cation channel 3 blocker | 7 | 1.0000 |
473 | Amine dehydrogenase inhibitor | 10 | 0.8736 |
474 | Amino acid-polyamine-organocation (APC) transporter antagonist | 82 | 0.9998 |
475 | Amino-acid N-acetyltransferase inhibitor | 25 | 0.9932 |
476 | Amino-acid racemase inhibitor | 6 | 0.9961 |
477 | Aminoacylase inhibitor | 19 | 0.9827 |
478 | Aminoacyl-tRNA hydrolase inhibitor | 5 | 0.9944 |
479 | Aminoacyl-tRNA synthetase inhibitor | 321 | 0.9748 |
480 | Aminobutyraldehyde dehydrogenase inhibitor | 3 | 0.8691 |
481 | Aminocarboxymuconate-semialdehyde decarboxylase inhibitor | 6 | 0.9885 |
482 | Aminoglycoside N6'-acetyltransferase inhibitor | 15 | 0.9997 |
483 | Aminolevulinate transaminase inhibitor | 26 | 0.9909 |
484 | Aminomuconate-semialdehyde dehydrogenase inhibitor | 4 | 0.9795 |
485 | Aminopeptidase A inhibitor | 55 | 0.9991 |
486 | Aminopeptidase B inhibitor | 45 | 0.9395 |
487 | Aminopeptidase I inhibitor | 26 | 0.9838 |
488 | Aminopeptidase microsomal inhibitor | 209 | 0.9787 |
489 | Aminopeptidase N inhibitor | 183 | 0.9820 |
490 | Aminopeptidase P inhibitor | 9 | 1.0000 |
491 | Aminopeptidase Y inhibitor | 8 | 0.9778 |
492 | AMP deaminase 2 inhibitor | 69 | 1.0000 |
493 | AMP deaminase 3 inhibitor | 21 | 0.9978 |
494 | AMP deaminase inhibitor | 103 | 0.9863 |
495 | AMP nucleosidase inhibitor | 15 | 0.9952 |
496 | AMPA 1 receptor antagonist | 681 | 0.9954 |
497 | AMPA 2 receptor antagonist | 452 | 0.9922 |
498 | AMPA 3 receptor antagonist | 437 | 0.9925 |
499 | AMPA 4 receptor antagonist | 222 | 0.9888 |
500 | AMPA 5 receptor antagonist | 4 | 1.0000 |
501 | AMPA receptor agonist | 72 | 0.9939 |
502 | AMPA receptor antagonist | 1317 | 0.9905 |
503 | Amylin agonist | 10 | 1.0000 |
504 | Amylo-alpha-1,6-glucosidase inhibitor | 26 | 0.9930 |
505 | Amyloid beta aggregation inhibitor | 39 | 0.9747 |
506 | Amyloid beta precursor protein antagonist | 295 | 0.9471 |
507 | Amylosucrase inhibitor | 5 | 0.9990 |
508 | Amyotrophic lateral sclerosis treatment | 180 | 0.9038 |
509 | Anabolic | 158 | 0.9603 |
510 | Analeptic | 234 | 0.8912 |
511 | Analgesic | 8418 | 0.8650 |
512 | Analgesic stimulant | 22 | 0.8677 |
513 | Analgesic, non-opioid | 6210 | 0.8827 |
514 | Anaphylatoxin receptor antagonist | 5 | 0.8968 |
515 | Androgen agonist | 219 | 0.9854 |
516 | Androgen antagonist | 1280 | 0.9821 |
517 | Andropause treatment | 85 | 0.9732 |
518 | Androst-4-ene-3,17-dione monooxygenase inhibitor | 9 | 0.9931 |
519 | Anemia | 228 | 0.8481 |
520 | Anemia, sideroblastic | 4 | 0.9738 |
521 | Anesthetic | 707 | 0.9413 |
522 | Anesthetic general | 151 | 0.9117 |
523 | Anesthetic inhalation | 20 | 0.9878 |
524 | Anesthetic local | 463 | 0.9611 |
525 | Angiogenesis inhibitor | 4489 | 0.9084 |
526 | Angiogenesis stimulant | 23 | 0.8636 |
527 | Angiotensin agonist | 12 | 0.9909 |
528 | Angiotensin antagonist | 3433 | 0.9894 |
529 | Angiotensin AT1 receptor antagonist | 3018 | 0.9897 |
530 | Angiotensin AT1A receptor antagonist | 973 | 0.9977 |
531 | Angiotensin AT2 receptor agonist | 7 | 0.9874 |
532 | Angiotensin AT2 receptor antagonist | 1039 | 0.9971 |
533 | Angiotensin II receptor agonist | 9 | 0.9259 |
534 | Angiotensin II receptor antagonist | 3407 | 0.9900 |
535 | Angiotensin-converting enzyme inhibitor | 694 | 0.9840 |
536 | Anhydrotetracycline monooxygenase inhibitor | 4 | 0.9959 |
537 | Anorexiant | 363 | 0.8281 |
538 | Anthranilate 3-monooxygenase (deaminating) inhibitor | 11 | 0.9584 |
539 | Anthranilate phosphoribosyltransferase inhibitor | 5 | 0.9966 |
540 | Anthranilate synthase inhibitor | 23 | 0.9848 |
541 | Anthranilate-CoA ligase inhibitor | 4 | 0.9820 |
542 | Anthrax lethal factor inhibitor | 61 | 0.9347 |
543 | Antiacne | 1202 | 0.9697 |
544 | Antiacromegalic | 71 | 0.9763 |
545 | Antiadrenergic | 6501 | 0.9702 |
546 | Antialcoholic | 121 | 0.9102 |
547 | Antiallergic | 6195 | 0.8818 |
548 | Antiamyloidogenic | 269 | 0.8962 |
549 | Antianemic | 182 | 0.9477 |
550 | Antianginal | 850 | 0.8299 |
551 | Antianorexic | 63 | 0.9316 |
552 | Antiarrhythmic | 2201 | 0.9347 |
553 | Antiarthritic | 9453 | 0.8648 |
554 | Antiasthmatic | 7609 | 0.8877 |
555 | Antibacterial | 6950 | 0.9192 |
556 | Antibacterial, ophthalmic | 11 | 0.9146 |
557 | Antibiotic | 3481 | 0.9682 |
558 | Antibiotic Aminoglycoside-like | 48 | 0.9685 |
559 | Antibiotic Anthracycline-like | 7 | 0.9622 |
560 | Antibiotic beta Lactam-like | 768 | 0.9951 |
561 | Antibiotic Carbacephem-like | 22 | 0.9998 |
562 | Antibiotic Carbapenem-like | 153 | 0.9987 |
563 | Antibiotic Cephalosporin-like | 348 | 0.9996 |
564 | Antibiotic Glycopeptide-like | 32 | 0.9809 |
565 | Antibiotic Isocephem-like | 7 | 1.0000 |
566 | Antibiotic Macrolide-like | 584 | 0.9982 |
567 | Antibiotic Naphthyridine-like | 30 | 0.9997 |
568 | Antibiotic Oxacephem-like | 12 | 0.9992 |
569 | Antibiotic Oxazolidinone-like | 90 | 0.9900 |
570 | Antibiotic Penem-like | 41 | 0.9999 |
571 | Antibiotic Penicillin-like | 50 | 0.9998 |
572 | Antibiotic Quinolone-like | 305 | 0.9918 |
573 | Antibiotic Rifamycin-like | 64 | 1.0000 |
574 | Antibiotic Tetracycline-like | 12 | 0.9807 |
575 | Antibiotic Tribactam-like | 17 | 1.0000 |
576 | Antibiotic Trimethoprim-like | 10 | 0.9998 |
577 | Anticarcinogenic | 368 | 0.9080 |
578 | Anticataract | 63 | 0.9497 |
579 | Anticholelithogenic | 41 | 0.9784 |
580 | Anticoagulant | 2397 | 0.9489 |
581 | Anticonvulsant | 1466 | 0.8832 |
582 | Antidepressant | 8006 | 0.9193 |
583 | Antidepressant, Imipramin-like | 87 | 0.9574 |
584 | Antidiabetic | 11530 | 0.8929 |
585 | Antidiabetic (type 1) | 102 | 0.9315 |
586 | Antidiabetic (type 2) | 2835 | 0.9415 |
587 | Antidiabetic symptomatic | 713 | 0.8985 |
588 | Antidiarrheal | 256 | 0.9030 |
589 | Antidiuretic hormone agonist | 151 | 0.9975 |
590 | Antidiuretic hormone antagonist | 1247 | 0.9947 |
591 | Antidote | 122 | 0.9318 |
592 | Antidote, heavy metal | 48 | 0.9819 |
593 | Antidote, organophosphates | 4 | 1.0000 |
594 | Antidyskinetic | 22 | 0.8011 |
595 | Antieczematic | 8 | 0.8230 |
596 | Antieczematic atopic | 333 | 0.8924 |
597 | Antiemetic | 1023 | 0.9583 |
598 | Antiemphysemic | 209 | 0.9475 |
599 | Antiepileptic | 2456 | 0.9294 |
600 | Antifibrinolytic | 17 | 0.8457 |
601 | Antifungal | 2087 | 0.9119 |
602 | Antifungal (Pneumocystis) | 9 | 0.9701 |
603 | Antifungal enhancer | 20 | 0.9556 |
604 | Antiglaucomic | 1378 | 0.9431 |
605 | Anti-Helicobacter pylori | 143 | 0.9031 |
606 | Antihelmintic | 461 | 0.9298 |
607 | Antihelmintic (Fasciola) | 5 | 0.9673 |
608 | Antihelmintic (Nematodes) | 56 | 0.8950 |
609 | Antihematotoxic | 31 | 0.8984 |
610 | Antihemorrhagic | 16 | 0.9462 |
611 | Antihistaminic | 2969 | 0.9525 |
612 | Antihyperaldosteronism | 81 | 0.9986 |
613 | Antihyperammonemic | 3 | 0.9980 |
614 | Antihypercholesterolemic | 248 | 0.9262 |
615 | Antihyperlipoproteinemic | 83 | 0.9553 |
616 | Antihypermotility | 77 | 0.9533 |
617 | Antihypertensive | 7874 | 0.9007 |
618 | Antihypertriglyceridemic | 137 | 0.9709 |
619 | Antihypotensive | 38 | 0.9002 |
620 | Antihypoxic | 38 | 0.8663 |
621 | Antiinfective | 178 | 0.8682 |
622 | Antiinfertility, female | 67 | 0.9257 |
623 | Antiinflammatory | 5983 | 0.8384 |
624 | Antiinflammatory steroid | 3 | 0.9999 |
625 | Antiinflammatory, intestinal | 9 | 0.9114 |
626 | Antiinflammatory, ophthalmic | 51 | 0.8549 |
627 | Antiischemic | 2210 | 0.8978 |
628 | Antiischemic, cerebral | 439 | 0.7724 |
629 | Antileprosy | 56 | 0.9390 |
630 | Antileukemic | 4964 | 0.9392 |
631 | Antimetabolite | 732 | 0.9877 |
632 | Antimetastatic | 20 | 0.8854 |
633 | Antimigraine | 1980 | 0.9437 |
634 | Antimitotic | 1925 | 0.9426 |
635 | Antimitotic, Podophyllotoxin-like | 3 | 0.9996 |
636 | Antimutagenic | 34 | 0.9587 |
637 | Antimycobacterial | 726 | 0.8861 |
638 | Antimycoplasmal | 37 | 0.9353 |
639 | Antimyopathies | 6 | 0.8705 |
640 | Antinaupathic | 17 | 0.9496 |
641 | Antineoplastic | 49620 | 0.8600 |
642 | Antineoplastic (bladder cancer) | 330 | 0.9195 |
643 | Antineoplastic (bone cancer) | 68 | 0.8915 |
644 | Antineoplastic (brain cancer) | 512 | 0.8931 |
645 | Antineoplastic (breast cancer) | 5569 | 0.9292 |
646 | Antineoplastic (carcinoma) | 1904 | 0.9626 |
647 | Antineoplastic (cervical cancer) | 2035 | 0.9598 |
648 | Antineoplastic (colon cancer) | 5457 | 0.9519 |
649 | Antineoplastic (colorectal cancer) | 5654 | 0.9465 |
650 | Antineoplastic (endocrine cancer) | 167 | 0.9092 |
651 | Antineoplastic (gastric cancer) | 541 | 0.9393 |
652 | Antineoplastic (glioblastoma multiforme) | 347 | 0.9156 |
653 | Antineoplastic (glioma) | 497 | 0.9348 |
654 | Antineoplastic (insulinoma) | 44 | 0.9999 |
655 | Antineoplastic (liver cancer) | 363 | 0.9181 |
656 | Antineoplastic (lung cancer) | 2975 | 0.9384 |
657 | Antineoplastic (lymphocytic leukemia) | 2803 | 0.9570 |
658 | Antineoplastic (lymphoma) | 979 | 0.9355 |
659 | Antineoplastic (melanoma) | 1397 | 0.9377 |
660 | Antineoplastic (multiple myeloma) | 199 | 0.8722 |
661 | Antineoplastic (non-Hodgkin's lymphoma) | 73 | 0.8131 |
662 | Antineoplastic (non-small cell lung cancer) | 872 | 0.9146 |
663 | Antineoplastic (ovarian cancer) | 2006 | 0.9504 |
664 | Antineoplastic (pancreatic cancer) | 312 | 0.8817 |
665 | Antineoplastic (renal cancer) | 466 | 0.9247 |
666 | Antineoplastic (sarcoma) | 320 | 0.9122 |
667 | Antineoplastic (small cell lung cancer) | 186 | 0.8764 |
668 | Antineoplastic (solid tumors) | 709 | 0.8687 |
669 | Antineoplastic (squamous cell carcinoma) | 1226 | 0.9673 |
670 | Antineoplastic (thyroid cancer) | 59 | 0.9074 |
671 | Antineoplastic (uterine cancer) | 139 | 0.9374 |
672 | Antineoplastic alkaloid | 23 | 0.9106 |
673 | Antineoplastic antibiotic | 1599 | 0.9783 |
674 | Antineoplastic antimetabolite | 166 | 0.9507 |
675 | Antineoplastic enhancer | 774 | 0.9081 |
676 | Antineoplastic, alkylator | 118 | 0.9671 |
677 | Antinephritic | 83 | 0.8514 |
678 | Antineurogenic pain | 561 | 0.8844 |
679 | Antineurotic | 47 | 0.8063 |
680 | Antinociceptive | 41 | 0.8573 |
681 | Antiobesity | 7769 | 0.9117 |
682 | Antiosteoporotic | 2666 | 0.9266 |
683 | Antioxidant | 843 | 0.9388 |
684 | Antiparasitic | 605 | 0.9272 |
685 | Antiparkinsonian | 2768 | 0.8938 |
686 | Antiparkinsonian, rigidity relieving | 37 | 0.9269 |
687 | Antiparkinsonian, tremor relieving | 114 | 0.9430 |
688 | Antiperistaltic | 10 | 0.9467 |
689 | Antiprotozoal | 2191 | 0.9152 |
690 | Antiprotozoal (Amoeba) | 88 | 0.8685 |
691 | Antiprotozoal (Babesia) | 5 | 0.9739 |
692 | Antiprotozoal (Coccidial) | 98 | 0.9027 |
693 | Antiprotozoal (Histomonas) | 7 | 0.9963 |
694 | Antiprotozoal (Leishmania) | 151 | 0.8793 |
695 | Antiprotozoal (Plasmodium) | 1322 | 0.9382 |
696 | Antiprotozoal (Toxoplasma) | 21 | 0.9204 |
697 | Antiprotozoal (Trichomonas) | 89 | 0.9183 |
698 | Antiprotozoal (Trypanosoma) | 225 | 0.8786 |
699 | Antiprotozoal activity enhancer | 5 | 1.0000 |
700 | Antipruritic | 268 | 0.8756 |
701 | Antipruritic, allergic | 146 | 0.8504 |
702 | Antipruritic, non-allergic | 68 | 0.9386 |
703 | Antipsoriatic | 1771 | 0.8972 |
704 | Antipsychotic | 6680 | 0.9291 |
705 | Antipyretic | 410 | 0.9186 |
706 | Antirickettsial | 18 | 0.9426 |
707 | Antischistosomal | 39 | 0.9434 |
708 | Antiseborrheic | 10 | 0.9069 |
709 | Antisecretoric | 192 | 0.9073 |
710 | Antiseptic | 170 | 0.9572 |
711 | Antismoking | 189 | 0.9738 |
712 | Antispirochetal | 35 | 0.9629 |
713 | Antithrombocytopenic | 144 | 0.9803 |
714 | Antithrombotic | 557 | 0.8755 |
715 | Antithyroid | 40 | 0.9460 |
716 | Antitoxic | 145 | 0.9049 |
717 | Antitreponemal | 8 | 0.9194 |
718 | Antituberculosic | 434 | 0.8837 |
719 | Antitussive | 247 | 0.9355 |
720 | Antitussive, narcotic | 35 | 0.9677 |
721 | Antiulcerative | 893 | 0.8868 |
722 | Antiuremic | 39 | 0.9324 |
723 | Antiviral | 11347 | 0.9180 |
724 | Antiviral (Adenovirus) | 23 | 0.8787 |
725 | Antiviral (CMV) | 15 | 0.8695 |
726 | Antiviral (Hepatitis B) | 53 | 0.9037 |
727 | Antiviral (Hepatitis C) | 1472 | 0.9647 |
728 | Antiviral (Hepatitis) | 1753 | 0.9559 |
729 | Antiviral (Herpes) | 142 | 0.8940 |
730 | Antiviral (Herpesvirus 3, Human) | 7 | 1.0000 |
731 | Antiviral (HIV) | 7050 | 0.9475 |
732 | Antiviral (Influenza A) | 31 | 0.8733 |
733 | Antiviral (Influenza) | 150 | 0.8826 |
734 | Antiviral (Parainfluenza) | 5 | 0.9999 |
735 | Antiviral (Picornavirus) | 31 | 0.8105 |
736 | Antiviral (Poxvirus) | 41 | 0.9041 |
737 | Antiviral (Rhinovirus) | 13 | 0.8066 |
738 | Antiviral (Trachoma) | 12 | 0.9872 |
739 | Anxiolytic | 8121 | 0.9103 |
740 | Apical sodium codependent bile acid transporter inhibitor | 16 | 1.0000 |
741 | Apnea | 24 | 0.8961 |
742 | APOA1 expression enhancer | 17 | 0.8257 |
743 | Apolipoprotein A inhibitor | 71 | 1.0000 |
744 | Apolipoprotein B inhibitor | 225 | 0.9955 |
745 | Apolipoprotein B-100 inhibitor | 50 | 0.9985 |
746 | Apoptosis agonist | 1299 | 0.8655 |
747 | Apoptosis antagonist | 248 | 0.9008 |
748 | Apyrase inhibitor | 17 | 0.8180 |
749 | AR expression inhibitor | 31 | 0.8773 |
750 | Arabinogalactan endo-1,4-beta-galactosidase inhibitor | 4 | 0.9982 |
751 | Arabinose isomerase inhibitor | 7 | 0.9934 |
752 | Arabinose-5-phosphate isomerase inhibitor | 4 | 0.9997 |
753 | Arachidonate-CoA ligase inhibitor | 7 | 0.9987 |
754 | Arachidonic acid antagonist | 93 | 0.9438 |
755 | Aralkylamine dehydrogenase inhibitor | 6 | 0.9992 |
756 | Aralkylamine N-acetyltransferase inhibitor | 16 | 0.9885 |
757 | Arginase inhibitor | 34 | 0.9930 |
758 | Arginine 2-monooxygenase inhibitor | 4 | 0.8953 |
759 | Arginine decarboxylase inhibitor | 38 | 0.9845 |
760 | Arginine deiminase inhibitor | 22 | 0.9473 |
761 | Arginine kinase inhibitor | 12 | 0.9951 |
762 | Arginine N-succinyltransferase inhibitor | 3 | 0.9997 |
763 | Arginine racemase inhibitor | 3 | 0.9994 |
764 | Arginine-tRNA ligase inhibitor | 17 | 0.9942 |
765 | Argininosuccinate lyase inhibitor | 10 | 0.9937 |
766 | Argininosuccinate synthase inhibitor | 21 | 0.9886 |
767 | Arginyltransferase inhibitor | 6 | 0.9938 |
768 | Aromatase inhibitor | 1202 | 0.9909 |
769 | Aromatic-amino-acid transaminase inhibitor | 14 | 0.9887 |
770 | Aromatic-hydroxylamine O-acetyltransferase inhibitor | 7 | 0.8507 |
771 | Aryl hydrocarbon receptor agonist | 12 | 0.9209 |
772 | Aryl hydrocarbon receptor antagonist | 57 | 0.9776 |
773 | Aryl sulfotransferase inhibitor | 30 | 0.9516 |
774 | Arylacetonitrilase inhibitor | 11 | 0.9642 |
775 | Aryl-acylamidase inhibitor | 35 | 0.9218 |
776 | Aryl-alcohol dehydrogenase (NADP+) inhibitor | 7 | 0.9854 |
777 | Aryl-alcohol dehydrogenase inhibitor | 10 | 0.9854 |
778 | Aryl-aldehyde dehydrogenase (NADP+) inhibitor | 6 | 0.9908 |
779 | Arylalkyl acylamidase inhibitor | 6 | 0.9881 |
780 | Arylamine N-acetyltransferase inhibitor | 33 | 0.9439 |
781 | Arylamine N-Acetyltransferase substrate | 103 | 0.9854 |
782 | Aryldialkylphosphatase inhibitor | 5 | 0.9838 |
783 | Arylesterase inhibitor | 9 | 0.9351 |
784 | Arylformamidase inhibitor | 28 | 0.9840 |
785 | Arylmalonate decarboxylase inhibitor | 3 | 0.9727 |
786 | Arylsulfatase inhibitor | 22 | 0.9741 |
787 | Arylsulfate sulfotransferase inhibitor | 7 | 0.9093 |
788 | Asparaginase inhibitor | 19 | 0.9648 |
789 | Asparagine synthase (glutamine-hydrolysing) inhibitor | 81 | 0.9935 |
790 | Asparagine-oxo-acid transaminase inhibitor | 17 | 0.9947 |
791 | Asparagine-tRNA ligase inhibitor | 6 | 0.9901 |
792 | Asparaginyl endopeptidase inhibitor | 54 | 0.9924 |
793 | Aspartate 1-decarboxylase inhibitor | 7 | 0.9958 |
794 | Aspartate 4-decarboxylase inhibitor | 19 | 0.9832 |
795 | Aspartate ammonia-lyase inhibitor | 26 | 0.9946 |
796 | Aspartate carbamoyltransferase inhibitor | 26 | 0.9858 |
797 | Aspartate kinase inhibitor | 24 | 0.9516 |
798 | Aspartate N-acetyltransferase inhibitor | 3 | 0.9999 |
799 | Aspartate racemase inhibitor | 4 | 0.9942 |
800 | Aspartate transaminase inhibitor | 21 | 0.9848 |
801 | Aspartate-ammonia ligase (ADP-forming) inhibitor | 4 | 0.9937 |
802 | Aspartate-ammonia ligase inhibitor | 3 | 0.9764 |
803 | Aspartate-phenylpyruvate transaminase inhibitor | 4 | 0.8708 |
804 | Aspartate-semialdehyde dehydrogenase inhibitor | 13 | 0.9928 |
805 | Aspartate-tRNA ligase inhibitor | 6 | 0.9855 |
806 | Aspartoacylase inhibitor | 4 | 0.9852 |
807 | Aspartyl aminopeptidase inhibitor | 8 | 0.9886 |
808 | Aspartyl protease inhibitor | 3 | 1.0000 |
809 | Aspartyltransferase inhibitor | 4 | 0.8491 |
810 | Aspergillopepsin I inhibitor | 8 | 0.9302 |
811 | Aspergillopepsin II inhibitor | 4 | 0.9479 |
812 | Aspergillus nuclease S1 inhibitor | 8 | 0.9495 |
813 | Aspulvinone dimethylallyltransferase inhibitor | 3 | 0.8428 |
814 | Assemblin inhibitor | 7 | 0.9949 |
815 | Astacin inhibitor | 19 | 0.9851 |
816 | Asthma | 202 | 0.7902 |
817 | Astringent | 11 | 0.9907 |
818 | Ataxia | 433 | 0.8297 |
819 | Atherosclerosis treatment | 3679 | 0.8892 |
820 | ATM kinase inhibitor | 74 | 0.9833 |
821 | ATP adenylyltransferase inhibitor | 7 | 0.9853 |
822 | ATP citrate lysase inhibitor | 47 | 0.9963 |
823 | ATP citrate synthase inhibitor | 20 | 0.9966 |
824 | ATP deaminase inhibitor | 5 | 0.9970 |
825 | ATP diphosphatase inhibitor | 4 | 0.9954 |
826 | ATP phosphoribosyltransferase inhibitor | 16 | 0.9237 |
827 | ATPase (Mitochondrial F1F0) inhibitor | 17 | 0.9998 |
828 | ATPase (Vacuolar H+) inhibitor | 73 | 0.9929 |
829 | ATPase inhibitor | 150 | 0.9327 |
830 | ATPase stimulant | 18 | 0.8749 |
831 | ATP-binding cassette A1 stimulant | 3 | 0.9529 |
832 | ATP-dependent RNA helicase inhibitor | 10 | 1.0000 |
833 | Atrolysin A inhibitor | 11 | 0.9515 |
834 | Atrolysin C inhibitor | 10 | 0.9811 |
835 | Attention deficit/hyperactivity disorder treatment | 666 | 0.9741 |
836 | Aureolysin inhibitor | 4 | 0.9838 |
837 | Aurora kinase inhibitor | 999 | 0.9818 |
838 | Aurora-A kinase inhibitor | 600 | 0.9823 |
839 | Aurora-B kinase inhibitor | 504 | 0.9851 |
840 | Aurora-C kinase inhibitor | 46 | 0.9655 |
841 | Autoimmune disorders treatment | 3972 | 0.8791 |
842 | Autophagy inducer | 3 | 0.9338 |
843 | Autotaxin inhibitor | 50 | 0.9734 |
844 | AXL receptor tyrosine kinase inhibitor | 40 | 0.9419 |
845 | Azobenzene reductase inhibitor | 5 | 0.9855 |
846 | Bacillus subtilis ribonuclease inhibitor | 6 | 0.9963 |
847 | Bacterial efflux pump inhibitor | 16 | 0.9125 |
848 | Bacterial leucyl aminopeptidase inhibitor | 29 | 0.9931 |
849 | Baculoviral IAP repeat-containing protein 4 inhibitor | 118 | 0.9914 |
850 | Baculoviral IAP repeat-containing protein inhibitor | 162 | 0.9915 |
851 | Bcl2 antagonist | 134 | 0.9300 |
852 | Bcl-xL inhibitor | 120 | 0.9815 |
853 | Bcr-Abl kinase inhibitor | 91 | 0.9502 |
854 | Behavioral disturbance | 1535 | 0.8342 |
855 | Benzaldehyde dehydrogenase (NAD+) inhibitor | 8 | 0.9941 |
856 | Benzaldehyde dehydrogenase (NADP+) inhibitor | 3 | 0.9776 |
857 | Benzoate 4-monooxygenase inhibitor | 19 | 0.9384 |
858 | Benzoate-CoA ligase inhibitor | 6 | 0.8950 |
859 | Benzodiazepine antagonist | 455 | 0.9885 |
860 | Benzodiazepine inverse agonist | 59 | 0.9912 |
861 | Benzodiazepine receptor peripheral-type antagonist | 425 | 0.9967 |
862 | Benzoin aldolase inhibitor | 3 | 0.9997 |
863 | Benzoylformate decarboxylase inhibitor | 9 | 0.8942 |
864 | Beta 1 adrenoreceptor agonist | 49 | 0.9764 |
865 | Beta 1 adrenoreceptor antagonist | 677 | 0.9888 |
866 | Beta 2 adrenoreceptor agonist | 683 | 0.9948 |
867 | Beta 2 adrenoreceptor antagonist | 670 | 0.9897 |
868 | Beta 3 adrenoreceptor agonist | 772 | 0.9969 |
869 | Beta 3 adrenoreceptor antagonist | 156 | 0.9876 |
870 | Beta adrenoreceptor agonist | 1554 | 0.9884 |
871 | Beta adrenoreceptor antagonist | 1418 | 0.9818 |
872 | Beta amyloid protein antagonist | 122 | 0.9730 |
873 | Beta galactosidase inhibitor | 81 | 0.9935 |
874 | Beta glucosidase inhibitor | 22 | 0.9982 |
875 | Beta glucuronidase inhibitor | 15 | 0.8693 |
876 | Beta lactamase II inhibitor | 18 | 1.0000 |
877 | Beta lactamase Imi-1 inhibitor | 5 | 0.9992 |
878 | Beta lactamase inhibitor | 437 | 0.9626 |
879 | Beta lactamase TEM-1 inhibitor | 42 | 0.9994 |
880 | Beta tubulin antagonist | 478 | 0.9907 |
881 | Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase inhibitor | 13 | 0.9933 |
882 | Beta-adrenergic receptor kinase inhibitor | 22 | 0.8262 |
883 | Beta-alanine-pyruvate transaminase inhibitor | 3 | 0.9893 |
884 | Beta-amylase inhibitor | 9 | 0.9940 |
885 | Beta-carotene 15,15'-monooxygenase inhibitor | 17 | 0.9417 |
886 | Beta-cyclopiazonate dehydrogenase inhibitor | 7 | 0.9829 |
887 | Beta-D-fucosidase inhibitor | 20 | 0.9895 |
888 | Beta-fructofuranosidase inhibitor | 43 | 0.9914 |
889 | Beta-galactoside alpha-2,3-sialyltransferase inhibitor | 10 | 0.9985 |
890 | Beta-glucosidase inhibitor | 59 | 0.9887 |
891 | Betaine-aldehyde dehydrogenase inhibitor | 18 | 0.9926 |
892 | Betaine-homocysteine S-methyltransferase inhibitor | 9 | 0.9982 |
893 | Beta-Lysine 5,6-aminomutase inhibitor | 4 | 0.9975 |
894 | Beta-mannosidase inhibitor | 10 | 0.9863 |
895 | Beta-N-acetylgalactosaminidase inhibitor | 3 | 0.9845 |
896 | Beta-N-acetylhexosaminidase inhibitor | 43 | 0.9803 |
897 | Beta-Phosphoglucomutase inhibitor | 5 | 0.9990 |
898 | Beta-ureidopropionase inhibitor | 16 | 0.9702 |
899 | Bile-salt sulfotransferase inhibitor | 4 | 0.9867 |
900 | Biliary tract disorders treatment | 94 | 0.8916 |
901 | Bilirubin oxidase inhibitor | 9 | 0.9172 |
902 | Biliverdin reductase inhibitor | 11 | 0.9936 |
903 | Biotin carboxylase inhibitor | 4 | 0.9862 |
904 | Biotin-[methylmalonyl-CoA-carboxytransferase] ligase inhibitor | 4 | 0.9996 |
905 | Biotin-[propionyl-CoA-carboxylase (ATP-hydrolysing)] ligase inhibitor | 3 | 0.9783 |
906 | Biotin-CoA ligase inhibitor | 3 | 0.9894 |
907 | Biotinidase inhibitor | 8 | 0.8388 |
908 | Biphenyl-2,3-diol 1,2-dioxygenase inhibitor | 15 | 0.9906 |
909 | Bipolar disorder treatment | 192 | 0.9633 |
910 | Bis(5'-adenosyl)-triphosphatase inhibitor | 4 | 0.9908 |
911 | Bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) inhibitor | 12 | 0.9960 |
912 | Bis(5'-nucleosyl)-tetraphosphatase (symmetrical) inhibitor | 11 | 0.9964 |
913 | Bisphosphoglycerate mutase inhibitor | 4 | 0.9843 |
914 | Bisphosphoglycerate phosphatase inhibitor | 5 | 0.9697 |
915 | Bisphosphonate | 55 | 0.9996 |
916 | Blasticidin-S deaminase inhibitor | 4 | 0.9776 |
917 | Bombesin 1 receptor antagonist | 10 | 0.9934 |
918 | Bombesin 2 receptor antagonist | 19 | 0.9812 |
919 | Bombesin 3 receptor agonist | 24 | 0.9948 |
920 | Bombesin agonist | 25 | 0.9960 |
921 | Bombesin antagonist | 148 | 0.9888 |
922 | Bone diseases treatment | 3281 | 0.9229 |
923 | Bone formation stimulant | 476 | 0.9203 |
924 | Bone morphogenic protein 1 inhibitor | 146 | 0.9997 |
925 | Bone morphogenic protein inhibitor | 148 | 0.9989 |
926 | Bontoxilysin inhibitor | 6 | 0.9511 |
927 | Bothrolysin inhibitor | 3 | 0.9824 |
928 | Botulin neurotoxin A light chain inhibitor | 11 | 0.8695 |
929 | Botulinum neurotoxin type B inhibitor | 8 | 1.0000 |
930 | Brachyurin inhibitor | 8 | 0.9774 |
931 | Bradycardic | 275 | 0.8012 |
932 | Bradykinin agonist | 15 | 0.9991 |
933 | Bradykinin antagonist | 1208 | 0.9957 |
934 | Bradykinin B1 receptor agonist | 6 | 1.0000 |
935 | Bradykinin B1 receptor antagonist | 568 | 0.9972 |
936 | Bradykinin B2 receptor agonist | 9 | 0.9997 |
937 | Bradykinin B2 receptor antagonist | 545 | 0.9990 |
938 | BRAF expression inhibitor | 4 | 0.9900 |
939 | Branched-chain-amino-acid transaminase inhibitor | 21 | 0.9943 |
940 | Breast cancer-resistant protein inhibitor | 39 | 0.9778 |
941 | Bronchoconstrictor | 198 | 0.8132 |
942 | Bronchodilator | 1813 | 0.9585 |
943 | Bruton tyrosine kinase inhibitor | 70 | 0.9609 |
944 | Bulimia treatment | 103 | 0.9973 |
945 | Bullous pemphigoid | 8 | 0.9616 |
946 | Butyrate-CoA ligase inhibitor | 10 | 0.9885 |
947 | Butyrylcholinesterase inhibitor | 952 | 0.9890 |
948 | Butyrylcholinesterase stimulant | 3 | 0.9992 |
949 | Butyryl-CoA dehydrogenase inhibitor | 9 | 0.9963 |
950 | Ca(v)2.2 blocker | 344 | 0.9835 |
951 | Ca2+/calmodulin-dependent kinase I inhibitor | 18 | 0.9146 |
952 | Ca2+/calmodulin-dependent kinase II inhibitor | 86 | 0.9606 |
953 | Ca2+/calmodulin-dependent protein kinase inhibitor | 96 | 0.9198 |
954 | Ca2+-transporting ATPase inhibitor | 12 | 0.8608 |
955 | Cachexia treatment | 140 | 0.9415 |
956 | Cadherin antagonist | 3 | 0.9996 |
957 | Calcineurin inhibitor | 13 | 0.9996 |
958 | Calcitonin gene-related peptide 1 receptor antagonist | 256 | 0.9968 |
959 | Calcitonin gene-related peptide antagonist | 649 | 0.9962 |
960 | Calcitonin stimulant | 17 | 0.9664 |
961 | Calcium antagonist | 72 | 0.9576 |
962 | Calcium channel (voltage-sensitive) activator | 6 | 0.8068 |
963 | Calcium channel (voltage-sensitive) blocker | 2248 | 0.9617 |
964 | Calcium channel activator | 49 | 0.9153 |
965 | Calcium channel blocker | 4357 | 0.9548 |
966 | Calcium channel L-type blocker | 1379 | 0.9857 |
967 | Calcium channel N-type blocker | 623 | 0.9510 |
968 | Calcium channel T-type blocker | 344 | 0.9834 |
969 | Calcium regulator | 259 | 0.8387 |
970 | Calcium release-activated channel blocker | 51 | 0.9967 |
971 | Calcium-sensing receptor agonist | 5 | 0.9847 |
972 | Calcium-sensing receptor antagonist | 87 | 0.9924 |
973 | Calpain inhibitor | 863 | 0.9326 |
974 | Camphor 1,2-monooxygenase inhibitor | 4 | 0.9845 |
975 | Cancer associated disorders treatment | 49 | 0.8612 |
976 | Cancer procoagulant inhibitor | 11 | 0.9750 |
977 | Candidapepsin 2 inhibitor | 10 | 0.9999 |
978 | Candidapepsin inhibitor | 17 | 0.9723 |
979 | Cannabinoid receptor antagonist | 1962 | 0.9902 |
980 | Capillary fragility treatment | 18 | 0.9700 |
981 | Carbamoyl-phosphate synthase (ammonia) inhibitor | 15 | 0.9903 |
982 | Carbamoyl-serine ammonia-lyase inhibitor | 3 | 0.9990 |
983 | Carbonic anhydrase I inhibitor | 812 | 0.9989 |
984 | Carbonic anhydrase I stimulant | 56 | 0.9995 |
985 | Carbonic anhydrase II inhibitor | 1211 | 0.9981 |
986 | Carbonic anhydrase II stimulant | 59 | 0.9929 |
987 | Carbonic anhydrase inhibitor | 1344 | 0.9976 |
988 | Carbonic anhydrase IV inhibitor | 810 | 0.9989 |
989 | Carbonic anhydrase IV stimulant | 50 | 0.9999 |
990 | Carbonic anhydrase IX inhibitor | 156 | 0.9990 |
991 | Carbonic anhydrase stimulant | 74 | 0.9912 |
992 | Carbonic anhydrase V inhibitor | 75 | 0.9905 |
993 | Carbonic anhydrase VII inhibitor | 22 | 0.9985 |
994 | Carbonic anhydrase XII inhibitor | 34 | 0.9993 |
995 | Carbonic anhydrase XIV inhibitor | 18 | 0.9792 |
996 | Carbonic anhydrase XV inhibitor | 3 | 1.0000 |
997 | Carbon-monoxide dehydrogenase inhibitor | 3 | 0.9756 |
998 | Carboxy-cis,cis-muconate cyclase inhibitor | 19 | 0.9979 |
999 | Carboxycyclohexadienyl dehydratase inhibitor | 5 | 0.9999 |
1000 | Carboxylate reductase inhibitor | 6 | 0.9976 |
1001 | Carboxylesterase inhibitor | 43 | 0.9798 |
1002 | Carboxymethylenebutenolidase inhibitor | 3 | 0.9944 |
1003 | Carboxypeptidase B inhibitor | 39 | 0.9958 |
1004 | Carboxypeptidase D inhibitor | 9 | 0.9528 |
1005 | Carboxypeptidase E inhibitor | 21 | 0.9448 |
1006 | Carboxypeptidase M inhibitor | 6 | 0.9960 |
1007 | Carboxypeptidase Taq inhibitor | 3 | 0.9263 |
1008 | Carboxypeptidase U inhibitor | 17 | 0.9934 |
1009 | Carcinogenic | 1813 | 0.9329 |
1010 | Carcinogenic, group 1 | 23 | 0.8685 |
1011 | Carcinogenic, group 2A | 36 | 0.9549 |
1012 | Carcinogenic, group 2B | 194 | 0.9602 |
1013 | Carcinogenic, group 3 | 387 | 0.9479 |
1014 | Carcinogenic, mouse | 456 | 0.9210 |
1015 | Carcinogenic, mouse, female | 384 | 0.9152 |
1016 | Carcinogenic, mouse, male | 365 | 0.9298 |
1017 | Carcinogenic, rat | 603 | 0.9314 |
1018 | Carcinogenic, rat, female | 445 | 0.9249 |
1019 | Carcinogenic, rat, male | 511 | 0.9305 |
1020 | Cardiac myosin stimulant | 4 | 1.0000 |
1021 | Cardiodepressant | 160 | 0.9148 |
1022 | Cardioprotectant | 187 | 0.8845 |
1023 | Cardiotonic | 3225 | 0.8896 |
1024 | Cardiovascular analeptic | 18 | 0.9339 |
1025 | Carminative | 4 | 0.9778 |
1026 | Carnitinamidase inhibitor | 7 | 0.9571 |
1027 | Carnitine 3-dehydrogenase inhibitor | 11 | 0.9846 |
1028 | Carnitine dehydratase inhibitor | 4 | 0.9921 |
1029 | Carnitine O-octanoyltransferase inhibitor | 7 | 0.9833 |
1030 | Carnitine palmitoyltransferase inhibitor | 23 | 0.9830 |
1031 | Carnosine synthase inhibitor | 14 | 0.9575 |
1032 | Caspase 2 inhibitor | 13 | 0.9468 |
1033 | Caspase 3 inhibitor | 629 | 0.9655 |
1034 | Caspase 3 stimulant | 83 | 0.8102 |
1035 | Caspase 6 inhibitor | 126 | 0.9992 |
1036 | Caspase 7 inhibitor | 303 | 0.9996 |
1037 | Caspase 8 inhibitor | 242 | 0.9935 |
1038 | Caspase 8 stimulant | 31 | 0.8330 |
1039 | Caspase 9 inhibitor | 37 | 0.9686 |
1040 | Catalase inhibitor | 27 | 0.9607 |
1041 | Catalase stimulant | 53 | 0.9270 |
1042 | Cataract | 115 | 0.8204 |
1043 | Catechol 1,2-dioxygenase inhibitor | 20 | 0.9909 |
1044 | Catechol 2,3-dioxygenase inhibitor | 32 | 0.9946 |
1045 | Catechol O methyltransferase inhibitor | 58 | 0.9816 |
1046 | Catechol oxidase inhibitor | 15 | 0.9748 |
1047 | Catenin beta inhibitor | 35 | 0.8642 |
1048 | Cathepsin B inhibitor | 665 | 0.9863 |
1049 | Cathepsin D inhibitor | 605 | 0.9802 |
1050 | Cathepsin E inhibitor | 38 | 0.9662 |
1051 | Cathepsin F inhibitor | 29 | 0.9761 |
1052 | Cathepsin G inhibitor | 97 | 0.9593 |
1053 | Cathepsin H inhibitor | 43 | 0.9396 |
1054 | Cathepsin K inhibitor | 661 | 0.9987 |
1055 | Cathepsin L inhibitor | 671 | 0.9858 |
1056 | Cathepsin S inhibitor | 649 | 0.9952 |
1057 | Cathepsin T inhibitor | 7 | 0.9472 |
1058 | Cathepsin V inhibitor | 31 | 0.9982 |
1059 | CC chemokine 1 receptor antagonist | 298 | 0.9948 |
1060 | CC chemokine 10 receptor antagonist | 10 | 1.0000 |
1061 | CC chemokine 2 receptor antagonist | 413 | 0.9857 |
1062 | CC chemokine 3 receptor antagonist | 339 | 0.9934 |
1063 | CC chemokine 4 receptor antagonist | 55 | 0.9521 |
1064 | CC chemokine 5 receptor agonist | 14 | 0.9998 |
1065 | CC chemokine 5 receptor antagonist | 461 | 0.9881 |
1066 | CC chemokine 9 receptor antagonist | 23 | 0.9762 |
1067 | CC chemokine receptor 2B antagonist | 3 | 0.9590 |
1068 | CC chemokine receptor agonist | 15 | 0.9840 |
1069 | CC chemokine receptor antagonist | 1506 | 0.9806 |
1070 | CD45 antagonist | 96 | 0.9789 |
1071 | CD80 antagonist | 81 | 1.0000 |
1072 | CDC25 phosphatase inhibitor | 32 | 0.9937 |
1073 | CDC25A inhibitor | 90 | 0.9740 |
1074 | CDC25B inhibitor | 147 | 0.9820 |
1075 | CDC25C inhibitor | 32 | 0.9670 |
1076 | CDC7 inhibitor | 94 | 0.9956 |
1077 | CDK/Cyclin complex inhibitor | 1090 | 0.9791 |
1078 | CDK1/cyclin B inhibitor | 307 | 0.9910 |
1079 | CDK2/cyclin A inhibitor | 379 | 0.9640 |
1080 | CDK2/cyclin A3 inhibitor | 30 | 1.0000 |
1081 | CDK2/cyclin E inhibitor | 439 | 0.9923 |
1082 | CDK4/cyclin D inhibitor | 425 | 0.9955 |
1083 | CDK4/cyclin D1 inhibitor | 249 | 0.9878 |
1084 | CDK4/cyclin D3 inhibitor | 7 | 1.0000 |
1085 | CDK5/p25 inhibitor | 48 | 0.9855 |
1086 | CDK9/cyclin T1 inhibitor | 7 | 0.8531 |
1087 | CDP-4-dehydro-6-deoxyglucose reductase inhibitor | 4 | 0.9856 |
1088 | CDP-diacylglycerol diphosphatase inhibitor | 6 | 0.9993 |
1089 | CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase inhibitor | 3 | 0.9776 |
1090 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase inhibitor | 15 | 0.9225 |
1091 | CDP-diacylglycerol-serine O-phosphatidyltransferase inhibitor | 6 | 0.9077 |
1092 | CDP-glycerol diphosphatase inhibitor | 6 | 0.9999 |
1093 | CDP-glycerol glycerophosphotransferase inhibitor | 4 | 0.8338 |
1094 | Celiac disease treatment | 47 | 0.9780 |
1095 | Cell adhesion inhibitor | 681 | 0.9582 |
1096 | Cell adhesion molecule inhibitor | 135 | 0.8599 |
1097 | Cell wall biosynthesis inhibitor | 20 | 0.8851 |
1098 | Cell wall synthesis inhibitor | 443 | 0.9599 |
1099 | Cellobiose phosphorylase inhibitor | 10 | 0.9929 |
1100 | Cellulase inhibitor | 12 | 0.9732 |
1101 | Cellulose 1,4-beta-cellobiosidase inhibitor | 11 | 0.8941 |
1102 | Cellulose synthase (UDP-forming) inhibitor | 13 | 0.8970 |
1103 | Centromere associated protein inhibitor | 7 | 0.9048 |
1104 | Ceramidase inhibitor | 12 | 0.9982 |
1105 | Ceramide glucosyltransferase inhibitor | 18 | 0.9537 |
1106 | Cerebroside-sulfatase inhibitor | 9 | 0.9807 |
1107 | Cerebrovascular disordes treatment | 478 | 0.9238 |
1108 | Cerevisin inhibitor | 8 | 0.9884 |
1109 | CF transmembrane conductance regulator agonist | 8 | 0.8484 |
1110 | CF transmembrane conductance regulator antagonist | 35 | 0.9731 |
1111 | Chalcone isomerase inhibitor | 26 | 0.9952 |
1112 | Channel-conductance-controlling ATPase inhibitor | 5 | 0.9639 |
1113 | Chaperonin ATPase inhibitor | 6 | 0.9652 |
1114 | Check point kinase 1 inhibitor | 488 | 0.9899 |
1115 | Check point kinase 2 inhibitor | 121 | 0.9856 |
1116 | Check point kinase inhibitor | 567 | 0.9893 |
1117 | Chelator | 117 | 0.9721 |
1118 | Chelator, Iron | 37 | 0.9963 |
1119 | Chemokine receptor agonist | 15 | 0.9840 |
1120 | Chemokine receptor antagonist | 2247 | 0.9784 |
1121 | Chemopreventive | 345 | 0.9419 |
1122 | Chemoprotective | 194 | 0.9141 |
1123 | Chemosensitizer | 203 | 0.8432 |
1124 | Chenodeoxycholoyltaurine hydrolase inhibitor | 3 | 0.9634 |
1125 | Chitin deacetylase inhibitor | 3 | 0.9994 |
1126 | Chitin synthase inhibitor | 31 | 0.9440 |
1127 | Chitinase inhibitor | 29 | 0.8941 |
1128 | Chitobiosyldiphosphodolichol beta-mannosyltransferase inhibitor | 5 | 0.9834 |
1129 | Chitosanase inhibitor | 8 | 0.9455 |
1130 | Chloramphenicol O-acetyltransferase inhibitor | 5 | 0.9954 |
1131 | Chlordecone reductase inhibitor | 4 | 0.9112 |
1132 | Chloride channel activator | 41 | 0.8813 |
1133 | Chloride channel blocker | 10 | 0.9503 |
1134 | Chloride peroxidase inhibitor | 3 | 0.8850 |
1135 | Chloride/bicarbonate exchanger inhibitor | 24 | 0.9915 |
1136 | Cholate-CoA ligase inhibitor | 9 | 0.9879 |
1137 | Cholecystokinin A agonist | 104 | 0.9993 |
1138 | Cholecystokinin A antagonist | 1477 | 0.9947 |
1139 | Cholecystokinin agonist | 109 | 0.9991 |
1140 | Cholecystokinin antagonist | 2074 | 0.9931 |
1141 | Cholecystokinin B antagonist | 1501 | 0.9946 |
1142 | Choleretic | 116 | 0.9383 |
1143 | Cholestanetriol 26-monooxygenase inhibitor | 9 | 0.9124 |
1144 | Cholestasis | 206 | 0.8288 |
1145 | Cholestenol delta-isomerase inhibitor | 8 | 0.9997 |
1146 | Cholestenone 5alpha-reductase inhibitor | 12 | 0.9174 |
1147 | Cholesterol absorption inhibitor | 192 | 0.9765 |
1148 | Cholesterol antagonist | 119 | 0.8763 |
1149 | Cholesterol ester transfer protein antagonist | 572 | 0.9931 |
1150 | Cholesterol esterase inhibitor | 183 | 0.9953 |
1151 | Cholesterol monooxygenase (side-chain-cleaving) inhibitor | 7 | 1.0000 |
1152 | Cholesterol oxidase inhibitor | 15 | 0.9837 |
1153 | Cholesterol synthesis inhibitor | 81 | 0.9672 |
1154 | Choline acetyltransferase stimulant | 5 | 0.9341 |
1155 | Choline dehydrogenase inhibitor | 5 | 0.9941 |
1156 | Choline kinase inhibitor | 12 | 0.9267 |
1157 | Choline sulfotransferase inhibitor | 20 | 0.9886 |
1158 | Choline-phosphate cytidylyltransferase inhibitor | 15 | 0.8990 |
1159 | Cholinergic | 3980 | 0.9615 |
1160 | Cholinergic antagonist | 4093 | 0.9704 |
1161 | Choline-sulfatase inhibitor | 8 | 0.9743 |
1162 | Choloylglycine hydrolase inhibitor | 3 | 0.9849 |
1163 | Chondroitin 6-sulfotransferase inhibitor | 4 | 0.9883 |
1164 | Chorea | 45 | 0.8993 |
1165 | Choreoathetosis | 29 | 0.8850 |
1166 | Chorismate mutase inhibitor | 22 | 0.9978 |
1167 | Chronic obstructive pulmonary disease treatment | 2161 | 0.9326 |
1168 | Chymase inhibitor | 177 | 0.9895 |
1169 | Chymosin inhibitor | 3 | 0.8770 |
1170 | Chymotrypsin inhibitor | 249 | 0.9718 |
1171 | Cis-1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase inhibitor | 3 | 0.9693 |
1172 | Citrate (Si)-synthase inhibitor | 26 | 0.9918 |
1173 | Clavaminate synthase inhibitor | 3 | 0.9747 |
1174 | Cleft palate | 9 | 0.8488 |
1175 | Clostripain inhibitor | 22 | 0.9424 |
1176 | Cl--transporting ATPase inhibitor | 5 | 0.8936 |
1177 | CMP-KDO synthase inhibitor | 3 | 0.9992 |
1178 | CMP-N-acetylneuraminate monooxygenase inhibitor | 13 | 0.9702 |
1179 | CMP-N-acylneuraminate phosphodiesterase inhibitor | 23 | 0.9859 |
1180 | CNS active muscle relaxant | 140 | 0.9665 |
1181 | Coactivator-associated arginine methyltransferase 1 inhibitor | 5 | 0.8750 |
1182 | Coagulant | 22 | 0.9765 |
1183 | Cocain dependency treatment | 201 | 0.9616 |
1184 | Coccolysin inhibitor | 11 | 0.9052 |
1185 | Coenzyme-B sulfoethylthiotransferase inhibitor | 3 | 0.8743 |
1186 | Cognition disorders treatment | 6742 | 0.8971 |
1187 | Collagenase 3 inhibitor | 1699 | 0.9900 |
1188 | Collagenase inhibitor | 753 | 0.9881 |
1189 | Colony stimulating factor agonist | 36 | 0.9498 |
1190 | Colony stimulating factor antagonist | 278 | 0.9712 |
1191 | Colorectum cell-derived growth factor antagonist | 5 | 1.0000 |
1192 | Coma | 311 | 0.8260 |
1193 | CO-methylating acetyl-CoA synthase inhibitor | 3 | 1.0000 |
1194 | Complement C5a chemotactic receptor antagonist | 103 | 0.9886 |
1195 | Complement C5a convertase stimulant | 3 | 1.0000 |
1196 | Complement factor 1 inhibitor | 34 | 0.9503 |
1197 | Complement factor 1r inhibitor | 31 | 0.9991 |
1198 | Complement factor D inhibitor | 3 | 0.8511 |
1199 | Complement inhibitor | 51 | 0.8929 |
1200 | Complement stimulant | 3 | 1.0000 |
1201 | Conjunctivitis | 341 | 0.7731 |
1202 | Consciousness alteration | 571 | 0.8078 |
1203 | Constipation treatment | 92 | 0.9469 |
1204 | Contraceptive | 791 | 0.9535 |
1205 | Contraceptive female | 119 | 0.9307 |
1206 | Contraceptive male | 177 | 0.9681 |
1207 | Coproporphyrinogen oxidase inhibitor | 28 | 0.9844 |
1208 | Corneal wound healing stimulator | 11 | 0.9883 |
1209 | Corticosteroid antagonist | 3 | 0.9245 |
1210 | Corticosteroid side-chain-isomerase inhibitor | 5 | 0.9693 |
1211 | Corticosteroid-like | 52 | 0.9986 |
1212 | Corticotropin releasing factor 1 receptor antagonist | 733 | 0.9997 |
1213 | Corticotropin releasing factor antagonist | 33 | 0.9850 |
1214 | Corticotropin-like | 3 | 0.9908 |
1215 | Cortisol sulfotransferase inhibitor | 14 | 0.9980 |
1216 | Cortisone alpha-reductase inhibitor | 4 | 0.9999 |
1217 | Cortisone beta-reductase inhibitor | 7 | 0.9993 |
1218 | CPB protease inhibitor | 3 | 0.9994 |
1219 | CpG-Oligodeoxynucleotides inhibitor | 27 | 1.0000 |
1220 | Creatinase inhibitor | 8 | 0.9916 |
1221 | Creatine kinase inhibitor | 30 | 0.9738 |
1222 | Creatininase inhibitor | 6 | 0.9013 |
1223 | Creatinine deaminase inhibitor | 3 | 0.9911 |
1224 | Crotonoyl-[acyl-carrier-protein] hydratase inhibitor | 3 | 0.9842 |
1225 | Cruzipain inhibitor | 168 | 0.9779 |
1226 | c-Src kinase inhibitor | 1446 | 0.9824 |
1227 | CTGF expression inhibitor | 11 | 0.9480 |
1228 | CTP synthase inhibitor | 14 | 0.9864 |
1229 | Cushing's syndrome treatment | 76 | 0.9699 |
1230 | Cutinase inhibitor | 6 | 0.9687 |
1231 | CXC chemokine 1 receptor antagonist | 113 | 0.9933 |
1232 | CXC chemokine 2 receptor antagonist | 124 | 0.9839 |
1233 | CXC chemokine 3 receptor antagonist | 155 | 0.9926 |
1234 | CXC chemokine 4 receptor antagonist | 145 | 0.9940 |
1235 | CXC chemokine 5 receptor antagonist | 328 | 0.9999 |
1236 | CXC chemokine L1/GRO-alpha antagonist | 17 | 1.0000 |
1237 | CXC chemokine receptor antagonist | 869 | 0.9888 |
1238 | Cyanate hydratase inhibitor | 13 | 0.9862 |
1239 | Cyanoalanine nitrilase inhibitor | 5 | 0.8426 |
1240 | Cyanosis | 162 | 0.8357 |
1241 | Cyclamate sulfohydrolase inhibitor | 4 | 0.9906 |
1242 | Cyclic AMP agonist | 15 | 0.8708 |
1243 | Cyclic AMP modulator | 40 | 0.8940 |
1244 | Cyclic AMP phosphodiesterase inhibitor | 188 | 0.8747 |
1245 | Cyclic GMP phosphodiesterase inhibitor | 19 | 0.8800 |
1246 | Cyclin-dependent kinase 1 inhibitor | 1143 | 0.9856 |
1247 | Cyclin-dependent kinase 2 inhibitor | 2002 | 0.9832 |
1248 | Cyclin-dependent kinase 4 inhibitor | 958 | 0.9903 |
1249 | Cyclin-dependent kinase 5 inhibitor | 700 | 0.9902 |
1250 | Cyclin-dependent kinase 6 inhibitor | 53 | 0.9663 |
1251 | Cyclin-dependent kinase 7 inhibitor | 53 | 0.9652 |
1252 | Cyclin-dependent kinase 9 inhibitor | 63 | 0.9825 |
1253 | Cyclin-dependent kinase inhibitor | 3665 | 0.9779 |
1254 | Cycloartenol synthase inhibitor | 19 | 0.9654 |
1255 | Cyclohexadienyl dehydrogenase inhibitor | 12 | 0.9993 |
1256 | Cyclohexanone monooxygenase inhibitor | 11 | 0.8499 |
1257 | Cyclohexyl-isocyanide hydratase inhibitor | 3 | 0.9812 |
1258 | Cyclomaltodextrin glucanotransferase inhibitor | 17 | 0.9995 |
1259 | Cyclomaltodextrinase inhibitor | 6 | 0.8355 |
1260 | Cyclooxygenase 1 inhibitor | 1376 | 0.9737 |
1261 | Cyclooxygenase 1 substrate | 3 | 0.9957 |
1262 | Cyclooxygenase 2 inhibitor | 3370 | 0.9772 |
1263 | Cyclooxygenase 3 inhibitor | 18 | 0.9972 |
1264 | Cyclooxygenase inhibitor | 4216 | 0.9660 |
1265 | Cyclooxygenase substrate | 15 | 0.9085 |
1266 | Cyclopentanone monooxygenase inhibitor | 5 | 0.9791 |
1267 | Cyclopropane-fatty-acyl-phospholipid synthase inhibitor | 10 | 0.9503 |
1268 | CYP11B substrate | 7 | 1.0000 |
1269 | CYP11B1 inhibitor | 313 | 0.9915 |
1270 | CYP11B1 substrate | 3 | 1.0000 |
1271 | CYP11B2 inhibitor | 315 | 0.9980 |
1272 | CYP11B2 substrate | 6 | 1.0000 |
1273 | CYP17 inhibitor | 7 | 0.9396 |
1274 | CYP17 substrate | 10 | 0.9857 |
1275 | CYP17A substrate | 4 | 0.9999 |
1276 | CYP19 inducer | 3 | 1.0000 |
1277 | CYP19 inhibitor | 43 | 0.9640 |
1278 | CYP19 substrate | 23 | 0.9742 |
1279 | CYP19A1 expression inhibitor | 24 | 0.8452 |
1280 | CYP19A1 substrate | 12 | 1.0000 |
1281 | CYP1A inducer | 45 | 0.9169 |
1282 | CYP1A inhibitor | 435 | 0.8861 |
1283 | CYP1A substrate | 620 | 0.8871 |
1284 | CYP1A1 inducer | 30 | 0.9603 |
1285 | CYP1A1 inhibitor | 83 | 0.9216 |
1286 | CYP1A1 substrate | 328 | 0.9196 |
1287 | CYP1A2 inducer | 24 | 0.8894 |
1288 | CYP1A2 inhibitor | 412 | 0.8901 |
1289 | CYP1A2 substrate | 477 | 0.8823 |
1290 | CYP1A3 substrate | 5 | 0.9954 |
1291 | CYP1B substrate | 83 | 0.9315 |
1292 | CYP1B1 inducer | 9 | 0.9991 |
1293 | CYP1B1 inhibitor | 62 | 0.9750 |
1294 | CYP1B1 substrate | 81 | 0.9427 |
1295 | CYP24 inhibitor | 11 | 0.9121 |
1296 | CYP24 substrate | 14 | 0.9763 |
1297 | CYP26 inhibitor | 19 | 0.9931 |
1298 | CYP26 substrate | 5 | 0.9492 |
1299 | CYP26A substrate | 4 | 0.9356 |
1300 | CYP27 substrate | 14 | 0.9835 |
1301 | CYP27A substrate | 12 | 0.9798 |
1302 | CYP27A1 inhibitor | 9 | 0.9995 |
1303 | CYP27A1 substrate | 8 | 0.9999 |
1304 | CYP2A substrate | 228 | 0.8866 |
1305 | CYP2A1 substrate | 16 | 0.8611 |
1306 | CYP2A10 substrate | 4 | 0.9785 |
1307 | CYP2A11 substrate | 3 | 0.9754 |
1308 | CYP2A13 substrate | 3 | 0.9996 |
1309 | CYP2A2 substrate | 8 | 0.9586 |
1310 | CYP2A3 substrate | 14 | 0.9598 |
1311 | CYP2A4 substrate | 3 | 0.9069 |
1312 | CYP2A5 inhibitor | 34 | 0.9959 |
1313 | CYP2A5 substrate | 8 | 0.9369 |
1314 | CYP2A6 inhibitor | 78 | 0.9611 |
1315 | CYP2A6 substrate | 200 | 0.8818 |
1316 | CYP2A8 substrate | 3 | 0.9558 |
1317 | CYP2B substrate | 442 | 0.9121 |
1318 | CYP2B1 substrate | 179 | 0.9487 |
1319 | CYP2B10 substrate | 3 | 0.8610 |
1320 | CYP2B11 substrate | 10 | 0.9274 |
1321 | CYP2B18 substrate | 4 | 0.8620 |
1322 | CYP2B2 substrate | 77 | 0.9118 |
1323 | CYP2B4 substrate | 37 | 0.9841 |
1324 | CYP2B5 substrate | 3 | 0.9534 |
1325 | CYP2B6 substrate | 213 | 0.8888 |
1326 | CYP2C substrate | 564 | 0.8703 |
1327 | CYP2C10 substrate | 18 | 0.9300 |
1328 | CYP2C11 substrate | 86 | 0.9131 |
1329 | CYP2C12 substrate | 10 | 0.8496 |
1330 | CYP2C18 inhibitor | 13 | 0.9830 |
1331 | CYP2C18 substrate | 35 | 0.9206 |
1332 | CYP2C19 inducer | 8 | 0.8330 |
1333 | CYP2C19 inhibitor | 361 | 0.8825 |
1334 | CYP2C19 substrate | 275 | 0.8897 |
1335 | CYP2C2 substrate | 5 | 0.9583 |
1336 | CYP2C29 substrate | 5 | 0.8303 |
1337 | CYP2C3 substrate | 6 | 0.8603 |
1338 | CYP2C6 substrate | 53 | 0.9087 |
1339 | CYP2C8 inducer | 9 | 0.9708 |
1340 | CYP2C8 inhibitor | 55 | 0.8136 |
1341 | CYP2C8 substrate | 170 | 0.8477 |
1342 | CYP2C9 inducer | 27 | 0.8199 |
1343 | CYP2C9 inhibitor | 748 | 0.9007 |
1344 | CYP2C9 substrate | 342 | 0.8723 |
1345 | CYP2D substrate | 461 | 0.8888 |
1346 | CYP2D1 substrate | 37 | 0.9439 |
1347 | CYP2D15 substrate | 5 | 0.8161 |
1348 | CYP2D16 substrate | 3 | 0.9175 |
1349 | CYP2D2 inhibitor | 7 | 0.9295 |
1350 | CYP2D6 inhibitor | 994 | 0.9359 |
1351 | CYP2D6 substrate | 438 | 0.8882 |
1352 | CYP2E substrate | 370 | 0.9073 |
1353 | CYP2E1 inducer | 12 | 0.8612 |
1354 | CYP2E1 inhibitor | 61 | 0.9526 |
1355 | CYP2E1 substrate | 364 | 0.9077 |
1356 | CYP2F1 substrate | 8 | 0.9452 |
1357 | CYP2G1 substrate | 11 | 0.9626 |
1358 | CYP2H substrate | 3 | 0.8461 |
1359 | CYP2J substrate | 5 | 0.8653 |
1360 | CYP2J2 substrate | 4 | 0.8625 |
1361 | CYP3A inducer | 74 | 0.8729 |
1362 | CYP3A substrate | 993 | 0.8528 |
1363 | CYP3A1 substrate | 48 | 0.8599 |
1364 | CYP3A11 substrate | 4 | 0.9992 |
1365 | CYP3A2 substrate | 59 | 0.8184 |
1366 | CYP3A3 substrate | 36 | 0.8504 |
1367 | CYP3A4 inducer | 70 | 0.8669 |
1368 | CYP3A4 inhibitor | 1396 | 0.9110 |
1369 | CYP3A4 substrate | 840 | 0.8479 |
1370 | CYP3A5 inducer | 4 | 0.9753 |
1371 | CYP3A5 substrate | 125 | 0.8508 |
1372 | CYP3A7 substrate | 41 | 0.8857 |
1373 | CYP3C substrate | 7 | 0.9867 |
1374 | CYP4A substrate | 39 | 0.8738 |
1375 | CYP4A1 substrate | 8 | 0.9914 |
1376 | CYP4A11 substrate | 17 | 0.8699 |
1377 | CYP4A2 substrate | 4 | 0.9750 |
1378 | CYP4B substrate | 16 | 0.9451 |
1379 | CYP4B1 substrate | 15 | 0.9446 |
1380 | CYP4F substrate | 21 | 0.9817 |
1381 | CYP4F12 substrate | 7 | 0.9652 |
1382 | CYP4F2 inhibitor | 34 | 0.9951 |
1383 | CYP4F2 substrate | 9 | 0.9490 |
1384 | CYP4F3 substrate | 10 | 0.9999 |
1385 | CYP4F8 substrate | 4 | 0.9997 |
1386 | CYP51 inhibitor | 14 | 0.9979 |
1387 | CYP7 inhibitor | 7 | 0.8234 |
1388 | CYP7 substrate | 8 | 0.9999 |
1389 | CYP7A1 substrate | 5 | 1.0000 |
1390 | CYP7B substrate | 4 | 0.9997 |
1391 | CYP7B1 substrate | 4 | 0.9997 |
1392 | Cystathionine beta-lyase inhibitor | 21 | 0.9876 |
1393 | Cystathionine beta-synthase inhibitor | 12 | 0.9897 |
1394 | Cystathionine gamma-lyase inhibitor | 26 | 0.9899 |
1395 | Cysteamine dioxygenase inhibitor | 9 | 0.9802 |
1396 | Cysteine desulfurase inhibitor | 5 | 0.9910 |
1397 | Cysteine dioxygenase inhibitor | 16 | 0.9980 |
1398 | Cysteine protease B inhibitor | 12 | 0.9998 |
1399 | Cysteine synthase inhibitor | 20 | 0.9345 |
1400 | Cysteine transaminase inhibitor | 3 | 0.9971 |
1401 | Cysteine-S-conjugate beta-lyase inhibitor | 3 | 0.9938 |
1402 | Cysteine-tRNA ligase inhibitor | 19 | 0.9907 |
1403 | Cystic fibrosis treatment | 231 | 0.8626 |
1404 | Cystinyl aminopeptidase inhibitor | 35 | 0.9435 |
1405 | Cytidine deaminase inhibitor | 511 | 0.9648 |
1406 | Cytidylate kinase inhibitor | 19 | 0.9965 |
1407 | Cytochrome P450 inhibitor | 3256 | 0.9077 |
1408 | Cytochrome P450 stimulant | 17 | 0.8168 |
1409 | Cytochrome-b5 reductase inhibitor | 21 | 0.8724 |
1410 | Cytochrome-b5 reductase substrate | 3 | 0.8905 |
1411 | Cytochrome-c3 hydrogenase inhibitor | 6 | 0.9941 |
1412 | Cytokine modulator | 140 | 0.9512 |
1413 | Cytokine production inhibitor | 757 | 0.9582 |
1414 | Cytokine production stimulant | 260 | 0.9853 |
1415 | Cytokine release inhibitor | 7 | 0.9888 |
1416 | Cytoprotectant | 37 | 0.8419 |
1417 | Cytosine deaminase inhibitor | 27 | 0.9769 |
1418 | Cytosol alanyl aminopeptidase inhibitor | 43 | 0.9435 |
1419 | Cytosole dipeptidase inhibitor | 5 | 0.9905 |
1420 | Cytosolic phospholipase A2 inhibitor | 151 | 0.9927 |
1421 | Cytostatic | 320 | 0.9112 |
1422 | Cytotoxic | 721 | 0.9308 |
1423 | D(-)-tartrate dehydratase inhibitor | 5 | 0.9995 |
1424 | D-2-hydroxy-acid dehydrogenase inhibitor | 6 | 0.9920 |
1425 | Dactylysin inhibitor | 22 | 0.9223 |
1426 | D-Ala-D-Ala ligase inhibitor | 6 | 0.9581 |
1427 | D-alanine 2-hydroxymethyltransferase inhibitor | 3 | 0.9850 |
1428 | D-alanine transaminase inhibitor | 18 | 0.9914 |
1429 | D-Alanine-alanyl-poly(glycerolphosphate) ligase inhibitor | 5 | 0.9998 |
1430 | D-Alanine-poly(phosphoribitol) ligase inhibitor | 5 | 0.9990 |
1431 | D-amino-acid dehydrogenase inhibitor | 5 | 0.9656 |
1432 | D-Amino-acid oxidase inhibitor | 36 | 0.9990 |
1433 | D-arabinonolactone oxidase inhibitor | 5 | 0.9915 |
1434 | D-aspartate oxidase inhibitor | 18 | 0.9987 |
1435 | D-benzoylarginine-4-nitroanilide amidase inhibitor | 5 | 0.9953 |
1436 | dCMP deaminase inhibitor | 19 | 0.9970 |
1437 | dCTP deaminase inhibitor | 10 | 0.9972 |
1438 | dCTP diphosphatase inhibitor | 3 | 1.0000 |
1439 | D-cysteine desulfhydrase inhibitor | 5 | 0.9911 |
1440 | Deacetoxycephalosporin-C synthase inhibitor | 10 | 0.9908 |
1441 | Decylcitrate synthase inhibitor | 4 | 0.9777 |
1442 | Dehydro-L-gulonate decarboxylase inhibitor | 3 | 0.9469 |
1443 | Delayed rectifier potassium channel activator | 162 | 0.9916 |
1444 | Delayed rectifier potassium channel blocker | 56 | 0.9951 |
1445 | Delirium | 103 | 0.8240 |
1446 | DELTA14-sterol reductase inhibitor | 13 | 0.8945 |
1447 | DELTA24-sterol reductase inhibitor | 7 | 0.8779 |
1448 | Dementia treatment | 13 | 0.8507 |
1449 | Demethylmacrocin O-methyltransferase inhibitor | 10 | 0.9998 |
1450 | Demethylsterigmatocystin 6-O-methyltransferase inhibitor | 3 | 0.9891 |
1451 | Demyelination | 9 | 0.9305 |
1452 | Deoxyadenosine kinase inhibitor | 13 | 0.9212 |
1453 | Deoxycytidine deaminase inhibitor | 5 | 0.9911 |
1454 | Deoxycytidine kinase inhibitor | 43 | 0.9747 |
1455 | Deoxycytidylate 5-hydroxymethyltransferase inhibitor | 7 | 0.9788 |
1456 | Deoxyguanosine kinase inhibitor | 37 | 0.9961 |
1457 | Deoxyhypusine monooxygenase inhibitor | 16 | 0.9983 |
1458 | Deoxyhypusine synthase inhibitor | 27 | 0.9864 |
1459 | Deoxynucleoside kinase inhibitor | 24 | 0.9998 |
1460 | Deoxyribonuclease (pyrimidine dimer) inhibitor | 3 | 0.9985 |
1461 | Deoxyribonuclease I inhibitor | 10 | 0.9498 |
1462 | Deoxyribonuclease X inhibitor | 3 | 0.9929 |
1463 | Deoxyribose-phosphate aldolase inhibitor | 4 | 0.9909 |
1464 | Dependence | 70 | 0.8414 |
1465 | Dependence treatment | 1217 | 0.9398 |
1466 | Depression | 125 | 0.8172 |
1467 | Dermatitis | 875 | 0.8179 |
1468 | Dermatologic | 3457 | 0.8876 |
1469 | Dethiobiotin synthase inhibitor | 7 | 0.9871 |
1470 | Dextranase inhibitor | 9 | 0.9477 |
1471 | Dextransucrase inhibitor | 18 | 0.9939 |
1472 | D-glutamate oxidase inhibitor | 9 | 0.9906 |
1473 | Diabetes insipidus treatment | 30 | 0.9982 |
1474 | Diabetic nephropathy treatment | 66 | 0.9004 |
1475 | Diabetic neuropathy treatment | 57 | 0.8156 |
1476 | Diabetic retinopathy treatment | 267 | 0.9318 |
1477 | Diacylglycerol cholinephosphotransferase inhibitor | 28 | 0.9789 |
1478 | Diacylglycerol kinase inhibitor | 23 | 0.9394 |
1479 | Diacylglycerol O-acyltransferase 1 inhibitor | 93 | 0.9977 |
1480 | Diacylglycerol O-acyltransferase inhibitor | 141 | 0.9848 |
1481 | Diamine N-acetyltransferase inhibitor | 12 | 0.9461 |
1482 | Diamine oxidase inhibitor | 32 | 0.9901 |
1483 | Diaminopimelate decarboxylase inhibitor | 13 | 0.9995 |
1484 | Diaminopimelate dehydrogenase inhibitor | 7 | 0.9926 |
1485 | Diaminopimelate epimerase inhibitor | 8 | 0.9987 |
1486 | Diaminopropionate ammonia-lyase inhibitor | 11 | 0.9919 |
1487 | Diarrhea | 316 | 0.8166 |
1488 | Dichloromethane dehalogenase inhibitor | 9 | 0.9996 |
1489 | Dichloromuconate cycloisomerase inhibitor | 4 | 0.9961 |
1490 | Diguanidinobutanase inhibitor | 6 | 0.9940 |
1491 | Dihydrodipicolinate reductase inhibitor | 8 | 0.8953 |
1492 | Dihydrodipicolinate synthase inhibitor | 16 | 0.9944 |
1493 | Dihydrofolate reductase (Mycobacterium avium) inhibitor | 11 | 0.9997 |
1494 | Dihydrofolate reductase (Pneumocystis carinii) inhibitor | 8 | 0.9999 |
1495 | Dihydrofolate reductase (Toxoplasma gondii) inhibitor | 11 | 0.9993 |
1496 | Dihydrofolate reductase inhibitor | 1812 | 0.9927 |
1497 | Dihydrofolate synthase inhibitor | 13 | 0.9324 |
1498 | Dihydrolipoamide S-acetyltransferase inhibitor | 4 | 0.9938 |
1499 | Dihydroneopterin aldolase inhibitor | 35 | 0.9997 |
1500 | Dihydroorotase inhibitor | 16 | 0.9693 |
1501 | Dihydroorotate dehydrogenase inhibitor | 196 | 0.9868 |
1502 | Dihydroorotate oxidase inhibitor | 84 | 0.9869 |
1503 | Dihydropteroate synthase inhibitor | 31 | 0.9864 |
1504 | Dihydropyrimidinase inhibitor | 15 | 0.9900 |
1505 | Dihydropyrimidine dehydrogenase inhibitor | 8 | 0.9852 |
1506 | Dihydrouracil dehydrogenase (NAD+) inhibitor | 5 | 0.9140 |
1507 | Dihydrouracil oxidase inhibitor | 8 | 0.9899 |
1508 | Dihydroxyacetanilide dehydrogenase inhibitor | 5 | 0.9997 |
1509 | Dihydroxyacetanilide epoxidase inhibitor | 5 | 0.9997 |
1510 | Dihydroxy-acid dehydratase inhibitor | 14 | 0.9469 |
1511 | Diiodophenylpyruvate reductase inhibitor | 3 | 0.9961 |
1512 | Diiodotyrosine transaminase inhibitor | 6 | 0.9991 |
1513 | Diisopropyl-fluorophosphatase inhibitor | 5 | 0.9906 |
1514 | Dimethylallyltranstransferase inhibitor | 19 | 0.9687 |
1515 | Dimethylargininase inhibitor | 3 | 0.9295 |
1516 | Dimethylhistidine N-methyltransferase inhibitor | 5 | 0.9923 |
1517 | Dimethylmaleate hydratase inhibitor | 3 | 0.9809 |
1518 | Dipeptidase E inhibitor | 4 | 0.9349 |
1519 | Dipeptidyl peptidase I inhibitor | 68 | 0.9794 |
1520 | Dipeptidyl peptidase II inhibitor | 350 | 0.9888 |
1521 | Dipeptidyl peptidase inhibitor | 1605 | 0.9880 |
1522 | Dipeptidyl peptidase IV inhibitor | 1195 | 0.9902 |
1523 | Dipeptidyl peptidase IX inhibitor | 149 | 0.9994 |
1524 | Dipeptidyl peptidase VIII inhibitor | 207 | 0.9970 |
1525 | Diphenylpicrylhydrazyl (DPPH) scavenger | 3 | 1.0000 |
1526 | Diphosphate-fructose-6-phosphate 1-phosphotransferase inhibitor | 17 | 0.9973 |
1527 | Diphosphate-serine phosphotransferase inhibitor | 8 | 0.9994 |
1528 | Diphosphomevalonate decarboxylase inhibitor | 13 | 0.9332 |
1529 | Di-trans,poly-cis-decaprenylcistransferase inhibitor | 4 | 0.9777 |
1530 | Diuretic | 736 | 0.9203 |
1531 | Diuretic inhibitor | 93 | 0.8720 |
1532 | Dizziness | 719 | 0.8120 |
1533 | D-lactaldehyde dehydrogenase inhibitor | 11 | 0.8602 |
1534 | D-lactate dehydrogenase (cytochrome) inhibitor | 7 | 0.9910 |
1535 | D-lactate dehydrogenase inhibitor | 7 | 0.8755 |
1536 | D-lactate-2-sulfatase inhibitor | 4 | 0.9990 |
1537 | D-Lysine 5,6-aminomutase inhibitor | 22 | 0.9944 |
1538 | D-malate dehydrogenase (decarboxylating) inhibitor | 10 | 0.9907 |
1539 | DNA damaging | 466 | 0.9633 |
1540 | DNA directed DNA polymerase inhibitor | 302 | 0.9560 |
1541 | DNA directed RNA polymerase inhibitor | 543 | 0.9374 |
1542 | DNA directed RNA polymerase stimulant | 9 | 0.9980 |
1543 | DNA gyrase inhibitor | 239 | 0.9897 |
1544 | DNA helicase inhibitor | 41 | 0.9789 |
1545 | DNA intercalator | 582 | 0.9803 |
1546 | DNA ligase (ATP) inhibitor | 21 | 0.8942 |
1547 | DNA methylase inhibitor | 41 | 0.9730 |
1548 | DNA methyltransferase I inhibitor | 10 | 0.9530 |
1549 | DNA nucleotidylexotransferase inhibitor | 21 | 0.9535 |
1550 | DNA polymerase I inhibitor | 25 | 0.8537 |
1551 | DNA polymerase III inhibitor | 83 | 0.9964 |
1552 | DNA repair enzyme inhibitor | 165 | 0.9717 |
1553 | DNA synthesis inhibitor | 292 | 0.8955 |
1554 | DNA topoisomerase IV inhibitor | 110 | 0.9925 |
1555 | DNA-(apurinic or apyrimidinic site) lyase inhibitor | 12 | 0.9259 |
1556 | DNA-3-methyladenine glycosylase I inhibitor | 5 | 0.9607 |
1557 | DNA-3-methyladenine glycosylase II inhibitor | 3 | 0.9951 |
1558 | DNA-dependent protein kinase inhibitor | 309 | 0.9946 |
1559 | D-Octopine dehydrogenase inhibitor | 20 | 0.9772 |
1560 | Dolichol kinase inhibitor | 8 | 0.9652 |
1561 | Dolichyldiphosphatase inhibitor | 3 | 0.9999 |
1562 | Dolichyl-diphosphooligosaccharide-protein glycotransferase inhibitor | 3 | 0.9217 |
1563 | Dolichyl-phosphatase inhibitor | 6 | 0.9869 |
1564 | Dolichyl-phosphate beta-D-mannosyltransferase (T. brucei) inhibitor | 3 | 1.0000 |
1565 | Dolichyl-phosphate beta-D-mannosyltransferase inhibitor | 19 | 0.9312 |
1566 | Dolichyl-phosphate beta-glucosyltransferase inhibitor | 5 | 0.9145 |
1567 | DOPA decarboxylase inhibitor | 10 | 0.9850 |
1568 | Dopachrome isomerase inhibitor | 7 | 0.9975 |
1569 | Dopamine D1A antagonist | 25 | 0.9994 |
1570 | Dopamine D2 agonist inducer | 3 | 1.0000 |
1571 | Dopamine D2A antagonist | 82 | 0.9858 |
1572 | Dopamine D2B antagonist | 31 | 0.9996 |
1573 | Dopamine D2L antagonist | 481 | 0.9887 |
1574 | Dopamine D2S antagonist | 122 | 0.9622 |
1575 | Dopamine D5 antagonist | 281 | 0.9932 |
1576 | Dopamine precursors | 25 | 0.9995 |
1577 | Dopamine release inhibitor | 3 | 1.0000 |
1578 | Dopamine release stimulant | 7 | 0.9530 |
1579 | Dopamine transporter inhibitor | 1221 | 0.9906 |
1580 | D-Ornithine 4,5-aminomutase inhibitor | 5 | 0.9915 |
1581 | D-proline reductase (dithiol) inhibitor | 5 | 0.9943 |
1582 | Drowsiness | 926 | 0.8185 |
1583 | Dry eye syndrome treatment | 46 | 0.9197 |
1584 | D-Serine ammonia-lyase inhibitor | 4 | 0.9992 |
1585 | D-stereospecific aminopeptidase inhibitor | 7 | 0.9957 |
1586 | dTDP-glucose 4,6-dehydratase inhibitor | 6 | 0.9998 |
1587 | D-threo-aldose 1-dehydrogenase inhibitor | 7 | 0.9369 |
1588 | dTMP kinase (Mycobacterium tuberculosis) inhibitor | 11 | 0.9998 |
1589 | dTMP kinase inhibitor | 29 | 0.9997 |
1590 | Dual specificity phosphatase 1 inhibitor | 11 | 0.9179 |
1591 | Dual specificity phosphatase inhibitor | 183 | 0.9508 |
1592 | Dual specificity protein phosphatase VHR inhibitor | 9 | 0.9990 |
1593 | dUTP diphosphatase inhibitor | 14 | 0.9950 |
1594 | D-xylulose reductase inhibitor | 4 | 0.9858 |
1595 | Dynamin GTPase inhibitor | 15 | 0.9968 |
1596 | Dynein ATPase inhibitor | 3 | 0.9787 |
1597 | Dyrk kinase inhibitor | 93 | 0.9804 |
1598 | Dysarthria | 100 | 0.8333 |
1599 | Dyskinesia | 817 | 0.8407 |
1600 | Dysmenorrhea treatment | 166 | 0.9737 |
1601 | Dyspepsia treatment | 74 | 0.9340 |
1602 | Dysphoria | 38 | 0.8889 |
1603 | Dyspnea | 318 | 0.8619 |
1604 | Dystonia | 96 | 0.8105 |
1605 | Ecdysone 20-monooxygenase inhibitor | 15 | 0.8663 |
1606 | Edema | 141 | 0.8132 |
1607 | Eicosanoid agonist | 6 | 0.9979 |
1608 | EIF4E expression inhibitor | 8 | 0.8337 |
1609 | Elastase 1 inhibitor | 58 | 0.9877 |
1610 | Elastase 2 inhibitor | 99 | 0.9985 |
1611 | Elastase inhibitor | 834 | 0.9877 |
1612 | Electrolyte absorption antagonist | 54 | 0.9547 |
1613 | Electron transport complex I inhibitor | 26 | 0.9849 |
1614 | Electron-transferring-flavoprotein dehydrogenase inhibitor | 3 | 0.8814 |
1615 | Embryotoxic | 1743 | 0.9065 |
1616 | Emetic | 788 | 0.8204 |
1617 | Endo-1,3(4)-beta-glucanase inhibitor | 3 | 0.9913 |
1618 | Endo-1,4-beta-xylanase inhibitor | 19 | 0.9823 |
1619 | Endo-beta-N-acetylglucosaminidase inhibitor | 7 | 0.9998 |
1620 | Endocannabinoid uptake inhibitor | 29 | 0.9920 |
1621 | Endocrine disruptor | 223 | 0.8517 |
1622 | Endoglycosylceramidase inhibitor | 4 | 0.9864 |
1623 | Endometrios treatment | 257 | 0.9763 |
1624 | Endonuclease (influenza) inhibitor | 11 | 0.9927 |
1625 | Endopeptidase inhibitor | 87 | 0.9301 |
1626 | Endopeptidase La inhibitor | 39 | 0.9192 |
1627 | Endopeptidase So inhibitor | 7 | 0.8983 |
1628 | Endothelial growth factor antagonist | 9 | 0.9448 |
1629 | Endothelial nitric-oxide synthase inhibitor | 270 | 0.9974 |
1630 | Endothelin A receptor antagonist | 1756 | 0.9967 |
1631 | Endothelin B receptor antagonist | 1423 | 0.9959 |
1632 | Endothelin receptor agonist | 13 | 0.9997 |
1633 | Endothelin receptor antagonist | 2756 | 0.9951 |
1634 | Endothelin-converting enzyme inhibitor | 112 | 0.9522 |
1635 | Endothiapepsin inhibitor | 5 | 0.9973 |
1636 | Enoyl-[acyl-carrier-protein] reductase (NADH) inhibitor | 120 | 0.9896 |
1637 | Enoyl-CoA hydratase inhibitor | 9 | 0.9954 |
1638 | Enteropeptidase inhibitor | 6 | 0.8343 |
1639 | Envelysin inhibitor | 18 | 0.9508 |
1640 | EphB4 antagonist | 280 | 0.9882 |
1641 | Ephrin antagonist | 369 | 0.9623 |
1642 | Epidermal growth factor antagonist | 893 | 0.9907 |
1643 | Epidermal growth factor receptor kinase inhibitor | 2326 | 0.9627 |
1644 | Epithelial sodium channel blocker | 50 | 0.9921 |
1645 | Epoxide hydrolase 2 inhibitor | 281 | 0.9984 |
1646 | Epoxide hydrolase inhibitor | 609 | 0.9923 |
1647 | Epoxide hydrolase substrate | 147 | 0.9787 |
1648 | Equilibrative nucleoside transport protein 1 inhibitor | 97 | 0.9955 |
1649 | Equilibrative nucleoside transport protein inhibitor | 127 | 0.9955 |
1650 | ErbB antagonist | 841 | 0.9833 |
1651 | ErbB-1 antagonist | 12 | 0.9850 |
1652 | ErbB-2 antagonist | 796 | 0.9836 |
1653 | ErbB-4 antagonist | 42 | 0.9771 |
1654 | Erectile dysfunction treatment | 310 | 0.9453 |
1655 | Erythro-3-hydroxyaspartate ammonia-lyase inhibitor | 4 | 0.9996 |
1656 | Erythropoiesis stimulant | 6 | 0.8483 |
1657 | Erythropoietin receptor agonist | 10 | 0.9999 |
1658 | Estradiol 17 beta dehydrogenase 2 inhibitor | 81 | 0.9773 |
1659 | Estradiol 17 beta dehydrogenase 3 inhibitor | 129 | 0.9954 |
1660 | Estradiol 17 beta dehydrogenase inhibitor | 310 | 0.9865 |
1661 | Estradiol 17 beta dehydrogenase stimulant | 19 | 0.9987 |
1662 | Estradiol 17alpha-dehydrogenase inhibitor | 3 | 0.9903 |
1663 | Estrogen agonist | 734 | 0.9797 |
1664 | Estrogen alpha receptor agonist | 44 | 0.9943 |
1665 | Estrogen antagonist | 2227 | 0.9654 |
1666 | Estrogen beta receptor agonist | 185 | 0.9963 |
1667 | Estrogen receptor beta antagonist | 1524 | 0.9724 |
1668 | Estrogen-related receptor alpha antagonist | 43 | 0.9905 |
1669 | Estrone sulfatase inhibitor | 240 | 0.9970 |
1670 | Estrone sulfotransferase inhibitor | 39 | 0.9673 |
1671 | Estrone sulfotransferase stimulant | 17 | 0.9987 |
1672 | Ethanolamine ammonia-lyase inhibitor | 10 | 0.9994 |
1673 | Ethanolamine kinase inhibitor | 15 | 0.9886 |
1674 | Ethanolamine oxidase inhibitor | 6 | 0.8978 |
1675 | Ethanolamine-phosphate cytidylyltransferase inhibitor | 7 | 0.9305 |
1676 | Ethanolaminephosphotransferase inhibitor | 28 | 0.9608 |
1677 | Ether-a-go-go potassium channel 1 blocker | 21 | 1.0000 |
1678 | Ether-a-go-go potassium channel blocker | 21 | 1.0000 |
1679 | Eukaryotic elongation factor 2 kinase inhibitor | 3 | 1.0000 |
1680 | Euphoria | 43 | 0.8404 |
1681 | Excitability | 300 | 0.8206 |
1682 | Excitatory amino acid transporter 1 inhibitor | 33 | 0.9989 |
1683 | Excitatory amino acid transporter 2 inhibitor | 44 | 0.9994 |
1684 | Excitatory amino acid transporter EAAC1 inhibitor | 6 | 0.9912 |
1685 | Exoribonuclease II inhibitor | 5 | 0.9379 |
1686 | Expectorant | 132 | 0.9329 |
1687 | Extrapyramidal disorders treatment | 120 | 0.9591 |
1688 | Extrapyramidal effect | 12 | 0.8657 |
1689 | Eye irritation, high | 528 | 0.9372 |
1690 | Eye irritation, inactive | 91 | 0.8967 |
1691 | Eye irritation, moderate | 229 | 0.9674 |
1692 | Eye irritation, weak | 348 | 0.9684 |
1693 | Factor IXa inhibitor | 9 | 0.9999 |
1694 | Factor VII inhibitor | 134 | 0.9956 |
1695 | Factor VIIa inhibitor | 214 | 0.9852 |
1696 | Factor Xa inhibitor | 1741 | 0.9929 |
1697 | Factor XIa inhibitor | 6 | 0.9427 |
1698 | Factor XIIIa inhibitor | 52 | 0.9830 |
1699 | Factor XIIIa stimulant | 3 | 0.9976 |
1700 | FAD diphosphatase inhibitor | 17 | 0.9930 |
1701 | Falcipain 2 inhibitor | 112 | 0.9758 |
1702 | Falcipain 3 inhibitor | 14 | 0.8963 |
1703 | Falcipain inhibitor | 112 | 0.9758 |
1704 | Farnesoid X receptor agonist | 96 | 0.9947 |
1705 | Farnesoid X receptor antagonist | 22 | 0.8842 |
1706 | Farnesyltransferase inhibitor | 2518 | 0.9877 |
1707 | Farnesyltranstransferase inhibitor | 5 | 0.9816 |
1708 | Fas antagonist | 5 | 1.0000 |
1709 | Fasciculation | 28 | 0.8701 |
1710 | Fatty acid elongase inhibitor | 18 | 0.9800 |
1711 | Fatty acid oxidation inhibitor | 45 | 0.9943 |
1712 | Fatty acid synthase inhibitor | 46 | 0.9891 |
1713 | Fatty liver | 42 | 0.8053 |
1714 | Fatty-acyl-CoA synthase inhibitor | 5 | 0.9353 |
1715 | Fatty-acyl-ethyl-ester synthase inhibitor | 3 | 0.9977 |
1716 | Female sexual dysfunction treatment | 127 | 0.9712 |
1717 | Ferredoxin hydrogenase inhibitor | 8 | 0.9573 |
1718 | Ferredoxin-NAD+ reductase inhibitor | 3 | 0.9674 |
1719 | Ferredoxin-NADP+ reductase inhibitor | 6 | 0.9780 |
1720 | Ferredoxin-nitrite reductase inhibitor | 12 | 0.9559 |
1721 | Ferrochelatase inhibitor | 5 | 0.9896 |
1722 | Feruloyl esterase inhibitor | 6 | 0.9208 |
1723 | Fibrillation, atrial | 16 | 0.8309 |
1724 | Fibrinogen receptor antagonist | 29 | 0.8844 |
1725 | Fibrinolytic | 38 | 0.8303 |
1726 | Fibroblast activation protein alpha inhibitor | 36 | 0.9995 |
1727 | Fibroblast growth factor 1 agonist | 3 | 0.9585 |
1728 | Fibroblast growth factor 1 antagonist | 579 | 0.9787 |
1729 | Fibroblast growth factor 2 antagonist | 143 | 0.9572 |
1730 | Fibroblast growth factor 3 antagonist | 177 | 0.9676 |
1731 | Fibroblast growth factor agonist | 4 | 0.9270 |
1732 | Fibroblast growth factor antagonist | 785 | 0.9756 |
1733 | Fibrolase inhibitor | 4 | 0.8907 |
1734 | Fibromyalgia syndrome treatment | 53 | 0.9362 |
1735 | Fibrosis treatment | 95 | 0.9545 |
1736 | Fibrosis, interstitial | 8 | 0.8614 |
1737 | Flavin-containing monooxygenase inhibitor | 9 | 0.9471 |
1738 | Flavin-containing monooxygenase substrate | 65 | 0.8973 |
1739 | FMN adenylyltransferase inhibitor | 7 | 0.9999 |
1740 | FMN reductase inhibitor | 22 | 0.9507 |
1741 | FMO1 substrate | 17 | 0.9050 |
1742 | FMO3 substrate | 38 | 0.8916 |
1743 | Focal adhesion kinase 1 inhibitor | 38 | 0.9501 |
1744 | Focal adhesion kinase 2 inhibitor | 140 | 0.9157 |
1745 | Focal adhesion kinase inhibitor | 202 | 0.9195 |
1746 | Folate antagonist | 21 | 0.8698 |
1747 | Folate transporter 1 inhibitor | 5 | 0.9997 |
1748 | Follicle-stimulating hormone agonist | 11 | 0.9469 |
1749 | Follicle-stimulating hormone antagonist | 54 | 0.9997 |
1750 | Folylpolyglutamate synthase inhibitor | 19 | 0.9998 |
1751 | Formaldehyde dehydrogenase (glutathione) inhibitor | 17 | 0.9769 |
1752 | Formaldehyde dehydrogenase inhibitor | 14 | 0.9871 |
1753 | Formaldehyde transketolase inhibitor | 6 | 0.9203 |
1754 | Formate C-acetyltransferase inhibitor | 5 | 0.9978 |
1755 | Formate dehydrogenase inhibitor | 21 | 0.9778 |
1756 | Formate-dihydrofolate ligase inhibitor | 14 | 0.8918 |
1757 | Formimidoylglutamase inhibitor | 3 | 0.9989 |
1758 | Formimidoyltetrahydrofolate cyclodeaminase inhibitor | 8 | 0.9914 |
1759 | Formyl peptide receptor antagonist | 58 | 0.9997 |
1760 | Formyltetrahydrofolate dehydrogenase inhibitor | 6 | 0.9917 |
1761 | Fragilysin inhibitor | 6 | 0.8580 |
1762 | Free fatty acid receptor 1 agonist | 28 | 0.9997 |
1763 | Free radical scavenger | 249 | 0.9392 |
1764 | Fructan beta-fructosidase inhibitor | 4 | 0.9647 |
1765 | Fructokinase inhibitor | 13 | 0.9969 |
1766 | Fructose 5-dehydrogenase (NADP+) inhibitor | 3 | 0.9899 |
1767 | Fructose 5-dehydrogenase inhibitor | 4 | 0.8004 |
1768 | Fructose-1,6-bisphosphatase inhibitor | 211 | 0.9989 |
1769 | Fructose-2,6-bisphosphate 2-phosphatase inhibitor | 12 | 0.9637 |
1770 | Fructose-2,6-bisphosphate 6-phosphatase inhibitor | 4 | 0.9967 |
1771 | Fructuronate reductase inhibitor | 3 | 0.9946 |
1772 | FtsZ polymerization inhibitor | 5 | 0.9998 |
1773 | Fucokinase inhibitor | 9 | 0.9965 |
1774 | Fucosterol-epoxide lyase inhibitor | 9 | 0.9326 |
1775 | Fumarate hydratase inhibitor | 24 | 0.9958 |
1776 | Fumarate reductase (NADH) inhibitor | 7 | 0.8936 |
1777 | Fumarylacetoacetase inhibitor | 14 | 0.9945 |
1778 | Furin inhibitor | 23 | 0.9824 |
1779 | Fusarinine-C ornithinesterase inhibitor | 3 | 0.8407 |
1780 | G protein-coupled receptor agonist | 73 | 0.9935 |
1781 | GABA A inverse agonist | 8 | 0.8922 |
1782 | GABA A receptor agonist | 231 | 0.9451 |
1783 | GABA A receptor antagonist | 2765 | 0.9873 |
1784 | GABA aminotransferase inhibitor | 14 | 0.8532 |
1785 | GABA B receptor agonist | 10 | 0.9188 |
1786 | GABA B receptor antagonist | 63 | 0.9940 |
1787 | GABA C receptor agonist | 3 | 0.9867 |
1788 | GABA C receptor antagonist | 24 | 0.9716 |
1789 | GABA inverse agonist | 8 | 0.8922 |
1790 | GABA receptor agonist | 386 | 0.9337 |
1791 | GABA receptor antagonist | 2835 | 0.9870 |
1792 | GABA transporter 1 inhibitor | 150 | 0.9956 |
1793 | GABA transporter 2 inhibitor | 11 | 0.9893 |
1794 | GABA transporter 3 inhibitor | 8 | 0.9900 |
1795 | GABA transporter inhibitor | 157 | 0.9938 |
1796 | GABA uptake inhibitor | 68 | 0.9934 |
1797 | Galactokinase inhibitor | 6 | 0.9818 |
1798 | Galactolipase inhibitor | 12 | 0.8999 |
1799 | Galactorrhea | 12 | 0.8594 |
1800 | Galactose 1-dehydrogenase (NADP+) inhibitor | 3 | 0.9893 |
1801 | Galactose oxidase inhibitor | 13 | 0.9774 |
1802 | Galactoside 2-alpha-L-fucosyltransferase inhibitor | 12 | 0.9856 |
1803 | Galactoside O-acetyltransferase inhibitor | 4 | 0.9761 |
1804 | Galactosylceramidase inhibitor | 8 | 0.9847 |
1805 | Galactosylceramide sulfotransferase inhibitor | 10 | 0.9750 |
1806 | Galactosylgalactosylglucosylceramidase inhibitor | 5 | 0.9956 |
1807 | Galacturan 1,4-alpha-galacturonidase inhibitor | 4 | 0.9915 |
1808 | Galectin 3 antagonist | 4 | 0.9989 |
1809 | Gallate decarboxylase inhibitor | 5 | 0.9813 |
1810 | Gametolysin inhibitor | 15 | 0.9271 |
1811 | Gamma-butyrobetaine dioxygenase inhibitor | 18 | 0.9188 |
1812 | Gamma-D-Glutamyl-meso-diaminopimelate peptidase inhibitor | 3 | 0.9820 |
1813 | Gamma-glutamyl hydrolase inhibitor | 42 | 0.9932 |
1814 | Gamma-glutamyltransferase inhibitor | 28 | 0.9128 |
1815 | Gamma-guanidinobutyraldehyde dehydrogenase inhibitor | 5 | 0.8899 |
1816 | Ganglioside galactosyltransferase inhibitor | 9 | 0.9696 |
1817 | Gastric antisecretory | 489 | 0.9209 |
1818 | Gastric emptying disorders treatment | 99 | 0.9614 |
1819 | Gastric emptying impairment | 3 | 0.9992 |
1820 | Gastricsin inhibitor | 25 | 0.9800 |
1821 | Gastrin inhibitor | 81 | 0.8352 |
1822 | Gastrin-releasing peptide antagonist | 50 | 0.9652 |
1823 | Gastritis treatment | 14 | 0.9225 |
1824 | Gastroesophageal reflux disease treatment | 220 | 0.9645 |
1825 | Gastrointestinal disorders treatment | 294 | 0.9427 |
1826 | Gastrointestinal disturbance | 176 | 0.8472 |
1827 | Gastrointestinal hemorrhage | 13 | 0.8250 |
1828 | Gastrointestinal motility stimulant | 79 | 0.9267 |
1829 | Gaucher disease treatment | 12 | 0.9744 |
1830 | GDP-L-fucose synthase inhibitor | 3 | 0.9991 |
1831 | GDP-mannose 4,6-dehydratase inhibitor | 8 | 0.9997 |
1832 | GDP-mannose 6-dehydrogenase inhibitor | 6 | 0.8995 |
1833 | Gelatinase inhibitor | 18 | 0.9729 |
1834 | General pump inhibitor | 40 | 0.8093 |
1835 | Genotoxic | 146 | 0.9488 |
1836 | Gentamicin 2''-nucleotidyltransferase inhibitor | 4 | 0.9968 |
1837 | Gentamicin 3'-N-acetyltransferase inhibitor | 12 | 0.9980 |
1838 | Gentisate 1,2-dioxygenase inhibitor | 6 | 0.9880 |
1839 | Geranylgeranyl-diphosphate geranylgeranyltransferase inhibitor | 9 | 0.9614 |
1840 | Geranylgeranyltransferase I inhibitor | 668 | 0.9951 |
1841 | Geranylgeranyltransferase inhibitor | 735 | 0.9944 |
1842 | Geranyltranstransferase (Leishmania) inhibitor | 27 | 0.9999 |
1843 | Geranyltranstransferase inhibitor | 105 | 0.9948 |
1844 | Gestagen antagonist | 7 | 0.9596 |
1845 | Gestagen-like | 56 | 0.9992 |
1846 | GHS receptor agonist | 25 | 0.9895 |
1847 | GHS receptor antagonist | 134 | 0.9969 |
1848 | Giant cell myocarditis | 3 | 0.9967 |
1849 | Gingipain K inhibitor | 6 | 0.9404 |
1850 | Gingipain R inhibitor | 7 | 0.9869 |
1851 | Glaucoma | 86 | 0.8410 |
1852 | Globoside alpha-N-acetylgalactosaminyltransferase inhibitor | 13 | 0.9641 |
1853 | Glucagon receptor antagonist | 362 | 0.9936 |
1854 | Glucagon-like peptide 1 agonist | 9 | 0.9362 |
1855 | Glucagon-like peptide 1 receptor antagonist | 30 | 0.9986 |
1856 | Glucan 1,3-alpha-glucosidase inhibitor | 19 | 0.9932 |
1857 | Glucan 1,3-beta-glucosidase inhibitor | 9 | 0.9913 |
1858 | Glucan 1,4-alpha-glucosidase inhibitor | 20 | 0.9964 |
1859 | Glucan 1,4-alpha-maltotetraohydrolase inhibitor | 3 | 0.9778 |
1860 | Glucan 1,4-alpha-maltotriohydrolase inhibitor | 3 | 0.9617 |
1861 | Glucan 1,4-beta-glucosidase inhibitor | 9 | 0.9804 |
1862 | Glucan 1,6-alpha-glucosidase inhibitor | 6 | 0.9888 |
1863 | Glucan endo-1,3-alpha-glucosidase inhibitor | 3 | 0.9958 |
1864 | Glucan endo-1,3-beta-D-glucosidase inhibitor | 11 | 0.8889 |
1865 | Glucan endo-1,6-beta-glucosidase inhibitor | 7 | 0.9140 |
1866 | Glucarate dehydratase inhibitor | 5 | 0.9909 |
1867 | Glucocorticoid agonist | 307 | 0.9936 |
1868 | Glucocorticoid antagonist | 900 | 0.9944 |
1869 | Gluconate 2-dehydrogenase (acceptor) inhibitor | 4 | 0.8010 |
1870 | Gluconate 5-dehydrogenase inhibitor | 3 | 0.9570 |
1871 | Gluconate dehydratase inhibitor | 4 | 0.9948 |
1872 | Gluconokinase inhibitor | 3 | 0.9731 |
1873 | Gluconolactonase inhibitor | 3 | 0.9788 |
1874 | Glucosamine 6-phosphate N-acetyltransferase inhibitor | 6 | 0.9958 |
1875 | Glucosamine N-acetyltransferase inhibitor | 6 | 0.9971 |
1876 | Glucosamine-1-phosphate N-acetyltransferase inhibitor | 4 | 0.9940 |
1877 | Glucosamine-6-phosphate deaminase inhibitor | 12 | 0.9826 |
1878 | Glucose 1-dehydrogenase inhibitor | 8 | 0.9855 |
1879 | Glucose oxidase inhibitor | 7 | 0.8550 |
1880 | Glucose-1,6-bisphosphate synthase inhibitor | 11 | 0.9975 |
1881 | Glucose-1-phosphatase inhibitor | 3 | 0.9917 |
1882 | Glucose-1-phosphate adenylyltransferase inhibitor | 15 | 0.9958 |
1883 | Glucose-1-phosphate cytidylyltransferase inhibitor | 12 | 0.9999 |
1884 | Glucose-6-phosphate isomerase inhibitor | 22 | 0.9986 |
1885 | Glucose-6-phosphate translocase inhibitor | 25 | 0.9975 |
1886 | Glucose-dependent insulinotropic receptor agonist | 62 | 0.9986 |
1887 | Glucosyl transferase inhibitor | 36 | 0.9478 |
1888 | Glucosylceramidase inhibitor | 48 | 0.9962 |
1889 | Glucuronate isomerase inhibitor | 5 | 0.9805 |
1890 | Glucuronolactone reductase inhibitor | 3 | 0.9890 |
1891 | Glutamate (mGluR group I) agonist | 30 | 0.9679 |
1892 | Glutamate (mGluR group I) antagonist | 565 | 0.9793 |
1893 | Glutamate (mGluR group II) agonist | 36 | 0.9899 |
1894 | Glutamate (mGluR group II) antagonist | 273 | 0.9994 |
1895 | Glutamate (mGluR group III) agonist | 13 | 0.9993 |
1896 | Glutamate (mGluR group III) antagonist | 77 | 0.9798 |
1897 | Glutamate (mGluR) agonist | 83 | 0.9876 |
1898 | Glutamate (mGluR) antagonist | 858 | 0.9866 |
1899 | Glutamate (mGluR1) agonist | 10 | 0.9983 |
1900 | Glutamate (mGluR1) antagonist | 255 | 0.9774 |
1901 | Glutamate (mGluR1a) agonist | 4 | 0.9999 |
1902 | Glutamate (mGluR2) agonist | 30 | 0.9981 |
1903 | Glutamate (mGluR2) antagonist | 197 | 0.9989 |
1904 | Glutamate (mGluR3) agonist | 11 | 0.9953 |
1905 | Glutamate (mGluR3) antagonist | 154 | 0.9991 |
1906 | Glutamate (mGluR4) agonist | 5 | 0.9927 |
1907 | Glutamate (mGluR4) antagonist | 29 | 0.9977 |
1908 | Glutamate (mGluR5) agonist | 17 | 0.9460 |
1909 | Glutamate (mGluR5) antagonist | 410 | 0.9830 |
1910 | Glutamate (mGluR5a) agonist | 4 | 0.9999 |
1911 | Glutamate (mGluR6) agonist | 8 | 0.9991 |
1912 | Glutamate (mGluR6) antagonist | 25 | 0.9707 |
1913 | Glutamate (mGluR8) agonist | 3 | 0.9977 |
1914 | Glutamate (mGluR8) antagonist | 42 | 0.9817 |
1915 | Glutamate 5-kinase inhibitor | 9 | 0.8882 |
1916 | Glutamate carboxypeptidase inhibitor | 21 | 0.9901 |
1917 | Glutamate decarboxylase inhibitor | 43 | 0.9734 |
1918 | Glutamate dehydrogenase (NADP+) inhibitor | 18 | 0.9917 |
1919 | Glutamate dehydrogenase [NAD(P)+] inhibitor | 45 | 0.9882 |
1920 | Glutamate dehydrogenase inhibitor | 34 | 0.9595 |
1921 | Glutamate formimidoyltransferase inhibitor | 11 | 0.9969 |
1922 | Glutamate N-acetyltransferase inhibitor | 4 | 0.9913 |
1923 | Glutamate racemase inhibitor | 72 | 0.9968 |
1924 | Glutamate receptor agonist | 370 | 0.9800 |
1925 | Glutamate receptor antagonist | 6051 | 0.9730 |
1926 | Glutamate release inhibitor | 58 | 0.9520 |
1927 | Glutamate synthase (ferredoxin) inhibitor | 21 | 0.9554 |
1928 | Glutamate synthase (NADPH) inhibitor | 54 | 0.9772 |
1929 | Glutamate uptake inhibitor | 9 | 0.9990 |
1930 | Glutamate-1-semialdehyde 2,1-aminomutase inhibitor | 9 | 0.9571 |
1931 | Glutamate-5-semialdehyde dehydrogenase inhibitor | 4 | 0.8871 |
1932 | Glutamate-cysteine ligase inhibitor | 36 | 0.9917 |
1933 | Glutamate-tRNA ligase inhibitor | 6 | 0.8257 |
1934 | Glutamin-(asparagin-)ase inhibitor | 13 | 0.9659 |
1935 | Glutaminase inhibitor | 20 | 0.9500 |
1936 | Glutamine synthetase inhibitor | 38 | 0.9652 |
1937 | Glutamine-fructose-6-phosphate transaminase inhibitor | 4 | 0.9942 |
1938 | Glutamine-phenylpyruvate transaminase inhibitor | 3 | 0.9666 |
1939 | Glutamine-pyruvate transaminase inhibitor | 7 | 0.9931 |
1940 | Glutamine-tRNA ligase inhibitor | 9 | 0.9891 |
1941 | Glutaminyl-peptide cyclotransferase inhibitor | 12 | 0.8868 |
1942 | Glutaminyl-tRNA synthase (glutamine-hydrolysing) inhibitor | 4 | 0.9947 |
1943 | Glutamyl endopeptidase II inhibitor | 3 | 0.8403 |
1944 | Glutarate-semialdehyde dehydrogenase inhibitor | 3 | 0.9824 |
1945 | Glutaryl-CoA dehydrogenase inhibitor | 5 | 0.9875 |
1946 | Glutathione dehydrogenase (ascorbate) inhibitor | 7 | 0.9572 |
1947 | Glutathione peroxidase inhibitor | 10 | 0.9461 |
1948 | Glutathione reductase (NADPH) stimulant | 11 | 0.9752 |
1949 | Glutathione reductase inhibitor | 46 | 0.9495 |
1950 | Glutathione reductase stimulant | 11 | 0.9752 |
1951 | Glutathione S-transferase inhibitor | 53 | 0.9728 |
1952 | Glutathione S-transferase substrate | 218 | 0.9635 |
1953 | Glutathione synthase inhibitor | 15 | 0.9827 |
1954 | Glutathione thiolesterase inhibitor | 3 | 0.9455 |
1955 | Glutathione-disulfide reductase inhibitor | 46 | 0.9852 |
1956 | Glutathionylspermidine synthase inhibitor | 17 | 0.9997 |
1957 | Glyceraldehyde-3-phosphate dehydrogenase (NADP+) inhibitor | 12 | 0.9616 |
1958 | Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) inhibitor | 16 | 0.9858 |
1959 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 23 | 0.9845 |
1960 | Glycerate kinase inhibitor | 12 | 0.9991 |
1961 | Glycerol 2-dehydrogenase (NADP+) inhibitor | 4 | 0.9763 |
1962 | Glycerol dehydratase inhibitor | 6 | 0.9951 |
1963 | Glycerol dehydrogenase (NADP+) inhibitor | 5 | 0.9770 |
1964 | Glycerol dehydrogenase inhibitor | 34 | 0.9854 |
1965 | Glycerol kinase inhibitor | 18 | 0.9934 |
1966 | Glycerol-1,2-cyclic-phosphate 2-phosphodiesterase inhibitor | 7 | 0.9991 |
1967 | Glycerol-1-phosphatase inhibitor | 3 | 0.9922 |
1968 | Glycerol-3-phosphate dehydrogenase (NAD+) inhibitor | 21 | 0.9806 |
1969 | Glycerol-3-phosphate dehydrogenase [NAD(P)+] inhibitor | 6 | 0.9989 |
1970 | Glycerol-3-phosphate dehydrogenase inhibitor | 28 | 0.9068 |
1971 | Glycerol-3-phosphate O-acyltransferase inhibitor | 23 | 0.9482 |
1972 | Glycerol-3-phosphate oxidase inhibitor | 6 | 0.8267 |
1973 | Glycerone-phosphate O-acyltransferase inhibitor | 10 | 0.9846 |
1974 | Glycerophosphocholine cholinephosphodiesterase inhibitor | 6 | 0.9942 |
1975 | Glycerophosphocholine phosphodiesterase inhibitor | 8 | 0.9962 |
1976 | Glyceryl-ether monooxygenase inhibitor | 11 | 0.8711 |
1977 | Glycine amidinotransferase inhibitor | 5 | 0.9552 |
1978 | Glycine C-acetyltransferase inhibitor | 12 | 0.9078 |
1979 | Glycine dehydrogenase (decarboxylating) inhibitor | 3 | 0.9860 |
1980 | Glycine hydroxymethyltransferase inhibitor | 30 | 0.9649 |
1981 | Glycine N-acyltransferase inhibitor | 6 | 0.9912 |
1982 | Glycine N-benzoyltransferase inhibitor | 6 | 0.9901 |
1983 | Glycine N-choloyltransferase inhibitor | 10 | 0.9943 |
1984 | Glycine N-methyltransferase inhibitor | 9 | 0.9940 |
1985 | Glycine receptor agonist | 13 | 0.9401 |
1986 | Glycine receptor antagonist | 77 | 0.9671 |
1987 | Glycine transaminase inhibitor | 7 | 0.9937 |
1988 | Glycine transporter 1 inhibitor | 466 | 0.9968 |
1989 | Glycine transporter 2 inhibitor | 74 | 0.9842 |
1990 | Glycine transporter inhibitor | 550 | 0.9922 |
1991 | Glycine-tRNA ligase inhibitor | 10 | 0.9072 |
1992 | Glycogen (starch) synthase inhibitor | 26 | 0.9452 |
1993 | Glycogen synthase kinase-3 alpha inhibitor | 345 | 0.9894 |
1994 | Glycogen synthase kinase-3 beta inhibitor | 882 | 0.9815 |
1995 | Glycogen synthase kinase-3 inhibitor | 1215 | 0.9817 |
1996 | Glycogen synthase stimulant | 9 | 0.8707 |
1997 | Glycogenin glucosyltransferase inhibitor | 8 | 0.9974 |
1998 | Glycolaldehyde dehydrogenase inhibitor | 6 | 0.9940 |
1999 | Glycolate dehydrogenase inhibitor | 3 | 0.9747 |
2000 | Glycolipid 2-alpha-mannosyltransferase inhibitor | 9 | 0.9978 |
2001 | Glycolipid 3-alpha-mannosyltransferase inhibitor | 12 | 0.9973 |
2002 | Glycopeptide alpha-N-acetylgalactosaminidase inhibitor | 8 | 0.9863 |
2003 | Glycoprotein 3-alpha-L-fucosyltransferase inhibitor | 10 | 0.9770 |
2004 | Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase inhibitor | 9 | 0.9565 |
2005 | Glycosylceramidase inhibitor | 14 | 0.9928 |
2006 | Glycosylphosphatidylinositol diacylglycerol-lyase inhibitor | 17 | 0.9730 |
2007 | Glycosylphosphatidylinositol phospholipase D inhibitor | 4 | 0.8797 |
2008 | Glyoxylate oxidase inhibitor | 3 | 0.9771 |
2009 | Glyoxylate reductase (NADP+) inhibitor | 12 | 0.9294 |
2010 | Glyoxylate reductase inhibitor | 4 | 0.9231 |
2011 | Gly-X carboxypeptidase inhibitor | 6 | 0.9863 |
2012 | GMP reductase inhibitor | 17 | 0.9968 |
2013 | GMP synthase inhibitor | 57 | 0.9848 |
2014 | Gonadotropin antagonist | 24 | 0.8662 |
2015 | Gout treatment | 117 | 0.9402 |
2016 | GP IIb/IIIa receptor antagonist | 2068 | 0.9911 |
2017 | G-protein-coupled bile acid receptor 1 agonist | 9 | 0.9605 |
2018 | G-protein-coupled receptor 120 agonist | 10 | 0.9999 |
2019 | G-protein-coupled receptor kinase inhibitor | 22 | 0.8262 |
2020 | Granulocyte macrophage colony stimulating factor agonist | 12 | 0.9743 |
2021 | Granulocyte stimulating factor agonist | 30 | 1.0000 |
2022 | Granzyme A inhibitor | 9 | 0.9766 |
2023 | Granzyme B inhibitor | 23 | 0.9691 |
2024 | Growth factor agonist | 244 | 0.9172 |
2025 | Growth factor antagonist | 3528 | 0.9682 |
2026 | Growth factor receptor-bound protein 2 antagonist | 72 | 0.9999 |
2027 | Growth hormone agonist | 10 | 0.9527 |
2028 | Growth hormone release inhibitor | 69 | 0.9828 |
2029 | Growth hormone release promoting | 58 | 0.9829 |
2030 | Growth hormone releasing factor agonist | 445 | 0.9959 |
2031 | Growth hormone releasing factor antagonist | 38 | 0.9997 |
2032 | Growth stimulant | 61 | 0.9387 |
2033 | GRP78 expression inhibitor | 5 | 0.9999 |
2034 | GST A substrate | 12 | 0.9043 |
2035 | GST M substrate | 13 | 0.9248 |
2036 | GST M1-1 substrate | 8 | 0.9101 |
2037 | GST P substrate | 15 | 0.9555 |
2038 | GST P1-1 substrate | 14 | 0.9580 |
2039 | GST T substrate | 8 | 0.9507 |
2040 | GST T1-1 substrate | 8 | 0.9507 |
2041 | GTP cyclohydrolase I inhibitor | 15 | 0.9939 |
2042 | GTP cyclohydrolase IIa inhibitor | 6 | 0.9999 |
2043 | Guanidinoacetase inhibitor | 6 | 0.9805 |
2044 | Guanidinoacetate kinase inhibitor | 12 | 0.9093 |
2045 | Guanidinoacetate N-methyltransferase inhibitor | 6 | 0.9809 |
2046 | Guanidinobutyrase inhibitor | 13 | 0.9925 |
2047 | Guanidinodeoxy-scyllo-inositol-4-phosphatase inhibitor | 3 | 0.9938 |
2048 | Guanidinopropionase inhibitor | 5 | 0.9950 |
2049 | Guanine deaminase inhibitor | 13 | 0.9830 |
2050 | Guanosine-3',5'-bis(diphosphate) 3'-diphosphatase inhibitor | 4 | 0.9204 |
2051 | Guanylate cyclase 1 inhibitor | 8 | 1.0000 |
2052 | Guanylate cyclase 1 stimulant | 10 | 0.9309 |
2053 | Guanylate cyclase inhibitor | 96 | 0.9622 |
2054 | Guanylate cyclase stimulant | 74 | 0.9571 |
2055 | Guanylate kinase inhibitor | 15 | 0.9913 |
2056 | Gynecological disorders treatment | 679 | 0.9743 |
2057 | H+/K+-transporting ATPase inhibitor | 601 | 0.9795 |
2058 | H+-exporting ATPase inhibitor | 12 | 0.9271 |
2059 | H+-transporting two-sector ATPase inhibitor | 6 | 0.9083 |
2060 | Hair growth stimulant | 508 | 0.9671 |
2061 | Haloacetate dehalogenase inhibitor | 3 | 0.9948 |
2062 | Haloalkane dehalogenase inhibitor | 4 | 0.9979 |
2063 | HCV IRES inhibitor | 9 | 0.8681 |
2064 | HCV NS3/NS4A protease inhibitor | 617 | 0.9842 |
2065 | HCV NS3-helicase inhibitor | 86 | 0.9688 |
2066 | HCV NS5A inhibitor | 20 | 0.9999 |
2067 | HCV NS5B polymerase inhibitor | 524 | 0.9948 |
2068 | HDL-cholesterol increasing | 175 | 0.9532 |
2069 | Headache | 838 | 0.8131 |
2070 | Heart failure treatment | 1565 | 0.9462 |
2071 | Heat shock protein 27 antagonist | 9 | 0.8160 |
2072 | Heat shock protein 70 agonist | 24 | 0.9444 |
2073 | Heat shock protein 70 antagonist | 23 | 0.9637 |
2074 | Heat shock protein 90 antagonist | 332 | 0.9756 |
2075 | Heat shock protein agonist | 25 | 0.9204 |
2076 | Heat shock protein antagonist | 364 | 0.9702 |
2077 | Hedgehog signaling activator | 4 | 1.0000 |
2078 | Hedgehog signaling inhibitor | 83 | 0.9708 |
2079 | Helicase E1 (Human papillomavirus) inhibitor | 28 | 0.9998 |
2080 | Hematemesis | 7 | 0.8318 |
2081 | Hematinic | 13 | 0.9337 |
2082 | Hematopoietic | 68 | 0.8997 |
2083 | Hematopoietic inhibitor | 18 | 0.9108 |
2084 | Hematotoxic | 1142 | 0.8266 |
2085 | Hematuria | 43 | 0.8519 |
2086 | Heme oxygenase inhibitor | 7 | 0.8033 |
2087 | Heme oxygenase stimulant | 10 | 0.9861 |
2088 | Hemostatic | 101 | 0.8983 |
2089 | Heparan-alpha-glucosaminide N-acetyltransferase inhibitor | 12 | 0.9861 |
2090 | Heparanase inhibitor | 60 | 0.9845 |
2091 | Heparin epidermal growth factor antagonist | 114 | 0.9996 |
2092 | Hepatic disorders treatment | 706 | 0.8964 |
2093 | Hepatitis | 397 | 0.7976 |
2094 | Hepatocyte growth factor agonist | 7 | 0.8722 |
2095 | Hepatocyte growth factor antagonist | 526 | 0.9773 |
2096 | Hepatocyte nuclear factor 4 alpha agonist | 6 | 0.9996 |
2097 | Hepatocyte nuclear factor 4 alpha antagonist | 6 | 0.9208 |
2098 | Hepatocyte nuclear factor agonist | 6 | 0.9996 |
2099 | Hepatocyte nuclear factor antagonist | 6 | 0.9208 |
2100 | Hepatoprotectant | 291 | 0.9033 |
2101 | Hepatotoxic | 1033 | 0.8370 |
2102 | HERG 1 channel blocker | 38 | 0.9411 |
2103 | HERG channel blocker | 1207 | 0.9520 |
2104 | Hexokinase inhibitor | 193 | 0.9557 |
2105 | Hexokinase stimulant | 119 | 0.9911 |
2106 | HIF1A expression inhibitor | 23 | 0.8290 |
2107 | High-mannose-oligosaccharide beta-1,4-N-acetylglucosaminyltransferase inhibitor | 3 | 0.9983 |
2108 | Hippurate hydrolase inhibitor | 4 | 0.9922 |
2109 | Hirsutism treatment | 82 | 0.9846 |
2110 | Histamine agonist | 118 | 0.9367 |
2111 | Histamine antagonist | 2720 | 0.9636 |
2112 | Histamine H1 receptor agonist | 5 | 0.9848 |
2113 | Histamine H1 receptor antagonist | 858 | 0.9771 |
2114 | Histamine H2 receptor agonist | 36 | 0.9789 |
2115 | Histamine H2 receptor antagonist | 375 | 0.9819 |
2116 | Histamine H3 receptor agonist | 55 | 0.9994 |
2117 | Histamine H3 receptor antagonist | 1447 | 0.9944 |
2118 | Histamine H4 receptor antagonist | 131 | 0.9955 |
2119 | Histamine N-methyltransferase inhibitor | 69 | 0.9807 |
2120 | Histamine release inhibitor | 118 | 0.8600 |
2121 | Histamine release stimulant | 21 | 0.8929 |
2122 | Histidine ammonia-lyase inhibitor | 34 | 0.9844 |
2123 | Histidine decarboxylase inhibitor | 33 | 0.9802 |
2124 | Histidine kinase inhibitor | 4 | 0.9246 |
2125 | Histidine N-acetyltransferase inhibitor | 6 | 0.8181 |
2126 | Histidine-tRNA ligase inhibitor | 19 | 0.9940 |
2127 | Histidinol dehydrogenase inhibitor | 21 | 0.9347 |
2128 | Histidinol-phosphatase inhibitor | 6 | 0.9731 |
2129 | Histone acetylation inducer | 9 | 1.0000 |
2130 | Histone acetyltransferase inhibitor | 43 | 0.9182 |
2131 | Histone deacetylase 1 inhibitor | 887 | 0.9954 |
2132 | Histone deacetylase 1A inhibitor | 8 | 0.9996 |
2133 | Histone deacetylase 1B inhibitor | 36 | 0.9999 |
2134 | Histone deacetylase 2 inhibitor | 523 | 0.9946 |
2135 | Histone deacetylase 3 inhibitor | 533 | 0.9931 |
2136 | Histone deacetylase 4 inhibitor | 487 | 0.9939 |
2137 | Histone deacetylase 6 inhibitor | 719 | 0.9969 |
2138 | Histone deacetylase 8 inhibitor | 312 | 0.9915 |
2139 | Histone deacetylase class I inhibitor | 1133 | 0.9951 |
2140 | Histone deacetylase class II inhibitor | 811 | 0.9957 |
2141 | Histone deacetylase class IIa inhibitor | 497 | 0.9940 |
2142 | Histone deacetylase class IIb inhibitor | 726 | 0.9969 |
2143 | Histone deacetylase class III inhibitor | 56 | 0.9653 |
2144 | Histone deacetylase inhibitor | 1924 | 0.9887 |
2145 | Histone deacetylase SIRT1 inhibitor | 38 | 0.9562 |
2146 | Histone deacetylase SIRT1 stimulant | 63 | 0.9942 |
2147 | Histone deacetylase SIRT2 inhibitor | 42 | 0.9706 |
2148 | Histone deacetylase SIRT2 stimulant | 5 | 0.9989 |
2149 | Histone deacetylase stimulant | 63 | 0.9942 |
2150 | Histone-arginine N-methyltransferase inhibitor | 9 | 0.9941 |
2151 | Histone-lysine N-methyltransferase inhibitor | 17 | 0.9992 |
2152 | HIV attachment inhibitor | 13 | 0.8900 |
2153 | HIV fusion inhibitor | 4 | 1.0000 |
2154 | HIV-1 integrase (3'-Processing) inhibitor | 358 | 0.9845 |
2155 | HIV-1 integrase (Overall Integration) inhibitor | 55 | 0.9774 |
2156 | HIV-1 integrase (Strand Transfer) inhibitor | 355 | 0.9860 |
2157 | HIV-1 integrase inhibitor | 884 | 0.9793 |
2158 | HIV-1 protease inhibitor | 2615 | 0.9913 |
2159 | HIV-1 reverse transcriptase inhibitor | 2106 | 0.9879 |
2160 | HIV-2 retropepsin inhibitor | 16 | 0.9990 |
2161 | HIV-2 reverse transcriptase inhibitor | 3 | 0.9851 |
2162 | HLA-A2 antigen antagonist | 188 | 0.9992 |
2163 | HMG CoA reductase inhibitor | 484 | 0.9918 |
2164 | HMG CoA synthase inhibitor | 5 | 0.9801 |
2165 | HMGCS2 expression enhancer | 5 | 0.9198 |
2166 | HMOX1 expression enhancer | 69 | 0.9033 |
2167 | Homoaconitate hydratase inhibitor | 3 | 0.9894 |
2168 | Homocitrate synthase inhibitor | 18 | 0.9821 |
2169 | Homocysteine desulfhydrase inhibitor | 8 | 0.9901 |
2170 | Homocysteine S-methyltransferase inhibitor | 4 | 0.9948 |
2171 | Homogentisate 1,2-dioxygenase inhibitor | 12 | 0.9552 |
2172 | Homoisocitrate dehydrogenase inhibitor | 3 | 0.9999 |
2173 | Homoserine dehydrogenase inhibitor | 14 | 0.8914 |
2174 | Homoserine kinase inhibitor | 24 | 0.9844 |
2175 | Homoserine O-acetyltransferase inhibitor | 11 | 0.9977 |
2176 | Homoserine O-succinyltransferase inhibitor | 3 | 0.9977 |
2177 | Homospermidine synthase inhibitor | 4 | 0.9949 |
2178 | Horrilysin inhibitor | 3 | 0.9846 |
2179 | Hot flush treatment | 91 | 0.9840 |
2180 | Huntington's disease treatment | 143 | 0.9511 |
2181 | Hyaluronic acid agonist | 3 | 0.9246 |
2182 | Hydrogen dehydrogenase inhibitor | 3 | 0.8996 |
2183 | Hydroperoxide dehydratase inhibitor | 12 | 0.9904 |
2184 | Hydroxyacylglutathione hydrolase inhibitor | 55 | 0.9754 |
2185 | Hydroxylamine oxidase inhibitor | 6 | 0.9056 |
2186 | Hydroxylamine reductase (NADH) inhibitor | 18 | 0.8748 |
2187 | Hydroxylamine reductase inhibitor | 6 | 0.8633 |
2188 | Hydroxylysine kinase inhibitor | 9 | 0.9973 |
2189 | Hydroxymethylbilane synthase inhibitor | 11 | 0.9606 |
2190 | Hydroxymethylglutaryl-CoA lyase inhibitor | 7 | 0.9534 |
2191 | Hydroxymethylglutaryl-CoA reductase inhibitor | 5 | 0.9953 |
2192 | Hydroxypyruvate reductase inhibitor | 17 | 0.9964 |
2193 | Hydroxyquinol 1,2-dioxygenase inhibitor | 9 | 0.9970 |
2194 | Hydroxysteroid dehydrogenase inhibitor | 4 | 0.9365 |
2195 | Hypercalcaemic | 19 | 0.8470 |
2196 | Hypercalcemia treatment | 43 | 0.9584 |
2197 | Hypercholesterolemic | 10 | 0.8511 |
2198 | Hyperglycemic | 71 | 0.8011 |
2199 | Hyperparathyroidism treatment | 68 | 0.9845 |
2200 | Hyperprolactinemia treatment | 9 | 0.9760 |
2201 | Hypertensive | 736 | 0.8149 |
2202 | Hypertensive, ophthalmic | 10 | 0.9578 |
2203 | Hyperthermic | 263 | 0.8439 |
2204 | Hyperuricemia | 4 | 0.9471 |
2205 | Hypnotic | 715 | 0.9230 |
2206 | Hypocalcaemic | 29 | 0.8539 |
2207 | Hypoglycemic | 413 | 0.9188 |
2208 | Hypogonadism treatment | 125 | 0.9988 |
2209 | Hypolipemic | 2014 | 0.8916 |
2210 | Hypomagnesemia | 3 | 0.9376 |
2211 | Hypomania | 22 | 0.9436 |
2212 | Hyponitrite reductase inhibitor | 3 | 0.9781 |
2213 | Hypotension | 1053 | 0.8323 |
2214 | Hypothermic | 295 | 0.8441 |
2215 | Hypotonia | 98 | 0.8001 |
2216 | Hypoxanthine phosphoribosyltransferase inhibitor | 37 | 0.9896 |
2217 | Hypoxia inducible factor 1 alpha inhibitor | 60 | 0.9438 |
2218 | I kappa B kinase 2 inhibitor | 310 | 0.9732 |
2219 | I kappa B kinase inhibitor | 387 | 0.9653 |
2220 | I(Ks) voltage-gated potassium channel blocker | 38 | 0.9996 |
2221 | ICAM 1 antagonist | 389 | 0.9955 |
2222 | ICAM1 expression inhibitor | 58 | 0.8807 |
2223 | Iduronate-2-sulfatase inhibitor | 3 | 0.9951 |
2224 | IgA-specific metalloendopeptidase inhibitor | 9 | 0.9751 |
2225 | IgA-specific serine endopeptidase inhibitor | 5 | 0.9531 |
2226 | Ileal bile acid transport inhibitor | 144 | 0.9983 |
2227 | Imidazoleacetate 4-monooxygenase inhibitor | 13 | 0.9896 |
2228 | Imidazoleglycerol-phosphate dehydratase inhibitor | 5 | 0.9981 |
2229 | Imidazoline I1 receptor agonist | 3 | 0.9786 |
2230 | Imidazoline I1 receptor antagonist | 52 | 0.9996 |
2231 | Imidazoline I2 receptor antagonist | 140 | 0.9997 |
2232 | Imidazoline receptor agonist | 6 | 0.9715 |
2233 | Imidazoline receptor antagonist | 158 | 0.9994 |
2234 | Immunoglobulin E antagonist | 39 | 0.9417 |
2235 | Immunoglobulin Fc receptor antagonist | 36 | 0.9467 |
2236 | Immunomodulator | 1484 | 0.8917 |
2237 | Immunostimulant | 675 | 0.9063 |
2238 | Immunosuppressant | 2090 | 0.8710 |
2239 | IMP cyclohydrolase inhibitor | 10 | 0.9998 |
2240 | Indanol dehydrogenase inhibitor | 13 | 0.9249 |
2241 | Indole-3-acetaldehyde reductase (NADPH) inhibitor | 11 | 0.9927 |
2242 | Indoleacetaldoxime dehydratase inhibitor | 12 | 0.9226 |
2243 | Indoleamine-pyrrole 2,3-dioxygenase inhibitor | 131 | 0.9825 |
2244 | Indolepyruvate C-methyltransferase inhibitor | 4 | 0.9738 |
2245 | Inducible nitric-oxide synthase inhibitor | 441 | 0.9769 |
2246 | Inflammation | 442 | 0.8062 |
2247 | Inflammatory Bowel disease treatment | 1272 | 0.8906 |
2248 | Inorganic diphosphatase inhibitor | 28 | 0.9560 |
2249 | Inosine kinase inhibitor | 4 | 0.9999 |
2250 | Inosine monophosphate dehydrogenase 1 inhibitor | 69 | 0.9992 |
2251 | Inosine monophosphate dehydrogenase 2 inhibitor | 346 | 0.9997 |
2252 | Inosine monophosphate dehydrogenase inhibitor | 452 | 0.9977 |
2253 | Inosine nucleosidase inhibitor | 4 | 0.9908 |
2254 | Inosine-adenosine-guanosine-nucleoside hydrolase inhibitor | 4 | 1.0000 |
2255 | Inositol 1,4,5-triphosphate receptor 1 antagonist | 10 | 1.0000 |
2256 | Inositol 1,4,5-triphosphate receptor antagonist | 12 | 0.9628 |
2257 | Inositol 1,4,5-trisphosphate 3-kinase B inhibitor | 11 | 0.9865 |
2258 | Inositol 1,4,5-trisphosphate 3-kinase inhibitor | 15 | 0.9489 |
2259 | Inositol oxygenase inhibitor | 34 | 0.9533 |
2260 | Inositol polyphosphate-5-phosphatase D stimulant | 7 | 0.9998 |
2261 | Inositol-3-phosphate synthase inhibitor | 20 | 0.9923 |
2262 | Inositol-polyphosphate 5-phosphatase inhibitor | 19 | 0.9851 |
2263 | Inotropic | 36 | 0.8742 |
2264 | Insecticide | 193 | 0.9607 |
2265 | Insulin antagonist | 339 | 0.9672 |
2266 | Insulin growth factor antagonist | 532 | 0.9838 |
2267 | Insulin like growth factor 1 antagonist | 488 | 0.9810 |
2268 | Insulin like growth factor 3 antagonist | 44 | 1.0000 |
2269 | Insulin promoter | 43 | 0.8291 |
2270 | Insulin secretagoues | 249 | 0.9593 |
2271 | Insulin sensitizer | 224 | 0.9684 |
2272 | Insulysin inhibitor | 49 | 0.8563 |
2273 | Integrin alpha1beta1 antagonist | 42 | 0.9940 |
2274 | Integrin alpha2 antagonist | 35 | 0.9825 |
2275 | Integrin alpha2beta1 antagonist | 25 | 0.9788 |
2276 | Integrin alpha4 antagonist | 2146 | 0.9979 |
2277 | Integrin alpha4beta1 antagonist | 941 | 0.9968 |
2278 | Integrin alpha4beta7 antagonist | 602 | 0.9978 |
2279 | Integrin alpha5beta1 antagonist | 163 | 0.9910 |
2280 | Integrin alpha5beta6 antagonist | 14 | 0.9999 |
2281 | Integrin alphaLbeta2 antagonist | 38 | 0.9996 |
2282 | Integrin alphaVbeta1 antagonist | 17 | 0.9555 |
2283 | Integrin alphaVbeta3 antagonist | 14 | 0.9885 |
2284 | Integrin alphaVbeta5 antagonist | 307 | 0.9984 |
2285 | Integrin alphaVbeta6 antagonist | 79 | 0.9985 |
2286 | Integrin antagonist | 4042 | 0.9917 |
2287 | Integrin-linked kinase inhibitor | 13 | 1.0000 |
2288 | Interferon agonist | 134 | 0.9651 |
2289 | Interferon alpha agonist | 4 | 0.9562 |
2290 | Interferon antagonist | 85 | 0.9555 |
2291 | Interferon gamma antagonist | 84 | 0.9595 |
2292 | Interferon inducer | 112 | 0.9839 |
2293 | Interleukin 1 antagonist | 919 | 0.9527 |
2294 | Interleukin 1 beta converting enzyme inhibitor | 289 | 0.9895 |
2295 | Interleukin 10 agonist | 37 | 0.9074 |
2296 | Interleukin 10 antagonist | 6 | 0.9666 |
2297 | Interleukin 12 agonist | 130 | 0.9624 |
2298 | Interleukin 1a antagonist | 17 | 0.9378 |
2299 | Interleukin 1b antagonist | 499 | 0.9681 |
2300 | Interleukin 2 agonist | 15 | 0.8700 |
2301 | Interleukin 2 antagonist | 228 | 0.9545 |
2302 | Interleukin 4 antagonist | 146 | 0.9512 |
2303 | Interleukin 5 antagonist | 131 | 0.9621 |
2304 | Interleukin 6 antagonist | 214 | 0.9260 |
2305 | Interleukin 8 antagonist | 209 | 0.9507 |
2306 | Interleukin agonist | 177 | 0.9374 |
2307 | Interleukin antagonist | 1566 | 0.9291 |
2308 | Intermittent claudication treatment | 17 | 0.8350 |
2309 | Interstitial nephritis | 97 | 0.8195 |
2310 | Inulinase inhibitor | 4 | 0.9877 |
2311 | Iodide peroxidase inhibitor | 21 | 0.9707 |
2312 | Iron antagonist | 8 | 0.9962 |
2313 | Iron-cytochrome-c reductase inhibitor | 3 | 0.9875 |
2314 | Irritable Bowel syndrome treatment | 1423 | 0.9453 |
2315 | Irritation | 65 | 0.9154 |
2316 | Isoamylase inhibitor | 15 | 0.9906 |
2317 | Isocitrate dehydrogenase (NAD+) inhibitor | 28 | 0.9759 |
2318 | Isocitrate dehydrogenase (NADP+) inhibitor | 24 | 0.9914 |
2319 | Isocitrate lyase inhibitor | 26 | 0.9848 |
2320 | Isoleucine-tRNA ligase inhibitor | 25 | 0.9873 |
2321 | Isomaltulose synthase inhibitor | 6 | 0.9937 |
2322 | Isopenicillin-N epimerase inhibitor | 9 | 0.8660 |
2323 | Isopenicillin-N synthase inhibitor | 8 | 0.9728 |
2324 | Isopentenyl-diphosphate DELTA-isomerase inhibitor | 22 | 0.9985 |
2325 | Isoquinoline 1-oxidoreductase inhibitor | 4 | 0.9842 |
2326 | Isovaleryl-CoA dehydrogenase inhibitor | 6 | 0.9868 |
2327 | JAK2 expression inhibitor | 4 | 0.9197 |
2328 | Janus tyrosine kinase 1 inhibitor | 59 | 0.9725 |
2329 | Janus tyrosine kinase 2 inhibitor | 381 | 0.9456 |
2330 | Janus tyrosine kinase 3 inhibitor | 406 | 0.9861 |
2331 | Janus tyrosine kinase inhibitor | 768 | 0.9604 |
2332 | JNK mitogen-activated protein kinase inhibitor | 43 | 0.9518 |
2333 | Juvenile-hormone esterase inhibitor | 86 | 0.9993 |
2334 | K(Ca) 3.1 channel activator | 4 | 0.9869 |
2335 | K(Ca) 3.1 channel blocker | 41 | 0.9838 |
2336 | K(ir) 6.2 channel activator | 13 | 0.9506 |
2337 | Kainate receptor 1 agonist | 5 | 0.9984 |
2338 | Kainate receptor 1 antagonist | 296 | 0.9977 |
2339 | Kainate receptor 2 antagonist | 135 | 0.9949 |
2340 | Kainate receptor 3 antagonist | 140 | 0.9978 |
2341 | Kainate receptor 4 antagonist | 134 | 0.9972 |
2342 | Kainate receptor 5 antagonist | 152 | 0.9972 |
2343 | Kainate receptor agonist | 26 | 0.9920 |
2344 | Kainate receptor antagonist | 461 | 0.9942 |
2345 | Kallikrein 13 inhibitor | 10 | 0.9988 |
2346 | Kallikrein 3 inhibitor | 29 | 0.9912 |
2347 | Kallikrein inhibitor | 94 | 0.9569 |
2348 | Kanamycin kinase inhibitor | 3 | 0.9999 |
2349 | Keratan sulfotransferase inhibitor | 7 | 0.9990 |
2350 | Keratolytic | 34 | 0.9450 |
2351 | Keratopathy | 92 | 0.8375 |
2352 | Keratoses actinic (solar) treatment | 68 | 0.9534 |
2353 | Ketohexokinase inhibitor | 15 | 0.9422 |
2354 | Ketol-acid reductoisomerase inhibitor | 10 | 0.9218 |
2355 | Ketosteroid monooxygenase inhibitor | 5 | 0.9998 |
2356 | Kexin inhibitor | 16 | 0.9835 |
2357 | Kidney function stimulant | 7 | 0.8506 |
2358 | Kinase inhibitor | 11 | 0.8667 |
2359 | Kinesin antagonist | 374 | 0.9920 |
2360 | Kinesin-like protein 1 inhibitor | 374 | 0.9920 |
2361 | KiSS-1 receptor agonist | 3 | 1.0000 |
2362 | Kynureninase inhibitor | 42 | 0.9879 |
2363 | Kynurenine 3 monooxygenase inhibitor | 70 | 0.9991 |
2364 | L lactate dehydrogenase A inhibitor | 16 | 1.0000 |
2365 | L lactate dehydrogenase A4 inhibitor | 15 | 1.0000 |
2366 | L lactate dehydrogenase B inhibitor | 6 | 1.0000 |
2367 | L lactate dehydrogenase B4 inhibitor | 6 | 1.0000 |
2368 | L lactate dehydrogenase C inhibitor | 16 | 1.0000 |
2369 | L lactate dehydrogenase C4 inhibitor | 16 | 1.0000 |
2370 | L lactate dehydrogenase inhibitor | 32 | 0.9620 |
2371 | L(+)-Tartrate dehydratase inhibitor | 7 | 0.9996 |
2372 | L-3-cyanoalanine synthase inhibitor | 10 | 0.9958 |
2373 | Laccase inhibitor | 18 | 0.9544 |
2374 | Lacrimal secretion stimulant | 72 | 0.9086 |
2375 | Lactaldehyde dehydrogenase inhibitor | 6 | 0.9982 |
2376 | Lactaldehyde reductase (NADPH) inhibitor | 4 | 0.9914 |
2377 | Lactaldehyde reductase inhibitor | 4 | 0.9872 |
2378 | Lactamase A inhibitor | 7 | 0.9950 |
2379 | Lactamase C inhibitor | 8 | 0.9825 |
2380 | Lactase inhibitor | 3 | 0.8672 |
2381 | Lactate 2-monooxygenase inhibitor | 13 | 0.9296 |
2382 | Lactate-malate transhydrogenase inhibitor | 5 | 0.9954 |
2383 | Lactose synthase inhibitor | 14 | 0.8878 |
2384 | Lactosylceramide alpha-2,3-sialyltransferase inhibitor | 20 | 0.9807 |
2385 | Lactoylglutathione lyase inhibitor | 90 | 0.9822 |
2386 | Laminaribiose phosphorylase inhibitor | 9 | 0.9756 |
2387 | L-amino-acid oxidase inhibitor | 20 | 0.9680 |
2388 | L-aminoadipate-semialdehyde dehydrogenase inhibitor | 9 | 0.9950 |
2389 | Lanosterol 14 alpha demethylase inhibitor | 76 | 0.9487 |
2390 | Laryngospasm | 75 | 0.8467 |
2391 | L-ascorbate peroxidase inhibitor | 16 | 0.9861 |
2392 | Lassitude treatment | 18 | 0.9422 |
2393 | Laxative | 50 | 0.9352 |
2394 | Lck kinase inhibitor | 966 | 0.9683 |
2395 | LDLR expression enhancer | 118 | 0.9225 |
2396 | LECT1 expression enhancer | 9 | 1.0000 |
2397 | Leishmanolysin inhibitor | 6 | 0.8611 |
2398 | Leucine dehydrogenase inhibitor | 5 | 0.9172 |
2399 | Leucine transaminase inhibitor | 5 | 0.9933 |
2400 | Leucine-tRNA ligase inhibitor | 30 | 0.9359 |
2401 | Leucolysin inhibitor | 6 | 0.9826 |
2402 | Leucyltransferase inhibitor | 14 | 0.9876 |
2403 | Leukocyte elastase inhibitor | 184 | 0.9687 |
2404 | Leukopenia | 542 | 0.8200 |
2405 | Leukopoiesis inhibitor | 23 | 0.8407 |
2406 | Leukopoiesis stimulant | 9 | 0.8304 |
2407 | Leukotriene A4 hydrolase inhibitor | 322 | 0.9973 |
2408 | Leukotriene agonist | 5 | 0.9909 |
2409 | Leukotriene antagonist | 1324 | 0.9780 |
2410 | Leukotriene B4 antagonist | 588 | 0.9823 |
2411 | Leukotriene B4 receptor 1 antagonist | 466 | 0.9965 |
2412 | Leukotriene B4 receptor 2 antagonist | 197 | 0.9994 |
2413 | Leukotriene C antagonist | 206 | 0.9768 |
2414 | Leukotriene C4 antagonist | 195 | 0.9870 |
2415 | Leukotriene D4 antagonist | 532 | 0.9917 |
2416 | Leukotriene E4 antagonist | 40 | 0.9661 |
2417 | Leukotriene synthesis inhibitor | 192 | 0.9649 |
2418 | Leukotriene-B4 20-monooxygenase inhibitor | 5 | 0.9559 |
2419 | Leukotriene-C4 synthase inhibitor | 9 | 0.8771 |
2420 | Levanase inhibitor | 9 | 0.9645 |
2421 | Levansucrase inhibitor | 5 | 0.9519 |
2422 | LFA antagonist | 261 | 0.9971 |
2423 | LFA-1 antagonist | 261 | 0.9971 |
2424 | L-fuconate dehydratase inhibitor | 7 | 0.9965 |
2425 | L-galactonolactone oxidase inhibitor | 8 | 0.9907 |
2426 | L-glucuronate reductase inhibitor | 17 | 0.9560 |
2427 | L-glutamate oxidase inhibitor | 3 | 0.9580 |
2428 | Licheninase inhibitor | 6 | 0.9789 |
2429 | L-iditol 2-dehydrogenase inhibitor | 100 | 0.9757 |
2430 | L-iduronidase inhibitor | 5 | 0.9900 |
2431 | Ligase inhibitor | 5 | 0.9859 |
2432 | Limulus clotting factor B inhibitor | 4 | 0.8393 |
2433 | Limulus clotting factor C inhibitor | 4 | 0.9590 |
2434 | Linoleate diol synthase inhibitor | 15 | 0.8892 |
2435 | Linoleate isomerase inhibitor | 22 | 0.9954 |
2436 | Linoleoyl-CoA desaturase inhibitor | 6 | 0.9579 |
2437 | Lipase inhibitor | 185 | 0.9869 |
2438 | Lipid metabolism regulator | 131 | 0.8771 |
2439 | Lipid peroxidase inhibitor | 282 | 0.9104 |
2440 | Lipocortins synthesis agonist | 75 | 0.9640 |
2441 | Lipocortins synthesis antagonist | 10 | 0.9546 |
2442 | Lipoprotein disorders treatment | 4601 | 0.9534 |
2443 | Lipoprotein lipase inhibitor | 18 | 0.8910 |
2444 | Lipoprotein lipase stimulant | 23 | 0.8833 |
2445 | Lipotropic | 11 | 0.9770 |
2446 | Lipoxin receptor agonist | 12 | 0.9999 |
2447 | Lipoxygenase inhibitor | 2749 | 0.9711 |
2448 | Lipoxygenase substrate | 25 | 0.9430 |
2449 | Liver cirrhosis treatment | 53 | 0.9186 |
2450 | Liver fibrosis treatment | 266 | 0.9295 |
2451 | Liver X receptor agonist | 623 | 0.9932 |
2452 | Liver X receptor alpha agonist | 227 | 0.9891 |
2453 | Liver X receptor antagonist | 7 | 0.9557 |
2454 | Liver X receptor beta agonist | 335 | 0.9936 |
2455 | L-lactate dehydrogenase (cytochrome) inhibitor | 6 | 0.9981 |
2456 | L-lysine 6-transaminase inhibitor | 6 | 0.9910 |
2457 | L-lysine oxidase inhibitor | 4 | 0.9929 |
2458 | Lombricine kinase inhibitor | 6 | 0.9838 |
2459 | Long-chain-acyl-CoA dehydrogenase inhibitor | 6 | 0.9947 |
2460 | Long-chain-aldehyde dehydrogenase inhibitor | 4 | 0.9699 |
2461 | Long-chain-fatty-acid-CoA ligase inhibitor | 23 | 0.9929 |
2462 | Loop diuretic | 8 | 0.8686 |
2463 | L-Serine ammonia-lyase inhibitor | 14 | 0.9948 |
2464 | L-threonine 3-dehydrogenase inhibitor | 10 | 0.8788 |
2465 | Luteinizing hormone-releasing hormone agonist | 19 | 0.9508 |
2466 | Luteinizing hormone-releasing hormone antagonist | 969 | 0.9882 |
2467 | Luteolytic | 4 | 0.9997 |
2468 | Lymphocytopoiesis inhibitor | 10 | 0.9617 |
2469 | Lysase inhibitor | 10 | 0.8343 |
2470 | Lysine 2,3-aminomutase inhibitor | 5 | 0.8888 |
2471 | Lysine 2-monooxygenase inhibitor | 19 | 0.9720 |
2472 | Lysine 6-dehydrogenase inhibitor | 3 | 0.9896 |
2473 | Lysine carboxypeptidase inhibitor | 35 | 0.9975 |
2474 | Lysine decarboxylase inhibitor | 10 | 0.9901 |
2475 | Lysine-tRNA ligase inhibitor | 44 | 0.9844 |
2476 | Lysophosphatidic acid receptor agonist | 9 | 0.9975 |
2477 | Lysophosphatidic acid receptor antagonist | 78 | 0.9929 |
2478 | Lysosomal Pro-X carboxypeptidase inhibitor | 45 | 0.9830 |
2479 | Lysostaphin inhibitor | 3 | 0.9701 |
2480 | Lysozyme inhibitor | 13 | 0.9856 |
2481 | Lysyl endopeptidase inhibitor | 16 | 0.9831 |
2482 | Lysyl oxidase inhibitor | 10 | 0.8398 |
2483 | M7G(5')pppN diphosphatase inhibitor | 4 | 0.9998 |
2484 | Macrocin O-methyltransferase inhibitor | 9 | 0.9998 |
2485 | Macrophage colony stimulating factor agonist | 4 | 0.8201 |
2486 | Macrophage colony stimulating factor antagonist | 161 | 0.9935 |
2487 | Macrophage elastase inhibitor | 182 | 0.9791 |
2488 | Macrophage migration inhibitory factor inhibitor | 83 | 0.9794 |
2489 | Macrophage scavenger receptor antagonist | 7 | 0.9998 |
2490 | Macrophage stimulant | 3 | 0.9588 |
2491 | Macular degeneration treatment | 256 | 0.9359 |
2492 | Magnesium-protoporphyrin IX methyltransferase inhibitor | 11 | 0.9795 |
2493 | Magnesium-protoporphyrin IX monomethyl ester (oxidative) cyclase inhibitor | 10 | 0.9654 |
2494 | Magnolysin inhibitor | 6 | 0.9991 |
2495 | Maillard reaction inhibitor | 35 | 0.8939 |
2496 | Malate dehydrogenase (acceptor) inhibitor | 12 | 0.8640 |
2497 | Malate dehydrogenase (decarboxylating) inhibitor | 20 | 0.9953 |
2498 | Malate dehydrogenase (NADP+) inhibitor | 9 | 0.9937 |
2499 | Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) inhibitor | 21 | 0.9952 |
2500 | Malate dehydrogenase (oxaloacetate-decarboxylating) inhibitor | 16 | 0.9859 |
2501 | Malate dehydrogenase inhibitor | 66 | 0.9351 |
2502 | Malate oxidase inhibitor | 5 | 0.8952 |
2503 | Malate synthase inhibitor | 18 | 0.9922 |
2504 | Malate-CoA ligase inhibitor | 5 | 0.9877 |
2505 | Male reproductive disfunction treatment | 565 | 0.9379 |
2506 | Maleate hydratase inhibitor | 11 | 0.9955 |
2507 | Maleate isomerase inhibitor | 6 | 0.9540 |
2508 | Maleylacetate reductase inhibitor | 4 | 0.9999 |
2509 | Maleylacetoacetate isomerase inhibitor | 6 | 0.9962 |
2510 | Malonate-semialdehyde dehydrogenase inhibitor | 3 | 0.9951 |
2511 | Malonyl-CoA decarboxylase inhibitor | 93 | 0.9962 |
2512 | Maltose-transporting ATPase inhibitor | 4 | 0.9801 |
2513 | Malyl-CoA lyase inhibitor | 6 | 0.9847 |
2514 | Mandelate 4-monooxygenase inhibitor | 11 | 0.9598 |
2515 | Mandelate racemase inhibitor | 27 | 0.9957 |
2516 | Manganese peroxidase inhibitor | 6 | 0.9183 |
2517 | Mannan endo-1,4-beta-mannosidase inhibitor | 3 | 0.9455 |
2518 | Mannan endo-1,6-alpha-mannosidase inhibitor | 4 | 0.9913 |
2519 | Mannitol 2-dehydrogenase inhibitor | 5 | 0.9998 |
2520 | Mannitol-1-phosphatase inhibitor | 3 | 0.9862 |
2521 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 18 | 0.9910 |
2522 | Mannokinase inhibitor | 9 | 0.9994 |
2523 | Mannonate dehydratase inhibitor | 9 | 0.9916 |
2524 | Mannose isomerase inhibitor | 5 | 0.9188 |
2525 | Mannose-1-phosphate guanylyltransferase inhibitor | 4 | 0.9999 |
2526 | Mannose-6-phosphate isomerase inhibitor | 109 | 0.9664 |
2527 | Mannosidase inhibitor | 72 | 0.9872 |
2528 | Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase inhibitor | 8 | 0.9797 |
2529 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase inhibitor | 22 | 0.9975 |
2530 | Mannosyl-oligosaccharide glucosidase inhibitor | 18 | 0.9970 |
2531 | Mannotetraose 2-alpha-N-acetylglucosaminyltransferase inhibitor | 4 | 0.9028 |
2532 | MAO A inhibitor | 463 | 0.9815 |
2533 | MAO A substrate | 25 | 0.9744 |
2534 | MAO B inhibitor | 672 | 0.9880 |
2535 | MAO B substrate | 17 | 0.9918 |
2536 | MAO inhibitor | 1124 | 0.9707 |
2537 | MAP kinase 1 inhibitor | 109 | 0.9306 |
2538 | MAP kinase 10 inhibitor | 293 | 0.9798 |
2539 | MAP kinase 14 inhibitor | 1528 | 0.9887 |
2540 | MAP kinase 8 inhibitor | 256 | 0.9745 |
2541 | MAP kinase 9 inhibitor | 320 | 0.9830 |
2542 | MAP kinase inhibitor | 2698 | 0.9754 |
2543 | MAP kinase kinase 1 inhibitor | 201 | 0.9735 |
2544 | MAP kinase kinase 4 inhibitor | 18 | 0.8885 |
2545 | MAP kinase kinase 7 inhibitor | 11 | 0.9600 |
2546 | MAP kinase kinase inhibitor | 180 | 0.9900 |
2547 | MAP kinase kinase kinase inhibitor | 143 | 0.9874 |
2548 | MAP kinase stimulant | 7 | 0.8717 |
2549 | MAP3K11 inhibitor | 37 | 0.9999 |
2550 | MAP3K5 inhibitor | 8 | 0.9004 |
2551 | MAP3K8 inhibitor | 56 | 0.9717 |
2552 | MAP3K9 inhibitor | 26 | 0.9987 |
2553 | MAP-kinase-activated kinase 1 inhibitor | 16 | 0.9664 |
2554 | MAP-kinase-activated kinase 2 inhibitor | 155 | 0.9629 |
2555 | MAP-kinase-activated kinase inhibitor | 180 | 0.9541 |
2556 | MarA inhibitor | 12 | 1.0000 |
2557 | MARK1 protein inhibitor | 7 | 1.0000 |
2558 | Matrilysin inhibitor | 331 | 0.9931 |
2559 | Matriptase inhibitor | 8 | 0.9995 |
2560 | Matrix metalloproteinase (membrane-type) inhibitor | 1124 | 0.9909 |
2561 | Matrix metalloproteinase 1 (membrane-type) inhibitor | 354 | 0.9913 |
2562 | Matrix metalloproteinase 1 inhibitor | 1586 | 0.9923 |
2563 | Matrix metalloproteinase 2 (membrane-type) inhibitor | 18 | 0.9967 |
2564 | Matrix metalloproteinase 3 (membrane-type) inhibitor | 878 | 0.9925 |
2565 | Matrix metalloproteinase inhibitor | 2580 | 0.9886 |
2566 | Mcl-1 antagonist | 989 | 0.9589 |
2567 | MDM2 inhibitor | 180 | 0.9377 |
2568 | Mediator release inhibitor | 146 | 0.8975 |
2569 | Melanin inhibitor | 32 | 0.9342 |
2570 | Melanin-concentrating hormone receptor 1 antagonist | 1035 | 0.9906 |
2571 | Melanin-concentrating hormone receptor antagonist | 1039 | 0.9906 |
2572 | Melanocortin 4 antagonist | 377 | 0.9970 |
2573 | Melanocortin agonist | 16 | 0.9600 |
2574 | Melanocortin antagonist | 510 | 0.9919 |
2575 | Melanocortin MC-4 agonist | 10 | 0.9830 |
2576 | Melatonin 1 agonist | 27 | 0.9959 |
2577 | Melatonin 1 antagonist | 560 | 0.9969 |
2578 | Melatonin 1a antagonist | 404 | 0.9974 |
2579 | Melatonin 1b antagonist | 127 | 0.9941 |
2580 | Melatonin 2 agonist | 15 | 0.9996 |
2581 | Melatonin 2 antagonist | 233 | 0.9991 |
2582 | Melatonin 3 antagonist | 100 | 0.9988 |
2583 | Melatonin 5 antagonist | 68 | 0.9995 |
2584 | Melatonin agonist | 98 | 0.9975 |
2585 | Melatonin antagonist | 789 | 0.9964 |
2586 | Membrane dipeptidase inhibitor | 43 | 0.9554 |
2587 | Membrane integrity agonist | 15 | 0.8324 |
2588 | Membrane integrity antagonist | 56 | 0.8667 |
2589 | Membrane permeability enhancer | 44 | 0.8802 |
2590 | Membrane permeability inhibitor | 40 | 0.8262 |
2591 | Membrane-oligosaccharide glycerophosphotransferase inhibitor | 6 | 0.9989 |
2592 | Menopausal disorders treatment | 53 | 0.8664 |
2593 | Menstruation disorders treatment | 235 | 0.9274 |
2594 | Mental retardation treatment | 7 | 0.9912 |
2595 | Meprin A inhibitor | 13 | 0.9747 |
2596 | Meprin B inhibitor | 3 | 0.9810 |
2597 | Metabolic disease treatment | 164 | 0.9214 |
2598 | Metallocarboxypeptidase D inhibitor | 7 | 0.9578 |
2599 | Metalloproteinase inhibitor | 2981 | 0.9865 |
2600 | Metalloproteinase-11 inhibitor | 31 | 0.9818 |
2601 | Metalloproteinase-2 inhibitor | 1812 | 0.9872 |
2602 | Metalloproteinase-3 inhibitor | 951 | 0.9924 |
2603 | Metalloproteinase-9 inhibitor | 1837 | 0.9895 |
2604 | Methane monooxygenase inhibitor | 13 | 0.9012 |
2605 | Methanol dehydrogenase inhibitor | 3 | 0.9840 |
2606 | Methemoglobinemia | 16 | 0.9551 |
2607 | Methenyltetrahydrofolate cyclohydrolase inhibitor | 7 | 0.9926 |
2608 | Methionine adenosyltransferase inhibitor | 27 | 0.9927 |
2609 | Methionine decarboxylase inhibitor | 6 | 0.9907 |
2610 | Methionine-tRNA ligase inhibitor | 139 | 0.9928 |
2611 | Methionyl aminopeptidase 1 inhibitor | 186 | 0.9978 |
2612 | Methionyl aminopeptidase 2 inhibitor | 230 | 0.9947 |
2613 | Methionyl aminopeptidase inhibitor | 455 | 0.9956 |
2614 | Methionyl-tRNA formyltransferase inhibitor | 7 | 0.9997 |
2615 | Methylamine-glutamate N-methyltransferase inhibitor | 3 | 0.9601 |
2616 | Methylaspartate ammonia-lyase inhibitor | 8 | 0.9838 |
2617 | Methylaspartate mutase inhibitor | 8 | 0.9991 |
2618 | Methylcrotonoyl-CoA carboxylase inhibitor | 11 | 0.9878 |
2619 | Methylenetetrahydrofolate dehydrogenase (NADP+) inhibitor | 10 | 0.9890 |
2620 | Methylenetetrahydrofolate reductase (NADPH) inhibitor | 10 | 0.9238 |
2621 | Methylglutamate dehydrogenase inhibitor | 7 | 0.9880 |
2622 | Methylglyoxal synthase inhibitor | 15 | 0.9982 |
2623 | Methylmalonyl-CoA carboxytransferase inhibitor | 7 | 0.9997 |
2624 | Methylmalonyl-CoA decarboxylase inhibitor | 7 | 0.9903 |
2625 | Methylmalonyl-CoA epimerase inhibitor | 9 | 0.9990 |
2626 | Methylmalonyl-CoA mutase inhibitor | 11 | 0.9912 |
2627 | Methylthioadenosine nucleosidase inhibitor | 16 | 0.9942 |
2628 | Methyltransferase inhibitor | 5 | 0.9997 |
2629 | Methyltransferase substrate | 4 | 0.9873 |
2630 | Methylumbelliferyl-acetate deacetylase inhibitor | 7 | 0.8731 |
2631 | Mevalonate kinase inhibitor | 11 | 0.9828 |
2632 | MexAB-OprM inhibitor | 3 | 1.0000 |
2633 | Microbial collagenase inhibitor | 514 | 0.9946 |
2634 | Microsomal triglyceride transfer protein inhibitor | 423 | 0.9992 |
2635 | Microtubule formation inhibitor | 320 | 0.9397 |
2636 | Microtubule stabilization | 142 | 0.9921 |
2637 | Mineralocorticoid | 16 | 0.9998 |
2638 | Mineralocorticoid antagonist | 441 | 0.9900 |
2639 | Miotic | 122 | 0.8950 |
2640 | Mitochondrial intermediate peptidase inhibitor | 6 | 0.9787 |
2641 | Mitochondrial processing peptidase inhibitor | 6 | 0.8265 |
2642 | MMP9 expression inhibitor | 16 | 0.8764 |
2643 | MO15-related protein kinase Pfmrk inhibitor | 18 | 0.9230 |
2644 | Monoamine oxidase substrate | 45 | 0.9832 |
2645 | Monoamine uptake inhibitor | 41 | 0.9159 |
2646 | Monocarboxylic acid transporter 1 inhibitor | 6 | 0.9733 |
2647 | Monocarboxylic acid transporter inhibitor | 6 | 0.9733 |
2648 | Monodehydroascorbate reductase (NADH) inhibitor | 17 | 0.9197 |
2649 | Monophenol monooxygenase inhibitor | 113 | 0.9637 |
2650 | Mood disorders treatment | 8303 | 0.9181 |
2651 | Morphine 6-dehydrogenase inhibitor | 13 | 0.9582 |
2652 | Motilin receptor agonist | 101 | 0.9920 |
2653 | Motilin receptor antagonist | 78 | 0.9999 |
2654 | Movement disorders treatment | 43 | 0.9388 |
2655 | mRNA (guanine-N7-)-methyltransferase inhibitor | 18 | 0.9655 |
2656 | mRNA (nucleoside-2'-O-)-methyltransferase inhibitor | 16 | 1.0000 |
2657 | mTOR inhibitor | 643 | 0.9941 |
2658 | Mucinaminylserine mucinaminidase inhibitor | 5 | 0.8302 |
2659 | Mucolytic | 104 | 0.9210 |
2660 | Mucomembranous protector | 33 | 0.8045 |
2661 | Muconate cycloisomerase inhibitor | 4 | 0.9976 |
2662 | Mucorpepsin inhibitor | 5 | 0.9649 |
2663 | Mucositis treatment | 14 | 0.8398 |
2664 | Multidrug resistance-associated protein 1 inhibitor | 223 | 0.9667 |
2665 | Multidrug resistance-associated protein inhibitor | 224 | 0.9623 |
2666 | Multiple inositol-polyphosphate phosphatase inhibitor | 5 | 0.9998 |
2667 | Multiple organ failure | 3 | 0.8848 |
2668 | Multiple sclerosis treatment | 959 | 0.8914 |
2669 | Muramoyltetrapeptide carboxypeptidase inhibitor | 5 | 0.9334 |
2670 | Muscle relaxant | 395 | 0.9217 |
2671 | Muscle weakness | 191 | 0.8482 |
2672 | Muscular dystrophy treatment | 62 | 0.8660 |
2673 | Mutagenic | 3542 | 0.9713 |
2674 | Mutagenic, Salmonella | 3302 | 0.9740 |
2675 | Myc inhibitor | 9 | 0.8699 |
2676 | Mycodextranase inhibitor | 6 | 0.9945 |
2677 | Mycolysin inhibitor | 3 | 0.9974 |
2678 | Mycothiol-S-conjugate amidase inhibitor | 3 | 0.8929 |
2679 | Mydriatic | 211 | 0.9042 |
2680 | Myelin associated glycoprotein antagonist | 4 | 1.0000 |
2681 | Myeloblastin inhibitor | 4 | 0.9831 |
2682 | Myocardial infarction treatment | 600 | 0.9504 |
2683 | Myocardial ischemia treatment | 1664 | 0.9511 |
2684 | Myocarditis | 25 | 0.8236 |
2685 | Myoclonus | 79 | 0.8420 |
2686 | Myosin ATPase inhibitor | 11 | 0.8730 |
2687 | Myosin-light-chain-phosphatase inhibitor | 6 | 0.9757 |
2688 | Myristoyl transferase 1 inhibitor | 73 | 0.9972 |
2689 | Myristoyl transferase inhibitor | 93 | 0.9975 |
2690 | Myt1 kinase inhibitor | 7 | 1.0000 |
2691 | N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase inhibitor | 8 | 0.9837 |
2692 | N-(long-chain-acyl)ethanolamine deacylase inhibitor | 7 | 0.9738 |
2693 | N4-(beta-N-acetylglucosaminyl)-L-asparaginase inhibitor | 10 | 0.9844 |
2694 | N6-methyl-lysine oxidase inhibitor | 4 | 0.9843 |
2695 | Na+ K+ transporting ATPase inhibitor | 165 | 0.9854 |
2696 | Na+-transporting two-sector ATPase inhibitor | 7 | 0.8289 |
2697 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 158 | 0.9986 |
2698 | N-acetylgalactosamine-4-sulfatase inhibitor | 3 | 0.9999 |
2699 | N-acetyl-gamma-glutamyl-phosphate reductase inhibitor | 3 | 0.9893 |
2700 | N-acetylglucosamine kinase inhibitor | 15 | 0.9929 |
2701 | N-acetylglucosamine-6-phosphate deacetylase inhibitor | 10 | 0.9938 |
2702 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase inhibitor | 6 | 0.9978 |
2703 | N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase inhibitor | 3 | 0.9403 |
2704 | N-acetyllactosamine synthase inhibitor | 6 | 0.9669 |
2705 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase inhibitor | 5 | 0.9707 |
2706 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase inhibitor | 7 | 0.9970 |
2707 | N-acetylmuramoyl-L-alanine amidase inhibitor | 11 | 0.9970 |
2708 | N-acetylneuraminate 4-O-acetyltransferase inhibitor | 3 | 0.9785 |
2709 | N-acetylneuraminate 7-O(or 9-O)-acetyltransferase inhibitor | 6 | 0.8127 |
2710 | N-acetylneuraminate lyase inhibitor | 14 | 0.9926 |
2711 | N-acetylneuraminate synthase inhibitor | 4 | 0.9911 |
2712 | N-Acyl-D-amino-acid deacylase inhibitor | 4 | 0.9890 |
2713 | N-Acyl-D-aspartate deacylase inhibitor | 3 | 0.9850 |
2714 | N-acylmannosamine kinase inhibitor | 5 | 0.8834 |
2715 | N-acylneuraminate cytidylyltransferase inhibitor | 15 | 0.9930 |
2716 | NAD(P)+ transhydrogenase (AB-specific) inhibitor | 31 | 0.9784 |
2717 | NAD(P)+ transhydrogenase (B-specific) inhibitor | 11 | 0.9630 |
2718 | NAD(P)+-arginine ADP-ribosyltransferase inhibitor | 11 | 0.8620 |
2719 | NAD(P)H dehydrogenase (quinone) 1 inhibitor | 50 | 0.9986 |
2720 | NAD(P)H dehydrogenase (quinone) inhibitor | 147 | 0.9804 |
2721 | NAD+ diphosphatase inhibitor | 11 | 0.9920 |
2722 | NAD+ kinase inhibitor | 17 | 0.9634 |
2723 | NAD+ nucleosidase inhibitor | 19 | 0.9937 |
2724 | NAD+ synthase (glutamine-hydrolysing) inhibitor | 4 | 0.9832 |
2725 | NAD+-dinitrogen-reductase ADP-D-ribosyltransferase inhibitor | 3 | 0.9934 |
2726 | NADH dehydrogenase inhibitor | 17 | 0.9554 |
2727 | NADH kinase inhibitor | 3 | 0.9754 |
2728 | NADH oxidase inhibitor | 18 | 0.9999 |
2729 | NADPH oxidase inhibitor | 76 | 0.9679 |
2730 | NADPH oxidoreductase inhibitor | 20 | 0.9894 |
2731 | NADPH peroxidase inhibitor | 4 | 0.9089 |
2732 | NADPH-cytochrome-c2 reductase inhibitor | 3 | 0.8785 |
2733 | NADPH-ferrihemoprotein reductase inhibitor | 10 | 0.8683 |
2734 | Nail discoloration | 4 | 0.8386 |
2735 | Naphthalene 1,2-dioxygenase inhibitor | 3 | 0.9674 |
2736 | Narcolepsy treatment | 12 | 0.9626 |
2737 | Narcotic antagonist | 71 | 0.9676 |
2738 | Nardilysin inhibitor | 8 | 0.9337 |
2739 | NAT1 substrate | 20 | 0.9948 |
2740 | NAT2 substrate | 35 | 0.9874 |
2741 | Nausea | 1042 | 0.8186 |
2742 | Nav1.1 sodium channel blocker | 164 | 0.9608 |
2743 | Nav1.2 sodium channel blocker | 222 | 0.9594 |
2744 | Nav1.3 sodium channel blocker | 160 | 0.9603 |
2745 | Nav1.4 sodium channel blocker | 23 | 0.9885 |
2746 | Nav1.5 sodium channel blocker | 91 | 0.9313 |
2747 | Nav1.7 sodium channel blocker | 97 | 0.9655 |
2748 | Nav1.8 sodium channel blocker | 190 | 0.9597 |
2749 | N-benzyloxycarbonylglycine hydrolase inhibitor | 6 | 0.8806 |
2750 | N-Carbamoyl-D-amino acid hydrolase inhibitor | 5 | 0.9863 |
2751 | N-carbamoyl-L-amino-acid hydrolase inhibitor | 10 | 0.9833 |
2752 | Necroptosis inhibitor | 6 | 0.9424 |
2753 | Necrosis | 183 | 0.8038 |
2754 | Necrosis treatment | 6 | 1.0000 |
2755 | Neolactotetraosylceramide alpha-2,3-sialyltransferase inhibitor | 6 | 0.9933 |
2756 | Nephritis | 124 | 0.8164 |
2757 | Nephrotic syndrome | 56 | 0.8089 |
2758 | Nephrotoxic | 787 | 0.8402 |
2759 | Nerve growth factor antagonist | 40 | 0.9928 |
2760 | Neuraminidase (Influenza A) inhibitor | 166 | 0.9999 |
2761 | Neuraminidase (Influenza B) inhibitor | 65 | 0.9998 |
2762 | Neuraminidase (influenza) inhibitor | 195 | 0.9977 |
2763 | Neuraminidase inhibitor | 309 | 0.9875 |
2764 | Neurodegenerative diseases treatment | 5571 | 0.8598 |
2765 | Neurokinin 1 antagonist | 1433 | 0.9957 |
2766 | Neurokinin 2 antagonist | 708 | 0.9903 |
2767 | Neurokinin 3 antagonist | 344 | 0.9918 |
2768 | Neurokinin antagonist | 2057 | 0.9926 |
2769 | Neuroleptic malignant syndrome | 51 | 0.9007 |
2770 | Neurolysin inhibitor | 25 | 0.9859 |
2771 | Neuronal nicotinic receptor antagonist | 739 | 0.9941 |
2772 | Neuronal nitric-oxide synthase inhibitor | 437 | 0.9966 |
2773 | Neuropathy treatment | 21 | 0.9992 |
2774 | Neuropeptide agonist | 16 | 0.9100 |
2775 | Neuropeptide antagonist | 1444 | 0.9687 |
2776 | Neuropeptide FF agonist | 8 | 0.8792 |
2777 | Neuropeptide FF antagonist | 66 | 0.9979 |
2778 | Neuropeptide FF1 antagonist | 30 | 0.9972 |
2779 | Neuropeptide FF2 agonist | 8 | 0.8792 |
2780 | Neuropeptide S antagonist | 4 | 0.8927 |
2781 | Neuropeptide Y agonist | 7 | 0.9577 |
2782 | Neuropeptide Y antagonist | 1374 | 0.9679 |
2783 | Neuropeptide Y1 agonist | 6 | 1.0000 |
2784 | Neuropeptide Y1 antagonist | 389 | 0.9539 |
2785 | Neuropeptide Y2 antagonist | 117 | 0.8752 |
2786 | Neuropeptide Y4 antagonist | 6 | 0.8028 |
2787 | Neuropeptide Y5 antagonist | 837 | 0.9923 |
2788 | Neuropsin inhibitor | 5 | 0.9891 |
2789 | Neurotensin 1 receptor agonist | 3 | 0.9981 |
2790 | Neurotensin 1 receptor antagonist | 53 | 0.9740 |
2791 | Neurotensin 2 receptor antagonist | 27 | 1.0000 |
2792 | Neurotensin 3 receptor antagonist | 25 | 1.0000 |
2793 | Neurotensin receptor agonist | 16 | 0.9984 |
2794 | Neurotensin receptor antagonist | 113 | 0.9936 |
2795 | Neurotoxic | 638 | 0.8575 |
2796 | Neurotransmitter antagonist | 9 | 0.8311 |
2797 | Neurotransmitter uptake inhibitor | 3 | 0.8987 |
2798 | Neurotrophic factor | 468 | 0.9612 |
2799 | Neurotrophic factor enhancer | 74 | 0.9296 |
2800 | Neutral endopeptidase inhibitor | 698 | 0.9953 |
2801 | Neutropenia treatment | 54 | 0.9997 |
2802 | Neutrophil collagenase inhibitor | 746 | 0.9882 |
2803 | Neutrophil fMLF receptor antagonist | 23 | 1.0000 |
2804 | Neutrophilic dermatosis (Sweet's syndrome) | 4 | 0.8396 |
2805 | NF-E2-related factor 2 stimulant | 10 | 0.9493 |
2806 | N-formylglutamate deformylase inhibitor | 16 | 0.9946 |
2807 | N-formylmethionyl-peptidase inhibitor | 3 | 0.9691 |
2808 | N-hydroxy-2-acetamidofluorene reductase inhibitor | 3 | 0.9809 |
2809 | N-hydroxyarylamine O-acetyltransferase inhibitor | 11 | 0.8409 |
2810 | Nicotinamidase inhibitor | 24 | 0.9839 |
2811 | Nicotinamide phosphoribosyltransferase inhibitor | 13 | 0.9667 |
2812 | Nicotinamide-nucleotide adenylyltransferase inhibitor | 7 | 0.9916 |
2813 | Nicotinamide-nucleotide amidase inhibitor | 6 | 1.0000 |
2814 | Nicotinate dehydrogenase inhibitor | 6 | 0.8542 |
2815 | Nicotinate phosphoribosyltransferase inhibitor | 17 | 0.9952 |
2816 | Nicotinate-nucleotide diphosphorylase (carboxylating) inhibitor | 32 | 0.9941 |
2817 | Nicotine dehydrogenase inhibitor | 5 | 0.8152 |
2818 | Nicotinic acid receptor 1 agonist | 102 | 0.9872 |
2819 | Nicotinic acid receptor 2 agonist | 26 | 0.9962 |
2820 | Nicotinic acid receptor agonist | 201 | 0.9929 |
2821 | Nicotinic alpha2beta2 receptor antagonist | 4 | 0.8885 |
2822 | Nicotinic alpha2beta4 receptor agonist | 4 | 0.8620 |
2823 | Nicotinic alpha3beta4 receptor agonist | 12 | 0.9911 |
2824 | Nicotinic alpha4 receptor agonist | 16 | 0.9998 |
2825 | Nicotinic alpha4beta2 receptor agonist | 34 | 0.9986 |
2826 | Nicotinic alpha4beta2 receptor antagonist | 18 | 0.9430 |
2827 | Nicotinic alpha4beta4 receptor agonist | 3 | 0.9002 |
2828 | Nicotinic alpha6 receptor agonist | 3 | 0.9964 |
2829 | Nicotinic alpha6beta3beta4alpha5 receptor antagonist | 3 | 0.8470 |
2830 | Nicotinic alpha7 receptor agonist | 535 | 0.9938 |
2831 | Nicotinic neuronal receptor agonist | 611 | 0.9908 |
2832 | Nicotinic receptor alpha7 subunit antagonist | 59 | 0.9913 |
2833 | Niemann-Pick C1-like 1 protein antagonist | 23 | 0.9197 |
2834 | Nitrate reductase (cytochrome) inhibitor | 11 | 0.8698 |
2835 | Nitrate reductase inhibitor | 30 | 0.9388 |
2836 | Nitric oxide antagonist | 146 | 0.9455 |
2837 | Nitric oxide donor | 197 | 0.9939 |
2838 | Nitric oxide scavenger | 4 | 0.9437 |
2839 | Nitric-oxide synthase inhibitor | 1075 | 0.9776 |
2840 | Nitric-oxide synthase stimulant | 19 | 0.9072 |
2841 | Nitrilase inhibitor | 18 | 0.9832 |
2842 | Nitrile hydratase inhibitor | 22 | 0.9874 |
2843 | Nitrite reductase (NO-forming) inhibitor | 3 | 0.9543 |
2844 | Nitrite reductase [NAD(P)H] inhibitor | 18 | 0.8771 |
2845 | NMDA 2 receptor antagonist | 941 | 0.9898 |
2846 | NMDA 2A receptor antagonist | 568 | 0.9947 |
2847 | NMDA 2B receptor antagonist | 396 | 0.9899 |
2848 | NMDA receptor agonist | 164 | 0.9811 |
2849 | NMDA receptor antagonist | 4021 | 0.9799 |
2850 | NMDA receptor glutamate site antagonist | 41 | 0.9986 |
2851 | NMDA receptor glycine site agonist | 127 | 0.9885 |
2852 | NMDA receptor glycine site antagonist | 586 | 0.9975 |
2853 | NMDA receptor glycine site B antagonist | 5 | 0.9992 |
2854 | NMDA receptor phencyclidine site antagonist | 152 | 0.9986 |
2855 | NMDA receptor polyamine site agonist | 3 | 0.9994 |
2856 | NMDA receptor polyamine site antagonist | 5 | 0.9416 |
2857 | N-methyl-2-oxoglutaramate hydrolase inhibitor | 9 | 0.9714 |
2858 | N-methylhydantoinase (ATP-hydrolysing) inhibitor | 5 | 0.9685 |
2859 | NMN nucleosidase inhibitor | 16 | 0.9928 |
2860 | Nociceptin (N/OFQ) receptor agonist | 8 | 0.9999 |
2861 | Nociceptin (N/OFQ) receptor antagonist | 320 | 0.9961 |
2862 | Non mutagenic, Salmonella | 450 | 0.9209 |
2863 | Non-steroidal antiinflammatory agent | 1075 | 0.9162 |
2864 | Nootropic | 1128 | 0.7596 |
2865 | NOS2 expression inhibitor | 43 | 0.9349 |
2866 | NOS3 expression enhancer | 73 | 0.9570 |
2867 | NTPase/helicase (JEV) inhibitor | 3 | 0.9998 |
2868 | NTPase/helicase (WNF) inhibitor | 9 | 0.9999 |
2869 | Nuclear receptor subfamily 4, group A, member 2 agonist | 24 | 0.9977 |
2870 | Nuclease inhibitor | 14 | 0.9615 |
2871 | Nucleoside deoxyribosyltransferase inhibitor | 8 | 0.9979 |
2872 | Nucleoside oxidase (H2O2-forming) inhibitor | 6 | 0.9676 |
2873 | Nucleoside phosphoacylhydrolase inhibitor | 4 | 0.9878 |
2874 | Nucleoside transporters inhibitor | 18 | 0.9988 |
2875 | Nucleoside-diphosphatase inhibitor | 10 | 0.9702 |
2876 | Nucleoside-triphosphate diphosphatase inhibitor | 7 | 0.9999 |
2877 | Nucleoside-triphosphate-adenylate kinase inhibitor | 7 | 0.9856 |
2878 | Nucleotidase inhibitor | 6 | 0.9447 |
2879 | Nucleotide diphosphatase inhibitor | 37 | 0.9794 |
2880 | Nucleotide metabolism regulator | 138 | 0.8675 |
2881 | Nucleotidyltransferase (FIV) inhibitor | 15 | 0.9961 |
2882 | Nucleotidyltransferase inhibitor | 18 | 0.9981 |
2883 | O6-alkylguanine-DNA alkyltransferase inhibitor | 130 | 0.9946 |
2884 | O-acetylhomoserine aminocarboxypropyltransferase inhibitor | 15 | 0.9789 |
2885 | O-aminophenol oxidase inhibitor | 12 | 0.9137 |
2886 | Obsessive-compulsive disorder treatment | 68 | 0.9473 |
2887 | Occult bleeding | 3 | 0.8960 |
2888 | Octadecanal decarbonylase inhibitor | 6 | 0.9942 |
2889 | Octopamine agonist | 67 | 0.9994 |
2890 | Octopamine antagonist | 5 | 0.8008 |
2891 | Ocular toxicity | 639 | 0.8211 |
2892 | Oleamide hydrolase inhibitor | 308 | 0.9909 |
2893 | Oligo-1,6-glucosidase inhibitor | 24 | 0.9900 |
2894 | Oligonucleotidase inhibitor | 10 | 0.9941 |
2895 | Oligopeptidase B inhibitor | 7 | 0.9716 |
2896 | Omega-amidase inhibitor | 8 | 0.9904 |
2897 | Omptin inhibitor | 4 | 0.8813 |
2898 | Opheline kinase inhibitor | 3 | 0.9794 |
2899 | Ophthalmic drug | 1892 | 0.8946 |
2900 | Opine dehydrogenase inhibitor | 4 | 0.9784 |
2901 | Opioid delta 1 receptor antagonist | 11 | 0.9549 |
2902 | Opioid delta 2 receptor antagonist | 12 | 0.9995 |
2903 | Opioid dependency treatment | 36 | 0.8757 |
2904 | Opioid kappa 1 receptor antagonist | 90 | 0.9915 |
2905 | Opioid kappa 2 receptor antagonist | 14 | 1.0000 |
2906 | Opioid kappa 2b receptor antagonist | 14 | 1.0000 |
2907 | Opioid kappa 3 receptor antagonist | 10 | 0.8496 |
2908 | Opioid mu 1 receptor antagonist | 21 | 0.9793 |
2909 | Opioid mu 2 receptor antagonist | 24 | 0.9853 |
2910 | Optic neuritis | 60 | 0.7812 |
2911 | Optic neuropathy | 68 | 0.7759 |
2912 | Orcinol 2-monooxygenase inhibitor | 7 | 0.9991 |
2913 | Orexin receptor 1 antagonist | 475 | 0.9601 |
2914 | Orexin receptor 2 antagonist | 244 | 0.9988 |
2915 | Orexin receptor antagonist | 742 | 0.9670 |
2916 | Ornithine carbamoyltransferase inhibitor | 40 | 0.9901 |
2917 | Ornithine cyclodeaminase inhibitor | 3 | 0.9881 |
2918 | Ornithine decarboxylase inhibitor | 102 | 0.9804 |
2919 | Ornithine-oxo-acid transaminase inhibitor | 39 | 0.9602 |
2920 | Orotate phosphoribosyltransferase inhibitor | 36 | 0.9947 |
2921 | Orotate reductase (NADH) inhibitor | 8 | 0.9867 |
2922 | Orotate reductase (NADPH) inhibitor | 5 | 0.9974 |
2923 | Orotidylate decarboxylase inhibitor | 4 | 0.9991 |
2924 | Orsellinate decarboxylase inhibitor | 5 | 1.0000 |
2925 | Oryzin inhibitor | 10 | 0.9179 |
2926 | Osmotic diuretic | 6 | 0.9985 |
2927 | Osteoarthritis treatment | 279 | 0.9500 |
2928 | Osteoclast antagonist | 81 | 0.9822 |
2929 | Ototoxicity | 43 | 0.8737 |
2930 | Ovulation inhibitor | 15 | 0.8575 |
2931 | Oxalate oxidase inhibitor | 13 | 0.9477 |
2932 | Oxaloacetate decarboxylase inhibitor | 15 | 0.9927 |
2933 | Oxaloacetate tautomerase inhibitor | 15 | 0.9960 |
2934 | Oxidizing agent | 16 | 0.9542 |
2935 | Oxidoreductase inhibitor | 82 | 0.8443 |
2936 | Oxoglutarate dehydrogenase (lipoamide) inhibitor | 17 | 0.9886 |
2937 | Oxygen scavenger | 9 | 0.8446 |
2938 | Oxytocic | 20 | 0.9050 |
2939 | Oxytocin agonist | 16 | 0.9563 |
2940 | Oxytocin antagonist | 793 | 0.9907 |
2941 | P2 nucleoside transporter inhibitor | 11 | 1.0000 |
2942 | p21-activated kinase 1 inhibitor | 9 | 0.8763 |
2943 | p21-activated kinase 4 inhibitor | 20 | 0.9510 |
2944 | p21-activated kinase inhibitor | 22 | 0.9248 |
2945 | P3 purinoceptor-like protein antagonist | 35 | 0.9999 |
2946 | p38 MAP kinase inhibitor | 423 | 0.9769 |
2947 | p53 inhibitor | 27 | 0.9643 |
2948 | Paget's disease treatment | 43 | 0.9791 |
2949 | Pain | 970 | 0.8176 |
2950 | Palmitoyl-CoA hydrolase inhibitor | 44 | 0.9787 |
2951 | Palpitation | 31 | 0.8475 |
2952 | Pancreatic disorders treatment | 148 | 0.9072 |
2953 | Pancreatic elastase inhibitor | 10 | 0.8008 |
2954 | Pancreatic endopeptidase E inhibitor | 6 | 0.9896 |
2955 | Pancreatic ribonuclease inhibitor | 10 | 0.9144 |
2956 | Panic | 13 | 0.9091 |
2957 | Pantetheine-phosphate adenylyltransferase inhibitor | 16 | 0.9666 |
2958 | Pantoate 4-dehydrogenase inhibitor | 3 | 0.9938 |
2959 | Pantoate-beta-alanine ligase inhibitor | 39 | 0.9736 |
2960 | Pantothenase inhibitor | 10 | 0.9887 |
2961 | Pantothenate kinase inhibitor | 18 | 0.9987 |
2962 | Papillary necrosis | 4 | 0.9968 |
2963 | Pappalysin-1 inhibitor | 4 | 0.9702 |
2964 | Para amino benzoic acid antagonist | 8 | 0.8823 |
2965 | Paralysis | 134 | 0.8005 |
2966 | Paraoxonase substrate | 5 | 0.9870 |
2967 | Parathyroid hormone antagonist | 19 | 0.9854 |
2968 | Parathyroid hormone secretion stimulant | 71 | 0.9981 |
2969 | Parkinsonism | 27 | 0.8627 |
2970 | P-benzoquinone reductase (NADPH) inhibitor | 8 | 0.8491 |
2971 | Pectate lyase inhibitor | 11 | 0.9810 |
2972 | Pectin lyase inhibitor | 11 | 0.9870 |
2973 | Pediculicide | 10 | 0.9647 |
2974 | Penicillin amidase inhibitor | 10 | 0.9579 |
2975 | Penicillopepsin inhibitor | 14 | 0.9713 |
2976 | Pepsin inhibitor | 80 | 0.9947 |
2977 | Peptide agonist | 3 | 0.9471 |
2978 | Peptide alpha-N-acetyltransferase inhibitor | 6 | 0.9354 |
2979 | Peptide deformylase inhibitor | 181 | 0.9908 |
2980 | Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase inhibitor | 6 | 0.9053 |
2981 | Peptide-tryptophan 2,3-dioxygenase inhibitor | 9 | 0.9828 |
2982 | Peptidoglycan beta-N-acetylmuramidase inhibitor | 3 | 0.9939 |
2983 | Peptidoglycan glycosyltransferase inhibitor | 4 | 0.9178 |
2984 | Peptidylamidoglycolate lyase inhibitor | 5 | 0.9887 |
2985 | Peptidyl-dipeptidase B inhibitor | 7 | 0.8547 |
2986 | Peptidyl-dipeptidase Dcp inhibitor | 6 | 0.9418 |
2987 | Peptidyl-glycinamidase inhibitor | 11 | 0.9756 |
2988 | Peptidylglycine monooxygenase inhibitor | 38 | 0.9864 |
2989 | Peptidyl-Lys metalloendopeptidase inhibitor | 22 | 0.9503 |
2990 | Peptidyl-prolyl cis-trans isomerase inhibitor | 388 | 0.9928 |
2991 | Peptidyltransferase inhibitor | 20 | 0.8964 |
2992 | Periodontitis treatment | 20 | 0.9723 |
2993 | Peristaltic stimulant | 174 | 0.9472 |
2994 | Peroxidase inhibitor | 16 | 0.9313 |
2995 | Peroxidase substrate | 33 | 0.9183 |
2996 | Peroxisome proliferator-activated receptor agonist | 1958 | 0.9883 |
2997 | Peroxisome proliferator-activated receptor alpha agonist | 1005 | 0.9919 |
2998 | Peroxisome proliferator-activated receptor alpha antagonist | 383 | 0.9956 |
2999 | Peroxisome proliferator-activated receptor antagonist | 966 | 0.9782 |
3000 | Peroxisome proliferator-activated receptor delta agonist | 409 | 0.9963 |
3001 | Peroxisome proliferator-activated receptor delta antagonist | 260 | 0.9964 |
3002 | Peroxisome proliferator-activated receptor gamma agonist | 935 | 0.9861 |
3003 | Peroxisome proliferator-activated receptor gamma antagonist | 810 | 0.9757 |
3004 | PfA-M1 aminopeptidase inhibitor | 55 | 0.9231 |
3005 | pFOX inhibitor | 5 | 0.9996 |
3006 | P-glycoprotein 1 inhibitor | 450 | 0.9359 |
3007 | P-glycoprotein inhibitor | 644 | 0.9340 |
3008 | P-glycoprotein substrate | 59 | 0.8506 |
3009 | Phenol 2-monooxygenase inhibitor | 25 | 0.9598 |
3010 | Phenol O-methyltransferase inhibitor | 3 | 0.9537 |
3011 | Phenylacetaldehyde dehydrogenase inhibitor | 5 | 0.9887 |
3012 | Phenylacetate-CoA ligase inhibitor | 8 | 0.9782 |
3013 | Phenylalanine 2-monooxygenase inhibitor | 6 | 0.9992 |
3014 | Phenylalanine 4-hydroxylase inhibitor | 30 | 0.9788 |
3015 | Phenylalanine decarboxylase inhibitor | 8 | 0.9827 |
3016 | Phenylalanine dehydrogenase inhibitor | 19 | 0.9872 |
3017 | Phenylalanine racemase (ATP-hydrolysing) inhibitor | 10 | 0.9787 |
3018 | Phenylalanine(histidine) transaminase inhibitor | 4 | 0.9823 |
3019 | Phenylalanine-tRNA ligase inhibitor | 22 | 0.9896 |
3020 | Phenylethanolamine N methyltransferase inhibitor | 88 | 0.9979 |
3021 | Phenylpyruvate decarboxylase inhibitor | 3 | 0.9938 |
3022 | Phenylpyruvate tautomerase inhibitor | 5 | 1.0000 |
3023 | Phloroglucinol reductase inhibitor | 13 | 0.9168 |
3024 | Phobic disorders treatment | 4 | 0.8161 |
3025 | Phosphatase inhibitor | 9 | 0.8017 |
3026 | Phosphate acetyltransferase inhibitor | 14 | 0.9845 |
3027 | Phosphate butyryltransferase inhibitor | 4 | 1.0000 |
3028 | Phosphate transporter inhibitor | 26 | 0.9813 |
3029 | Phosphatidate cytidylyltransferase inhibitor | 17 | 0.9831 |
3030 | Phosphatidate phosphatase inhibitor | 24 | 0.9469 |
3031 | Phosphatidylcholine-retinol O-acyltransferase inhibitor | 4 | 0.8246 |
3032 | Phosphatidylcholine-sterol O-acyltransferase inhibitor | 16 | 0.8973 |
3033 | Phosphatidylglycerol-membrane-oligosaccharide glycerophosphotransferase inhibitor | 3 | 0.9961 |
3034 | Phosphatidylglycerophosphatase inhibitor | 8 | 0.9716 |
3035 | Phosphatidylinositol 3-kinase alpha inhibitor | 622 | 0.9889 |
3036 | Phosphatidylinositol 3-kinase beta inhibitor | 303 | 0.9901 |
3037 | Phosphatidylinositol 3-kinase delta inhibitor | 290 | 0.9889 |
3038 | Phosphatidylinositol 3-kinase gamma inhibitor | 520 | 0.9938 |
3039 | Phosphatidylinositol 3-kinase inhibitor | 1201 | 0.9863 |
3040 | Phosphatidylinositol 3-kinase stimulant | 6 | 0.8208 |
3041 | Phosphatidylinositol diacylglycerol-lyase inhibitor | 12 | 0.9256 |
3042 | Phosphatidylinositol kinase inhibitor | 1235 | 0.9859 |
3043 | Phosphatidylserine decarboxylase inhibitor | 10 | 0.9343 |
3044 | Phosphoadenylylsulfatase inhibitor | 5 | 0.9979 |
3045 | Phosphodiesterase 10A inhibitor | 106 | 0.9912 |
3046 | Phosphodiesterase 11A inhibitor | 68 | 0.9943 |
3047 | Phosphodiesterase 1B inhibitor | 223 | 0.9776 |
3048 | Phosphodiesterase 3A inhibitor | 257 | 0.9835 |
3049 | Phosphodiesterase 4A inhibitor | 744 | 0.9861 |
3050 | Phosphodiesterase 4B inhibitor | 1050 | 0.9875 |
3051 | Phosphodiesterase 4C inhibitor | 925 | 0.9889 |
3052 | Phosphodiesterase 4D inhibitor | 1053 | 0.9882 |
3053 | Phosphodiesterase 5A inhibitor | 469 | 0.9829 |
3054 | Phosphodiesterase 6A inhibitor | 176 | 0.9987 |
3055 | Phosphodiesterase 6B inhibitor | 106 | 0.9979 |
3056 | Phosphodiesterase 7A inhibitor | 55 | 0.9865 |
3057 | Phosphodiesterase 9A inhibitor | 32 | 0.9995 |
3058 | Phosphodiesterase I inhibitor | 403 | 0.9656 |
3059 | Phosphodiesterase II inhibitor | 120 | 0.9740 |
3060 | Phosphodiesterase III inhibitor | 1127 | 0.9863 |
3061 | Phosphodiesterase inhibitor | 5905 | 0.9709 |
3062 | Phosphodiesterase IV inhibitor | 3418 | 0.9868 |
3063 | Phosphodiesterase IX inhibitor | 35 | 0.9998 |
3064 | Phosphodiesterase V inhibitor | 1029 | 0.9844 |
3065 | Phosphodiesterase VI inhibitor | 260 | 0.9971 |
3066 | Phosphodiesterase VII inhibitor | 167 | 0.9837 |
3067 | Phosphodiesterase X inhibitor | 106 | 0.9912 |
3068 | Phosphodiesterase XI inhibitor | 68 | 0.9943 |
3069 | Phosphoenolpyruvate carboxykinase (ATP) inhibitor | 34 | 0.9456 |
3070 | Phosphoenolpyruvate carboxykinase (diphosphate) inhibitor | 8 | 0.9947 |
3071 | Phosphoenolpyruvate carboxykinase (GTP) inhibitor | 25 | 0.9970 |
3072 | Phosphoenolpyruvate carboxylase inhibitor | 73 | 0.9892 |
3073 | Phosphoenolpyruvate mutase inhibitor | 3 | 0.9865 |
3074 | Phosphoenolpyruvate-protein phosphotransferase inhibitor | 4 | 0.9901 |
3075 | Phosphofructokinase-1 inhibitor | 33 | 0.9847 |
3076 | Phosphoglucomutase inhibitor | 16 | 0.9947 |
3077 | Phosphogluconate 2-dehydrogenase inhibitor | 14 | 0.9989 |
3078 | Phosphogluconate dehydrogenase (decarboxylating) inhibitor | 56 | 0.9901 |
3079 | Phosphoglycerate dehydrogenase inhibitor | 16 | 0.9960 |
3080 | Phosphoglycerate kinase inhibitor | 189 | 0.9956 |
3081 | Phosphoglycerate mutase inhibitor | 10 | 0.9910 |
3082 | Phosphoglycerate phosphatase inhibitor | 6 | 0.9995 |
3083 | Phosphoglycolate phosphatase inhibitor | 12 | 0.9928 |
3084 | Phosphoinositide 5-phosphatase inhibitor | 11 | 0.9058 |
3085 | Phosphoinositide dependent kinase 1 inhibitor | 39 | 0.9814 |
3086 | Phosphoinositide phospholipase C inhibitor | 9 | 0.9386 |
3087 | Phosphoketolase inhibitor | 10 | 0.9974 |
3088 | Phospholipase A1 inhibitor | 16 | 0.9449 |
3089 | Phospholipase A2 IIa inhibitor | 127 | 0.9905 |
3090 | Phospholipase A2 inhibitor | 541 | 0.9648 |
3091 | Phospholipase C inhibitor | 51 | 0.9282 |
3092 | Phospholipase D inhibitor | 107 | 0.9686 |
3093 | Phospholipase D1 inhibitor | 41 | 0.9606 |
3094 | Phospholipase D2 inhibitor | 86 | 0.9872 |
3095 | Phospholipase inhibitor | 687 | 0.9604 |
3096 | Phospholipid-translocating ATPase inhibitor | 4 | 0.8761 |
3097 | Phosphomannomutase inhibitor | 17 | 0.9979 |
3098 | Phosphomevalonate kinase inhibitor | 14 | 0.9924 |
3099 | Phospho-N-acetylmuramoyl-pentapeptide-transferase inhibitor | 127 | 0.9967 |
3100 | Phosphonoacetate hydrolase inhibitor | 6 | 0.9919 |
3101 | Phosphopantothenoylcysteine decarboxylase inhibitor | 7 | 0.9411 |
3102 | Phosphopyruvate hydratase inhibitor | 7 | 0.9997 |
3103 | Phosphoribosylformylglycinamidine cyclo-ligase inhibitor | 3 | 0.9999 |
3104 | Phosphoribosylformylglycinamidine synthase inhibitor | 7 | 0.9980 |
3105 | Phosphoribosylglycinamide formyltransferase inhibitor | 121 | 0.9998 |
3106 | Phosphoribulokinase inhibitor | 10 | 0.9931 |
3107 | Phosphorylase a inhibitor | 26 | 0.9908 |
3108 | Phosphorylase b inhibitor | 5 | 0.9637 |
3109 | Phosphorylase inhibitor | 279 | 0.9853 |
3110 | Phosphorylase kinase inhibitor | 57 | 0.9721 |
3111 | Phosphoserine phosphatase inhibitor | 10 | 0.9887 |
3112 | Phosphoserine transaminase inhibitor | 5 | 0.9991 |
3113 | Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) inhibitor | 43 | 0.9523 |
3114 | Photoallergy dermatitis | 58 | 0.8445 |
3115 | Photosensitizer | 29 | 0.9440 |
3116 | Phthalate 4,5-dioxygenase inhibitor | 3 | 0.8714 |
3117 | Phytanoyl-CoA dioxygenase inhibitor | 3 | 0.9786 |
3118 | Picornain 2A inhibitor | 10 | 0.9809 |
3119 | Picornain 3C inhibitor | 8 | 0.9779 |
3120 | Piloerection | 13 | 0.8744 |
3121 | Pim kinase inhibitor | 150 | 0.9643 |
3122 | Pim-1 kinase inhibitor | 91 | 0.9473 |
3123 | Pim-2 kinase inhibitor | 60 | 0.9538 |
3124 | Pim-3 kinase inhibitor | 19 | 0.9493 |
3125 | Pin1 inhibitor | 5 | 0.8888 |
3126 | Pitrilysin inhibitor | 10 | 0.9409 |
3127 | Plasmanylethanolamine desaturase inhibitor | 8 | 0.9804 |
3128 | Plasmepsin I inhibitor | 63 | 0.9997 |
3129 | Plasmepsin II inhibitor | 99 | 0.9741 |
3130 | Plasmepsin inhibitor | 108 | 0.9755 |
3131 | Plasmin inhibitor | 323 | 0.9876 |
3132 | Plasminogen activator inhibitor | 134 | 0.9857 |
3133 | Plasminogen activator inhibitor antagonist | 165 | 0.9843 |
3134 | Plasminogen activator stimulant | 14 | 0.9719 |
3135 | Plastoquinol-plastocyanin reductase inhibitor | 7 | 0.9391 |
3136 | Platelet activating factor alpha antagonist | 605 | 0.9833 |
3137 | Platelet activating factor antagonist | 2431 | 0.9715 |
3138 | Platelet activating factor beta antagonist | 921 | 0.9814 |
3139 | Platelet adhesion inhibitor | 17 | 0.8238 |
3140 | Platelet aggregation inhibitor | 3826 | 0.9100 |
3141 | Platelet aggregation stimulant | 7 | 0.8475 |
3142 | Platelet antagonist | 1928 | 0.9517 |
3143 | Platelet derived growth factor receptor kinase inhibitor | 13 | 0.8643 |
3144 | Platelet growth factor antagonist | 756 | 0.9866 |
3145 | Platelet growth factor beta antagonist | 186 | 0.9928 |
3146 | Plus-end-directed kinesin ATPase inhibitor | 3 | 0.9867 |
3147 | Pneumotoxic | 17 | 0.9551 |
3148 | Polar-amino-acid-transporting ATPase inhibitor | 4 | 0.9662 |
3149 | Polarisation inhibitor | 41 | 0.9362 |
3150 | Polarisation stimulant | 9 | 0.9084 |
3151 | Polo-like kinase inhibitor | 295 | 0.9758 |
3152 | Polo-like kinase-1 inhibitor | 214 | 0.9772 |
3153 | Poly(3-hydroxybutyrate) depolymerase inhibitor | 13 | 0.9877 |
3154 | Poly(ADP-ribose) glycohydrolase inhibitor | 19 | 0.9748 |
3155 | Poly(ADP-ribose) polymerase 1 inhibitor | 622 | 0.9950 |
3156 | Poly(ADP-ribose) polymerase 2 inhibitor | 53 | 0.9887 |
3157 | Poly(ADP-ribose) polymerase inhibitor | 1241 | 0.9894 |
3158 | Poly(alpha-L-guluronate) lyase inhibitor | 5 | 0.9793 |
3159 | Poly(beta-D-mannuronate) lyase inhibitor | 4 | 0.9679 |
3160 | Polyamine biosynthesis inhibitor | 18 | 0.9913 |
3161 | Polyamine oxidase inhibitor | 14 | 0.9568 |
3162 | Polyamine-transporting ATPase inhibitor | 3 | 0.9530 |
3163 | Polygalacturonase inhibitor | 6 | 0.9672 |
3164 | Polyneuridine-aldehyde esterase inhibitor | 3 | 0.9876 |
3165 | Polynucleotide 5'-hydroxy-kinase inhibitor | 15 | 0.9194 |
3166 | Polynucleotide adenylyltransferase inhibitor | 27 | 0.9472 |
3167 | Polypeptide N-acetylgalactosaminyltransferase inhibitor | 16 | 0.9884 |
3168 | Polyphosphate kinase inhibitor | 4 | 0.9953 |
3169 | Polyphosphate-glucose phosphotransferase inhibitor | 5 | 0.9996 |
3170 | Polyporopepsin inhibitor | 6 | 0.8342 |
3171 | Polyribonucleotide nucleotidyltransferase inhibitor | 9 | 0.9054 |
3172 | Porphobilinogen synthase inhibitor | 22 | 0.9855 |
3173 | Porphyria | 28 | 0.8727 |
3174 | Postcoital contraceptive | 42 | 0.9905 |
3175 | Postmenopausal disorders treatment | 242 | 0.9815 |
3176 | Postsynaptic density protein 95 inhibitor | 3 | 1.0000 |
3177 | Posttraumatic stress disorder treatment | 30 | 0.9443 |
3178 | Postural (orthostatic) hypotension | 27 | 0.8790 |
3179 | Potassium channel (ATP-sensitive) activator | 172 | 0.9797 |
3180 | Potassium channel (ATP-sensitive) blocker | 239 | 0.9884 |
3181 | Potassium channel (Ca-activated) activator | 186 | 0.9716 |
3182 | Potassium channel (Ca-activated) blocker | 261 | 0.9835 |
3183 | Potassium channel (Inward rectifier) 1 blocker | 80 | 0.9983 |
3184 | Potassium channel (Inward rectifier) 11 blocker | 86 | 0.9937 |
3185 | Potassium channel (Inward rectifier) activator | 172 | 0.9797 |
3186 | Potassium channel (Inward rectifier) blocker | 394 | 0.9897 |
3187 | Potassium channel (Voltage-sensitive) activator | 162 | 0.9916 |
3188 | Potassium channel (Voltage-sensitive) blocker | 2102 | 0.9549 |
3189 | Potassium channel activator | 1430 | 0.9809 |
3190 | Potassium channel blocker | 3131 | 0.9498 |
3191 | Potassium channel intermediate-conductance Ca-activated 4 blocker | 34 | 1.0000 |
3192 | Potassium channel intermediate-conductance Ca-activated activator | 4 | 0.9869 |
3193 | Potassium channel intermediate-conductance Ca-activated blocker | 66 | 0.9891 |
3194 | Potassium channel KCNQ activator | 162 | 0.9916 |
3195 | Potassium channel KCNQ blocker | 8 | 0.9973 |
3196 | Potassium channel KCNQ2 activator | 45 | 0.9998 |
3197 | Potassium channel KCNQ3 activator | 6 | 0.9829 |
3198 | Potassium channel Kv1.1 blocker | 135 | 0.9826 |
3199 | Potassium channel Kv1.3 blocker | 245 | 0.9894 |
3200 | Potassium channel Kv1.5 blocker | 444 | 0.9829 |
3201 | Potassium channel Kv4.3 blocker | 82 | 0.9785 |
3202 | Potassium channel large-conductance Ca-activated activator | 161 | 0.9808 |
3203 | Potassium channel small-conductance Ca-activated 3 activator | 6 | 0.9900 |
3204 | Potassium channel small-conductance Ca-activated 3 blocker | 42 | 0.9997 |
3205 | Potassium channel small-conductance Ca-activated activator | 9 | 0.9990 |
3206 | Potassium channel small-conductance Ca-activated blocker | 125 | 0.9966 |
3207 | Pregnane X receptor agonist | 13 | 0.9471 |
3208 | Pregnane X receptor antagonist | 35 | 0.9873 |
3209 | Premature ejaculation treatment | 112 | 0.9794 |
3210 | Premenstrual syndrome treatment | 26 | 0.9567 |
3211 | Preneoplastic conditions treatment | 8 | 0.8643 |
3212 | Prenyl-diphosphatase inhibitor | 5 | 0.9747 |
3213 | Prephenate dehydratase inhibitor | 23 | 0.9938 |
3214 | Prephenate dehydrogenase inhibitor | 20 | 0.9501 |
3215 | Prepilin peptidase inhibitor | 3 | 0.9948 |
3216 | Preterm labor treatment | 87 | 0.9747 |
3217 | Prion diseases treatment | 31 | 0.8309 |
3218 | PRL phosphatase inhibitor | 28 | 0.9609 |
3219 | Procollagen C-endopeptidase inhibitor | 17 | 0.9658 |
3220 | Procollagen galactosyltransferase inhibitor | 13 | 0.9974 |
3221 | Procollagen glucosyltransferase inhibitor | 13 | 0.9942 |
3222 | Procollagen N-endopeptidase inhibitor | 7 | 0.9729 |
3223 | Procollagen-lysine 5-dioxygenase inhibitor | 21 | 0.9629 |
3224 | Procollagen-proline 3-dioxygenase inhibitor | 14 | 0.9999 |
3225 | Progesterone agonist | 173 | 0.9925 |
3226 | Progesterone antagonist | 1088 | 0.9961 |
3227 | Progesterone receptor A antagonist | 98 | 0.9997 |
3228 | Progesterone receptor B antagonist | 66 | 0.9990 |
3229 | Progesterone receptor B1 antagonist | 24 | 0.9999 |
3230 | Prokinetic | 512 | 0.9798 |
3231 | Prokineticin receptor 1 antagonist | 3 | 1.0000 |
3232 | Prolactin inhibitor | 43 | 0.9680 |
3233 | Prolactin release inhibitor | 63 | 0.9878 |
3234 | Proliferative diseases treatment | 207 | 0.9141 |
3235 | Proline dehydrogenase inhibitor | 4 | 0.9981 |
3236 | Proline racemase inhibitor | 17 | 0.9942 |
3237 | Proline transporter inhibitor | 23 | 1.0000 |
3238 | Prolyl aminopeptidase inhibitor | 13 | 0.9376 |
3239 | Prolyl endopeptidase inhibitor | 354 | 0.9865 |
3240 | Pro-opiomelanocortin converting enzyme inhibitor | 5 | 0.9402 |
3241 | Propanediol dehydratase inhibitor | 17 | 0.9940 |
3242 | Propionate CoA-transferase inhibitor | 4 | 0.9992 |
3243 | Propionate-CoA ligase inhibitor | 7 | 0.9940 |
3244 | Prostacyclin agonist | 62 | 0.9844 |
3245 | Prostacyclin antagonist | 138 | 0.9948 |
3246 | Prostaglandin A1 agonist | 3 | 1.0000 |
3247 | Prostaglandin agonist | 324 | 0.9900 |
3248 | Prostaglandin antagonist | 1739 | 0.9870 |
3249 | Prostaglandin D2 agonist | 9 | 0.9769 |
3250 | Prostaglandin D2 antagonist | 564 | 0.9978 |
3251 | Prostaglandin E1 agonist | 20 | 0.9995 |
3252 | Prostaglandin E1 antagonist | 4 | 0.9555 |
3253 | Prostaglandin E2 agonist | 120 | 0.9963 |
3254 | Prostaglandin E2 antagonist | 717 | 0.9869 |
3255 | Prostaglandin EP1 antagonist | 127 | 0.9978 |
3256 | Prostaglandin EP12 antagonist | 50 | 0.9996 |
3257 | Prostaglandin EP2 agonist | 38 | 0.9996 |
3258 | Prostaglandin EP2 antagonist | 173 | 0.9984 |
3259 | Prostaglandin EP3 antagonist | 471 | 0.9976 |
3260 | Prostaglandin EP4 agonist | 70 | 1.0000 |
3261 | Prostaglandin EP4 antagonist | 290 | 0.9983 |
3262 | Prostaglandin F2 alpha agonist | 26 | 0.9997 |
3263 | Prostaglandin F2 alpha antagonist | 48 | 0.9811 |
3264 | Prostaglandin H2 antagonist | 379 | 0.9981 |
3265 | Prostaglandin-A1 DELTA-isomerase inhibitor | 4 | 0.9251 |
3266 | Prostaglandin-E synthase inhibitor | 158 | 0.9971 |
3267 | Prostaglandin-E2 9-reductase inhibitor | 15 | 0.8922 |
3268 | Prostaglandin-E2 synthase 1 inhibitor | 32 | 0.9957 |
3269 | Prostaglandin-I synthase inhibitor | 42 | 0.9886 |
3270 | Prostate cancer treatment | 2865 | 0.9315 |
3271 | Prostate disorders treatment | 394 | 0.8980 |
3272 | Prostatic (benign) hyperplasia treatment | 1874 | 0.9665 |
3273 | Protease (Human cytomegalovirus) inhibitor | 149 | 0.9994 |
3274 | Protease 3C (Human rhinovirus) inhibitor | 177 | 0.9933 |
3275 | Protease activated receptor 1 antagonist | 145 | 0.9902 |
3276 | Protease activated receptor antagonist | 161 | 0.9792 |
3277 | Protease inhibitor | 513 | 0.9506 |
3278 | Proteasome ATPase inhibitor | 3 | 0.9027 |
3279 | Proteasome endopeptidase complex inhibitor | 32 | 0.9662 |
3280 | Proteasome inhibitor | 133 | 0.9635 |
3281 | Protein 30S ribosomal subunit inhibitor | 63 | 0.9738 |
3282 | Protein 50S ribosomal subunit inhibitor | 108 | 0.9878 |
3283 | Protein C (activated) inhibitor | 14 | 0.9913 |
3284 | Protein glycation inhibitor | 4 | 1.0000 |
3285 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 567 | 0.9893 |
3286 | Protein kinase (CK1) delta inhibitor | 45 | 0.9643 |
3287 | Protein kinase (CK1) epsilon inhibitor | 21 | 0.9533 |
3288 | Protein kinase (CK1) inhibitor | 60 | 0.9366 |
3289 | Protein kinase (CK2) inhibitor | 97 | 0.9616 |
3290 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 690 | 0.9837 |
3291 | Protein kinase (PKA, PKC, AKT, GRK, AGC-related, RSK, DBF2, SGK) inhibitor | 92 | 0.9667 |
3292 | Protein kinase A inhibitor | 438 | 0.9859 |
3293 | Protein kinase B alpha inhibitor | 42 | 0.9486 |
3294 | Protein kinase B beta inhibitor | 258 | 0.9846 |
3295 | Protein kinase B gamma inhibitor | 120 | 0.9685 |
3296 | Protein kinase B inhibitor | 721 | 0.9748 |
3297 | Protein kinase B stimulant | 27 | 0.9510 |
3298 | Protein kinase C alpha inhibitor | 602 | 0.9879 |
3299 | Protein kinase C beta I inhibitor | 68 | 0.9993 |
3300 | Protein kinase C beta II inhibitor | 85 | 0.9997 |
3301 | Protein kinase C beta inhibitor | 463 | 0.9824 |
3302 | Protein kinase C delta inhibitor | 560 | 0.9885 |
3303 | Protein kinase C epsilon inhibitor | 397 | 0.9841 |
3304 | Protein kinase C eta inhibitor | 346 | 0.9820 |
3305 | Protein kinase C gamma inhibitor | 372 | 0.9894 |
3306 | Protein kinase C inhibitor | 1355 | 0.9726 |
3307 | Protein kinase C mu inhibitor | 144 | 0.9856 |
3308 | Protein kinase C nu inhibitor | 135 | 0.9836 |
3309 | Protein kinase C stimulant | 61 | 0.9882 |
3310 | Protein kinase C theta inhibitor | 379 | 0.9875 |
3311 | Protein kinase C zeta inhibitor | 177 | 0.9935 |
3312 | Protein kinase inhibitor | 14972 | 0.9373 |
3313 | Protein kinase stimulant | 101 | 0.9450 |
3314 | Protein N-acetylglucosaminyltransferase inhibitor | 8 | 0.9952 |
3315 | Protein phosphatase 2A inhibitor | 50 | 0.9987 |
3316 | Protein phosphatase inhibitor | 1971 | 0.9642 |
3317 | Protein synthesis inhibitor | 356 | 0.9422 |
3318 | Protein synthesis stimulant | 9 | 0.9627 |
3319 | Protein-arginine deiminase inhibitor | 7 | 0.9277 |
3320 | Protein-arginine N-methyltransferase inhibitor | 6 | 1.0000 |
3321 | Protein-disulfide reductase (glutathione) inhibitor | 11 | 0.8021 |
3322 | Protein-glucosylgalactosylhydroxylysine glucosidase inhibitor | 3 | 0.9918 |
3323 | Protein-glutamate methylesterase inhibitor | 13 | 0.9618 |
3324 | Protein-glutamate O-methyltransferase inhibitor | 4 | 0.9888 |
3325 | Protein-L-isoaspartate (D-aspartate) O-methyltransferase inhibitor | 3 | 0.9998 |
3326 | Protein-Npi-phosphohistidine-sugar phosphotransferase inhibitor | 12 | 0.9600 |
3327 | Protein-serine-threonine kinase inhibitor | 2400 | 0.9610 |
3328 | Protein-S-isoprenylcysteine O-methyltransferase inhibitor | 26 | 0.9706 |
3329 | Protein-synthesizing GTPase inhibitor | 15 | 0.9005 |
3330 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 607 | 0.9695 |
3331 | Protein-tyrosine kinase Lyn inhibitor | 204 | 0.9598 |
3332 | Protein-tyrosine kinase p55(blk) inhibitor | 33 | 0.9245 |
3333 | Protein-tyrosine phosphatase 1B inhibitor | 1185 | 0.9823 |
3334 | Protein-tyrosine phosphatase 2C inhibitor | 59 | 0.9701 |
3335 | Protein-tyrosine phosphatase beta inhibitor | 11 | 0.9983 |
3336 | Protein-tyrosine phosphatase C inhibitor | 4 | 1.0000 |
3337 | Protein-tyrosine phosphatase epsilon inhibitor | 5 | 1.0000 |
3338 | Protein-tyrosine phosphatase inhibitor | 1813 | 0.9687 |
3339 | Protein-tyrosine phosphatase mu inhibitor | 4 | 0.9998 |
3340 | Protein-tyrosine phosphatase yopH inhibitor | 9 | 0.9908 |
3341 | Protein-tyrosine sulfotransferase inhibitor | 10 | 0.9789 |
3342 | Protocatechuate 3,4-dioxygenase inhibitor | 28 | 0.9933 |
3343 | Protocatechuate 4,5-dioxygenase inhibitor | 11 | 0.9995 |
3344 | Protocollagen prolyl hydroxylase inhibitor | 105 | 0.9837 |
3345 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 257 | 0.9945 |
3346 | Proto-oncogene tyrosine-protein kinase Fgr inhibitor | 14 | 0.9047 |
3347 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 84 | 0.9384 |
3348 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 386 | 0.9782 |
3349 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 42 | 0.9291 |
3350 | Prunasin beta-glucosidase inhibitor | 6 | 0.9729 |
3351 | Pseudolysin inhibitor | 4 | 0.8089 |
3352 | Pseudoporphyria | 7 | 0.8393 |
3353 | Pseudouridylate synthase inhibitor | 4 | 0.9763 |
3354 | Psychomotor impairment | 34 | 0.8232 |
3355 | Psychoses | 62 | 0.8137 |
3356 | Psychosexual dysfunction treatment | 61 | 0.9444 |
3357 | Pteridine reductase inhibitor | 9 | 0.9787 |
3358 | Pterin deaminase inhibitor | 4 | 0.9314 |
3359 | Pullulanase inhibitor | 7 | 0.9503 |
3360 | Pulmonary edema | 94 | 0.8605 |
3361 | Pulmonary hypertension treatment | 133 | 0.8936 |
3362 | Pure red cell aplasia | 9 | 0.8919 |
3363 | Purine antagonist | 21 | 0.9987 |
3364 | Purine biosynthesis inhibitor | 14 | 0.9935 |
3365 | Purine nucleosidase inhibitor | 26 | 0.9967 |
3366 | Purine nucleoside phosphorylase inhibitor | 232 | 0.9969 |
3367 | Purinergic P2 agonist | 17 | 0.9768 |
3368 | Purinergic P2 antagonist | 864 | 0.9803 |
3369 | Purinergic P2T antagonist | 74 | 0.9809 |
3370 | Purinergic P2X agonist | 6 | 0.9994 |
3371 | Purinergic P2X antagonist | 525 | 0.9867 |
3372 | Purinergic P2X1 antagonist | 15 | 0.9391 |
3373 | Purinergic P2X2 antagonist | 41 | 0.9891 |
3374 | Purinergic P2X3 antagonist | 53 | 0.9762 |
3375 | Purinergic P2X4 antagonist | 14 | 0.9980 |
3376 | Purinergic P2X7 antagonist | 452 | 0.9945 |
3377 | Purinergic P2Y agonist | 7 | 0.9516 |
3378 | Purinergic P2Y antagonist | 274 | 0.9820 |
3379 | Purinergic P2Y1 antagonist | 75 | 0.9731 |
3380 | Purinergic P2Y12 antagonist | 178 | 0.9855 |
3381 | Purinergic receptor agonist | 17 | 0.9768 |
3382 | Purinergic receptor antagonist | 906 | 0.9772 |
3383 | Puromycin-sensitive aminopeptidase inhibitor | 4 | 1.0000 |
3384 | Putrescine carbamoyltransferase inhibitor | 6 | 0.9988 |
3385 | Putrescine oxidase inhibitor | 14 | 0.9853 |
3386 | Pyridoxal 4-dehydrogenase inhibitor | 9 | 0.9998 |
3387 | Pyridoxal kinase inhibitor | 45 | 0.9637 |
3388 | Pyridoxamine-oxaloacetate transaminase inhibitor | 13 | 0.9984 |
3389 | Pyridoxamine-phosphate oxidase inhibitor | 9 | 0.9968 |
3390 | Pyridoxamine-pyruvate transaminase inhibitor | 4 | 0.9997 |
3391 | Pyridoxine 4-oxidase inhibitor | 3 | 0.9790 |
3392 | Pyridoxine 5-dehydrogenase inhibitor | 6 | 0.9921 |
3393 | Pyrimidine antagonist | 41 | 0.9827 |
3394 | Pyrimidine-deoxynucleoside 2'-dioxygenase inhibitor | 6 | 0.9911 |
3395 | Pyroglutamyl-peptidase I inhibitor | 40 | 0.9537 |
3396 | Pyroglutamyl-peptidase II inhibitor | 14 | 0.8603 |
3397 | Pyrroline-5-carboxylate reductase inhibitor | 17 | 0.9902 |
3398 | Pyruvate carboxylase inhibitor | 27 | 0.9358 |
3399 | Pyruvate decarboxylase inhibitor | 7 | 0.9325 |
3400 | Pyruvate dehydrogenase (cytochrome) inhibitor | 4 | 0.9885 |
3401 | Pyruvate dehydrogenase (lipoamide) inhibitor | 22 | 0.9776 |
3402 | Pyruvate dehydrogenase inhibitor | 25 | 0.9529 |
3403 | Pyruvate dehydrogenase kinase inhibitor | 192 | 0.9722 |
3404 | Pyruvate dehydrogenase stimulant | 48 | 0.9986 |
3405 | Pyruvate kinase inhibitor | 38 | 0.9725 |
3406 | Pyruvate synthase inhibitor | 5 | 0.9994 |
3407 | Pyruvate, phosphate dikinase inhibitor | 21 | 0.9922 |
3408 | Pyruvate, water dikinase inhibitor | 10 | 0.9946 |
3409 | QT interval prolongation | 117 | 0.8617 |
3410 | Quercetin 2,3-dioxygenase inhibitor | 11 | 0.9829 |
3411 | Queuine tRNA-ribosyltransferase inhibitor | 37 | 0.9961 |
3412 | Quinate 5-dehydrogenase inhibitor | 4 | 0.9994 |
3413 | Quinoline-4-carboxylate 2-oxidoreductase inhibitor | 4 | 0.9785 |
3414 | Quinoprotein glucose dehydrogenase inhibitor | 4 | 0.9726 |
3415 | Quisqualate antagonist | 4 | 0.9557 |
3416 | Radical formation agonist | 28 | 0.9597 |
3417 | Radioprotector | 246 | 0.8950 |
3418 | Radiosensitizer | 183 | 0.8517 |
3419 | Raf kinase B inhibitor | 280 | 0.9891 |
3420 | Raf kinase C inhibitor | 93 | 0.9770 |
3421 | Raf kinase inhibitor | 665 | 0.9839 |
3422 | RAS guanyl releasing protein antagonist | 4 | 1.0000 |
3423 | Raynaud's phenomenon treatment | 11 | 0.8713 |
3424 | Reductant | 62 | 0.9113 |
3425 | Reductase inhibitor | 4 | 0.9057 |
3426 | RELA expression inhibitor | 14 | 0.8559 |
3427 | Releasing hormone agonist | 23 | 0.9442 |
3428 | Renal disease treatment | 1001 | 0.9383 |
3429 | Renal failure treatment | 489 | 0.9468 |
3430 | Renal tissue kallikrein inhibitor | 14 | 0.9141 |
3431 | Renilla-luciferin 2-monooxygenase inhibitor | 12 | 0.9891 |
3432 | Renin inhibitor | 1609 | 0.9931 |
3433 | Replication protein E1 (HPV) antagonist | 3 | 1.0000 |
3434 | Reproductive dysfunction | 219 | 0.7925 |
3435 | Respiratory analeptic | 175 | 0.8796 |
3436 | Respiratory distress syndrome treatment | 321 | 0.9097 |
3437 | Respiratory failure | 323 | 0.8336 |
3438 | Respiratory impairment | 35 | 0.8073 |
3439 | Restenosis treatment | 784 | 0.9404 |
3440 | Restless leg syndrome treatment | 21 | 0.9452 |
3441 | RET inhibitor | 81 | 0.9335 |
3442 | Retinal dehydrogenase inhibitor | 7 | 0.9047 |
3443 | Retinoic acid alpha receptor agonist | 27 | 0.9973 |
3444 | Retinoic acid alpha receptor antagonist | 243 | 0.9988 |
3445 | Retinoic acid beta receptor agonist | 15 | 0.9925 |
3446 | Retinoic acid beta receptor antagonist | 249 | 0.9995 |
3447 | Retinoic acid metabolism inhibitor | 8 | 0.9139 |
3448 | Retinoic acid receptor agonist | 147 | 0.9944 |
3449 | Retinoic acid receptor antagonist | 383 | 0.9975 |
3450 | Retinoic acid receptor gamma antagonist | 278 | 0.9966 |
3451 | Retinoid X alpha receptor agonist | 23 | 0.9952 |
3452 | Retinoid X alpha receptor antagonist | 212 | 0.9998 |
3453 | Retinoid X beta receptor antagonist | 58 | 0.9996 |
3454 | Retinoid X gamma receptor antagonist | 63 | 0.9997 |
3455 | Retinoid X receptor agonist | 110 | 0.9980 |
3456 | Retinoid X receptor antagonist | 221 | 0.9998 |
3457 | Retinol dehydrogenase inhibitor | 6 | 0.9662 |
3458 | Retinol O-fatty-acyltransferase inhibitor | 7 | 0.9944 |
3459 | Retinopathy treatment | 22 | 0.9208 |
3460 | Retinoprotector | 21 | 0.8230 |
3461 | Retinyl-palmitate esterase inhibitor | 18 | 0.9816 |
3462 | Retroperitoneal fibrosis | 9 | 0.8101 |
3463 | Reverse transcriptase (Hepatitis B) inhibitor | 36 | 1.0000 |
3464 | Rhamnulose-1-phosphate aldolase inhibitor | 7 | 0.9757 |
3465 | Rheumatoid arthritis treatment | 1677 | 0.9074 |
3466 | Rhinitis treatment | 284 | 0.8633 |
3467 | Rhizopuspepsin inhibitor | 4 | 0.9403 |
3468 | Rho-associated kinase I inhibitor | 76 | 0.9780 |
3469 | Rho-associated kinase II inhibitor | 230 | 0.9897 |
3470 | Rho-associated kinase inhibitor | 341 | 0.9897 |
3471 | Rhodesain inhibitor | 78 | 0.9967 |
3472 | Rhodopsin kinase inhibitor | 34 | 0.9410 |
3473 | Rhodotorulapepsin inhibitor | 9 | 0.9677 |
3474 | Ribitol 2-dehydrogenase inhibitor | 6 | 0.9953 |
3475 | Riboflavin kinase inhibitor | 24 | 0.9974 |
3476 | Riboflavin phosphotransferase inhibitor | 4 | 0.9893 |
3477 | Riboflavin synthase inhibitor | 12 | 0.9988 |
3478 | Ribonuclease inhibitor | 48 | 0.9494 |
3479 | Ribonuclease L inhibitor | 9 | 1.0000 |
3480 | Ribonuclease T2 inhibitor | 26 | 0.9989 |
3481 | Ribonuclease U2 inhibitor | 5 | 0.9894 |
3482 | Ribonucleoside diphosphate reductase inhibitor | 93 | 0.9814 |
3483 | Ribonucleoside triphosphate reductase inhibitor | 17 | 0.8985 |
3484 | Ribonucleotide reductase inhibitor | 199 | 0.9860 |
3485 | Ribose-5-phosphate adenylyltransferase inhibitor | 7 | 0.9912 |
3486 | Ribose-5-phosphate isomerase inhibitor | 21 | 0.9919 |
3487 | Ribose-5-phosphate-ammonia ligase inhibitor | 7 | 0.9871 |
3488 | Ribose-phosphate diphosphokinase inhibitor | 38 | 0.9933 |
3489 | Ribosomal protein S6 kinase 1, 70-kDa inhibitor | 64 | 0.9633 |
3490 | Ribosomal protein S6 kinase inhibitor | 121 | 0.9707 |
3491 | Ribosomal protein S6 kinase, 70-kDa inhibitor | 98 | 0.9568 |
3492 | Ribosomal protein S6 kinase, 90kD, polypeptide 5 inhibitor | 4 | 1.0000 |
3493 | Ribosomal protein S6 kinase, 90-kDa inhibitor | 42 | 0.9624 |
3494 | Ribosylpyrimidine nucleosidase inhibitor | 9 | 0.9981 |
3495 | Ribulose-bisphosphate carboxylase inhibitor | 15 | 0.9869 |
3496 | Ribulose-phosphate 3-epimerase inhibitor | 3 | 0.8606 |
3497 | RNA agonist | 3 | 0.9993 |
3498 | RNA directed DNA polymerase inhibitor | 129 | 0.9089 |
3499 | RNA ligase (ATP) inhibitor | 15 | 0.9999 |
3500 | RNA synthesis inhibitor | 106 | 0.8979 |
3501 | RNA-directed RNA polymerase (Influenza A) inhibitor | 13 | 0.9998 |
3502 | RNA-directed RNA polymerase inhibitor | 26 | 0.8614 |
3503 | RNA-directed RNA polymerase stimulant | 7 | 0.9984 |
3504 | Rotamase (FKBP) inhibitor | 6 | 0.9968 |
3505 | Rotamase (FKBP12) inhibitor | 77 | 0.9932 |
3506 | rRNA (adenosine-2'-O-)-methyltransferase inhibitor | 12 | 0.9985 |
3507 | Rubefacient | 7 | 0.9703 |
3508 | Rubredoxin-NAD+ reductase inhibitor | 14 | 0.8197 |
3509 | Ryanodine receptor 1 antagonist | 7 | 0.9934 |
3510 | Ryanodine receptor antagonist | 7 | 0.9934 |
3511 | Saccharolysin inhibitor | 4 | 0.9865 |
3512 | Saccharopepsin inhibitor | 3 | 0.8770 |
3513 | Saccharopine dehydrogenase (NAD+, L-glutamate-forming) inhibitor | 4 | 0.9930 |
3514 | Saccharopine dehydrogenase (NAD+, L-lysine-forming) inhibitor | 19 | 0.9790 |
3515 | Saccharopine dehydrogenase (NADP+, L-glutamate-forming) inhibitor | 5 | 0.9905 |
3516 | Saccharopine dehydrogenase (NADP+, L-lysine-forming) inhibitor | 12 | 0.9948 |
3517 | S-adenosyl-L-homocysteine hydrolase inhibitor | 69 | 0.9997 |
3518 | S-adenosyl-L-methionine decarboxylase inhibitor | 58 | 0.9985 |
3519 | Salicylate 1-monooxygenase inhibitor | 6 | 0.9660 |
3520 | S-alkylcysteine lyase inhibitor | 3 | 0.9744 |
3521 | Saluretic | 95 | 0.9280 |
3522 | Saponin-like | 8 | 1.0000 |
3523 | Sarcopenia treatment | 25 | 0.9786 |
3524 | Sarcosine oxidase inhibitor | 14 | 0.9850 |
3525 | Sclerosant | 4 | 0.9424 |
3526 | Scyllo-inosamine-4-phosphate amidinotransferase inhibitor | 4 | 0.9939 |
3527 | Scytalone dehydratase inhibitor | 21 | 0.9915 |
3528 | Secretase alpha stimulant | 11 | 0.8479 |
3529 | Secretase beta 1 inhibitor | 754 | 0.9906 |
3530 | Secretase beta 2 inhibitor | 296 | 0.9965 |
3531 | Secretase beta inhibitor | 956 | 0.9898 |
3532 | Secretase gamma inhibitor | 415 | 0.9981 |
3533 | Secretase inhibitor | 1367 | 0.9875 |
3534 | Secretase stimulant | 11 | 0.8479 |
3535 | Secretory phospholipase A2 inhibitor | 151 | 0.9888 |
3536 | Sedative | 1223 | 0.9176 |
3537 | Sedoheptulose-bisphosphatase inhibitor | 7 | 0.9545 |
3538 | Selectin antagonist | 219 | 0.9854 |
3539 | Selectin E antagonist | 147 | 0.9817 |
3540 | Selectin L antagonist | 30 | 0.9993 |
3541 | Selectin P antagonist | 65 | 0.9984 |
3542 | Selenide, water dikinase inhibitor | 4 | 0.9998 |
3543 | Selenocysteine lyase inhibitor | 3 | 0.9895 |
3544 | Sensitization | 161 | 0.9250 |
3545 | Sensory disturbance | 800 | 0.8177 |
3546 | Sepiapterin deaminase inhibitor | 12 | 0.9969 |
3547 | Sepiapterin reductase inhibitor | 46 | 0.9573 |
3548 | Sepsis treatment | 154 | 0.9339 |
3549 | Septic shock treatment | 922 | 0.9211 |
3550 | Serine 3-dehydrogenase inhibitor | 6 | 0.9891 |
3551 | Serine carboxypeptidase inhibitor | 38 | 0.9800 |
3552 | Serine O-acetyltransferase inhibitor | 15 | 0.9593 |
3553 | Serine protease unspecified inhibitor | 22 | 0.9419 |
3554 | Serine-glyoxylate transaminase inhibitor | 12 | 0.9938 |
3555 | Serine-phosphoethanolamine synthase inhibitor | 10 | 0.9869 |
3556 | Serine-pyruvate transaminase inhibitor | 4 | 0.9833 |
3557 | Serine-sulfate ammonia-lyase inhibitor | 30 | 0.9955 |
3558 | Serine-tRNA ligase inhibitor | 6 | 0.9905 |
3559 | Serine-type D-Ala-D-Ala carboxypeptidase inhibitor | 36 | 0.9954 |
3560 | Serralysin inhibitor | 22 | 0.9629 |
3561 | Serratia marcescens nuclease inhibitor | 7 | 0.9708 |
3562 | Serum-glucocorticoid regulated kinase 1 inhibitor | 24 | 0.8755 |
3563 | Serum-glucocorticoid regulated kinase inhibitor | 52 | 0.9333 |
3564 | Severe acute respiratory syndrome treatment | 29 | 0.9270 |
3565 | S-formylglutathione hydrolase inhibitor | 8 | 0.8870 |
3566 | Shab potassium channel blocker | 4 | 0.8520 |
3567 | Shaker potassium channel blocker | 824 | 0.9843 |
3568 | Shal potassium channel blocker | 82 | 0.9785 |
3569 | Shikimate 5-dehydrogenase inhibitor | 6 | 0.9840 |
3570 | Shikimate kinase inhibitor | 22 | 0.9718 |
3571 | Shikimate O-hydroxycinnamoyltransferase inhibitor | 4 | 0.9751 |
3572 | Shivering | 6 | 0.8362 |
3573 | Shock treatment | 55 | 0.9752 |
3574 | Sialorrhea | 22 | 0.8348 |
3575 | Sickle-cell anemia treatment | 54 | 0.9236 |
3576 | Sigma 1 receptor agonist | 14 | 0.9656 |
3577 | Sigma 1 receptor antagonist | 1058 | 0.9949 |
3578 | Sigma 2 receptor antagonist | 585 | 0.9958 |
3579 | Sigma 3 receptor antagonist | 11 | 0.9999 |
3580 | Sigma receptor agonist | 23 | 0.9321 |
3581 | Sigma receptor antagonist | 2161 | 0.9874 |
3582 | Signal peptidase I inhibitor | 12 | 0.9697 |
3583 | Signal peptidase IB inhibitor | 3 | 1.0000 |
3584 | Signal transduction pathways inhibitor | 3899 | 0.9214 |
3585 | Simian immunodeficiency virus proteinase inhibitor | 4 | 0.8632 |
3586 | Sirtuin 2 inhibitor | 39 | 0.9968 |
3587 | Sirtuin inhibitor | 47 | 0.9962 |
3588 | Site-specific DNA-methyltransferase (adenine-specific) inhibitor | 4 | 0.9909 |
3589 | Skeletal muscle relaxant | 219 | 0.9180 |
3590 | Skin irritation, corrasive | 15 | 0.9072 |
3591 | Skin irritation, high | 405 | 0.9556 |
3592 | Skin irritation, inactive | 188 | 0.9358 |
3593 | Skin irritation, moderate | 269 | 0.9756 |
3594 | Skin irritation, weak | 468 | 0.9683 |
3595 | Skin irritative effect | 1117 | 0.9594 |
3596 | Skin whitener | 48 | 0.9748 |
3597 | Sleep apnea treatment | 79 | 0.9597 |
3598 | Sleep disorders treatment | 1271 | 0.9611 |
3599 | Sleep disturbance | 1188 | 0.8204 |
3600 | Small monomeric GTPase inhibitor | 3 | 0.9947 |
3601 | S-methyl-5-thioadenosine phosphorylase inhibitor | 47 | 0.9955 |
3602 | S-methyl-5-thioribose kinase inhibitor | 9 | 0.9913 |
3603 | SMN2 expression enhancer | 22 | 0.9208 |
3604 | Smo receptor agonist | 3 | 1.0000 |
3605 | Smo receptor antagonist | 122 | 0.9935 |
3606 | Smooth muscle myosin light chain kinase inhibitor | 46 | 0.9002 |
3607 | Snapalysin inhibitor | 4 | 0.9873 |
3608 | Sneezing | 56 | 0.8172 |
3609 | Sodium channel (voltage-gated) blocker | 537 | 0.9647 |
3610 | Sodium channel blocker | 1004 | 0.9381 |
3611 | Sodium channel blocker class Ib | 6 | 0.9721 |
3612 | Sodium/bile acid cotransporter inhibitor | 16 | 0.9703 |
3613 | Sodium/calcium exchanger 1 inhibitor | 25 | 0.9727 |
3614 | Sodium/calcium exchanger inhibitor | 109 | 0.9874 |
3615 | Sodium/glucose cotransporter 1 inhibitor | 180 | 0.9920 |
3616 | Sodium/glucose cotransporter 2 inhibitor | 425 | 0.9980 |
3617 | Sodium/glucose cotransporter inhibitor | 587 | 0.9940 |
3618 | Sodium/hydrogen exchanger 1 inhibitor | 296 | 0.9986 |
3619 | Sodium/hydrogen exchanger 2 inhibitor | 157 | 0.9995 |
3620 | Sodium/hydrogen exchanger 3 inhibitor | 220 | 0.9987 |
3621 | Sodium/hydrogen exchanger 5 inhibitor | 6 | 0.9956 |
3622 | Sodium/hydrogen exchanger inhibitor | 665 | 0.9982 |
3623 | Sodium-dependent vitamin C transporter 2 inhibitor | 3 | 1.0000 |
3624 | Somatostatin 1 antagonist | 219 | 0.9939 |
3625 | Somatostatin 2 agonist | 7 | 0.9875 |
3626 | Somatostatin 2 antagonist | 319 | 0.9936 |
3627 | Somatostatin 3 antagonist | 276 | 0.9943 |
3628 | Somatostatin 4 antagonist | 311 | 0.9941 |
3629 | Somatostatin 5 agonist | 15 | 0.9991 |
3630 | Somatostatin 5 antagonist | 279 | 0.9929 |
3631 | Somatostatin agonist | 34 | 0.9632 |
3632 | Somatostatin antagonist | 397 | 0.9922 |
3633 | Sorbitol-6-phosphate 2-dehydrogenase inhibitor | 3 | 0.9766 |
3634 | Sorbose dehydrogenase inhibitor | 3 | 0.9948 |
3635 | Spasmolytic | 1457 | 0.9068 |
3636 | Spasmolytic, Papaverin-like | 188 | 0.9330 |
3637 | Spasmolytic, urinary | 24 | 0.8539 |
3638 | Spermicide | 54 | 0.8635 |
3639 | Spermidine dehydrogenase inhibitor | 5 | 0.8197 |
3640 | Spermidine synthase inhibitor | 36 | 0.9952 |
3641 | Spermine antagonist | 3 | 0.9997 |
3642 | Spermine synthase inhibitor | 23 | 0.9953 |
3643 | Sphinganine kinase inhibitor | 6 | 0.8230 |
3644 | Sphinganine-1-phosphate aldolase inhibitor | 6 | 0.9794 |
3645 | Sphingomyelinase inhibitor | 15 | 0.9853 |
3646 | Sphingosine 1-phosphate receptor 1 agonist | 107 | 0.9996 |
3647 | Sphingosine 1-phosphate receptor 1 antagonist | 122 | 0.9299 |
3648 | Sphingosine 1-phosphate receptor 3 agonist | 12 | 1.0000 |
3649 | Sphingosine 1-phosphate receptor 3 antagonist | 157 | 0.9844 |
3650 | Sphingosine 1-phosphate receptor 4 agonist | 5 | 0.9999 |
3651 | Sphingosine 1-phosphate receptor 4 antagonist | 208 | 0.9473 |
3652 | Sphingosine 1-phosphate receptor 5 agonist | 5 | 0.8629 |
3653 | Sphingosine 1-phosphate receptor 5 antagonist | 91 | 0.9877 |
3654 | Sphingosine 1-phosphate receptor agonist | 108 | 0.9996 |
3655 | Sphingosine 1-phosphate receptor antagonist | 344 | 0.9481 |
3656 | Sphingosine kinase 1 inhibitor | 23 | 0.9988 |
3657 | Sphingosine kinase inhibitor | 32 | 0.9907 |
3658 | Sphingosine kinase stimulant | 3 | 1.0000 |
3659 | Splenomegaly | 27 | 0.8291 |
3660 | Sporulation kinase A inhibitor | 11 | 0.9942 |
3661 | Squalene epoxidase inhibitor | 71 | 0.9604 |
3662 | Squalene synthetase inhibitor | 504 | 0.9936 |
3663 | Squalene-hopene cyclase inhibitor | 35 | 0.9692 |
3664 | Src kinase inhibitor | 2629 | 0.9691 |
3665 | Stearoyl-CoA desaturase inhibitor | 299 | 0.9817 |
3666 | Stem cell growth factor agonist | 190 | 0.9716 |
3667 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 365 | 0.9949 |
3668 | Steroid 9alpha-monooxygenase inhibitor | 3 | 0.9979 |
3669 | Steroid DELTA-isomerase inhibitor | 28 | 0.9730 |
3670 | Steroid N-acetylglucosaminyltransferase inhibitor | 4 | 0.9570 |
3671 | Steroid sulfotransferase inhibitor | 11 | 0.9268 |
3672 | Steroid synthesis inhibitor | 10 | 0.8688 |
3673 | Steroid-like | 18 | 0.9974 |
3674 | Sterol 24-C-methyltransferase inhibitor | 27 | 0.9851 |
3675 | Sterol 3-beta-glucosyltransferase inhibitor | 12 | 0.9573 |
3676 | Stipitatonate decarboxylase inhibitor | 5 | 0.9983 |
3677 | Stomatitis | 255 | 0.7835 |
3678 | Streptogrisin A inhibitor | 3 | 0.9996 |
3679 | Streptomycin 6-kinase inhibitor | 6 | 0.9968 |
3680 | Streptopain inhibitor | 13 | 0.9869 |
3681 | Stroke treatment | 4811 | 0.9224 |
3682 | Strombine dehydrogenase inhibitor | 5 | 0.9996 |
3683 | Stromelysin 2 inhibitor | 11 | 0.9019 |
3684 | Styrene-oxide isomerase inhibitor | 3 | 0.9865 |
3685 | Substance P antagonist | 307 | 0.9803 |
3686 | Subtilisin inhibitor | 27 | 0.9605 |
3687 | Succinate dehydrogenase inhibitor | 14 | 0.9573 |
3688 | Succinate-CoA ligase (ADP-forming) inhibitor | 16 | 0.9825 |
3689 | Succinate-hydroxymethylglutarate CoA-transferase inhibitor | 8 | 0.9924 |
3690 | Succinate-semialdehyde dehydrogenase [NAD(P)+] inhibitor | 7 | 0.8456 |
3691 | Succinate-semialdehyde dehydrogenase inhibitor | 20 | 0.9926 |
3692 | Succinic dehydrogenase inhibitor | 8 | 0.9681 |
3693 | Sucrose alpha-glucosidase inhibitor | 19 | 0.9960 |
3694 | Sucrose phosphorylase inhibitor | 5 | 0.9996 |
3695 | Sucrose synthase inhibitor | 16 | 0.9923 |
3696 | Sucrose-phosphate phosphatase inhibitor | 7 | 0.9980 |
3697 | Sucrose-phosphate synthase inhibitor | 19 | 0.9730 |
3698 | Sugar-phosphatase inhibitor | 3 | 0.9015 |
3699 | Sulfate adenylyltransferase (ADP) inhibitor | 8 | 0.9858 |
3700 | Sulfate adenylyltransferase inhibitor | 14 | 0.9831 |
3701 | Sulfinoalanine decarboxylase inhibitor | 18 | 0.9935 |
3702 | Sulfite dehydrogenase inhibitor | 9 | 0.8467 |
3703 | Sulfite oxidase inhibitor | 9 | 0.9377 |
3704 | Sulfite reductase inhibitor | 6 | 0.9703 |
3705 | Sulfonylureas | 3 | 0.9993 |
3706 | Sulfotransferase substrate | 183 | 0.9624 |
3707 | Sulfur dioxygenase inhibitor | 6 | 0.9869 |
3708 | Sulfur reductase inhibitor | 8 | 0.8660 |
3709 | SULT1A1 substrate | 42 | 0.9783 |
3710 | SULT1A2 substrate | 24 | 0.9936 |
3711 | SULT1A3 substrate | 17 | 0.9777 |
3712 | SULT1E1 substrate | 4 | 0.9859 |
3713 | SULT2A1 substrate | 9 | 0.9415 |
3714 | Superoxide dismutase inhibitor | 15 | 0.8843 |
3715 | Sweating | 107 | 0.8098 |
3716 | Sweetener | 24 | 0.9559 |
3717 | Syk tyrosine kinase inhibitor | 268 | 0.9754 |
3718 | Synaptic vesicle protein SV2, levetiracetam binding site antagonist | 32 | 1.0000 |
3719 | Systemic lupus erythematosus treatment | 124 | 0.8686 |
3720 | T cell inhibitor | 247 | 0.9533 |
3721 | T cell receptor antagonist | 17 | 1.0000 |
3722 | T cell receptor gamma-delta antagonist | 17 | 1.0000 |
3723 | T2-induced deoxynucleotide kinase inhibitor | 3 | 0.9999 |
3724 | Tachycardiac | 437 | 0.8110 |
3725 | Tagaturonate reductase inhibitor | 3 | 0.9946 |
3726 | Tankyrase 2 inhibitor | 5 | 1.0000 |
3727 | Tankyrase inhibitor | 10 | 0.8892 |
3728 | Tannase inhibitor | 14 | 0.9957 |
3729 | Tardive dyskinesia treatment | 40 | 0.9347 |
3730 | Tartrate decarboxylase inhibitor | 5 | 0.9998 |
3731 | Tartrate dehydrogenase inhibitor | 5 | 1.0000 |
3732 | Taurine dehydrogenase inhibitor | 7 | 0.8612 |
3733 | Taurine-2-oxoglutarate transaminase inhibitor | 3 | 0.9758 |
3734 | Taurocyamine kinase inhibitor | 3 | 0.9794 |
3735 | Tauropine dehydrogenase inhibitor | 8 | 0.9594 |
3736 | T-cell protein-tyrosine phosphatase inhibitor | 243 | 0.9915 |
3737 | TEC kinase inhibitor | 25 | 0.9745 |
3738 | Telangiectasia | 18 | 0.8955 |
3739 | Telomerase inhibitor | 206 | 0.9613 |
3740 | Telomerase stimulant | 6 | 1.0000 |
3741 | Tentoxilysin inhibitor | 4 | 0.9454 |
3742 | Teratogen | 1552 | 0.9052 |
3743 | Testosterone 17beta-dehydrogenase (NADP+) inhibitor | 3 | 0.8648 |
3744 | Testosterone 17beta-dehydrogenase inhibitor | 11 | 0.9698 |
3745 | Testosterone agonist | 5 | 0.9964 |
3746 | Tetanus neurotoxin inhibitor | 3 | 1.0000 |
3747 | Tetracycline antiport transporter antagonist | 36 | 1.0000 |
3748 | Tetrahydroxynaphthalene reductase inhibitor | 7 | 0.9819 |
3749 | TGF beta receptor type I kinase inhibitor | 197 | 0.9965 |
3750 | TGF beta receptor type II kinase inhibitor | 14 | 1.0000 |
3751 | TH expression enhancer | 11 | 0.8851 |
3752 | Theanine hydrolase inhibitor | 13 | 0.9991 |
3753 | Thermitase inhibitor | 12 | 0.9022 |
3754 | Thermolysin inhibitor | 23 | 0.9966 |
3755 | Thermomycolin inhibitor | 3 | 0.9956 |
3756 | Thiamine pyridinylase inhibitor | 5 | 0.8594 |
3757 | Thiamine-phosphate diphosphorylase inhibitor | 7 | 0.9880 |
3758 | Thiamine-phosphate kinase inhibitor | 5 | 0.9862 |
3759 | Thiamine-triphosphatase inhibitor | 9 | 0.8771 |
3760 | Thiazolidinedione | 18 | 0.9995 |
3761 | Thimet oligopeptidase inhibitor | 20 | 0.9374 |
3762 | Thioether S-methyltransferase inhibitor | 3 | 0.9947 |
3763 | Thiol oxidase inhibitor | 13 | 0.9485 |
3764 | Thiol protease inhibitor | 232 | 0.9279 |
3765 | Thiol S-methyltransferase inhibitor | 8 | 0.9809 |
3766 | Thiol sulfotransferase inhibitor | 4 | 0.9999 |
3767 | Thiopurine S-methyltransferase inhibitor | 17 | 0.9438 |
3768 | Thioredoxin inhibitor | 3 | 0.9190 |
3769 | Thioredoxin reductase inhibitor | 53 | 0.9299 |
3770 | Thiosulfate dehydrogenase inhibitor | 10 | 0.8789 |
3771 | Thiosulfate sulfurtransferase inhibitor | 21 | 0.9878 |
3772 | Threonine aldolase inhibitor | 5 | 0.9759 |
3773 | Threonine ammonia-lyase inhibitor | 27 | 0.9848 |
3774 | Threonine synthase inhibitor | 11 | 0.9984 |
3775 | Threonine-tRNA ligase inhibitor | 5 | 0.9319 |
3776 | Thrombin inhibitor | 2482 | 0.9799 |
3777 | Thrombocytopenia | 494 | 0.8163 |
3778 | Thrombocytopoiesis inhibitor | 11 | 0.8399 |
3779 | Thrombolytic | 143 | 0.9304 |
3780 | Thrombophlebitis | 146 | 0.8016 |
3781 | Thrombopoietin agonist | 113 | 0.9997 |
3782 | Thromboxane A2 antagonist | 280 | 0.9826 |
3783 | Thromboxane agonist | 3 | 0.9995 |
3784 | Thromboxane antagonist | 491 | 0.9752 |
3785 | Thromboxane B2 antagonist | 18 | 0.8416 |
3786 | Thromboxane synthase inhibitor | 900 | 0.9864 |
3787 | Thromboxane synthase stimulant | 3 | 0.9890 |
3788 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 38 | 0.9999 |
3789 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 15 | 1.0000 |
3790 | Thymidine kinase 1 inhibitor | 28 | 0.9802 |
3791 | Thymidine kinase 2 inhibitor | 25 | 0.9999 |
3792 | Thymidine kinase inhibitor | 192 | 0.9827 |
3793 | Thymidine phosphorylase inhibitor | 65 | 0.9939 |
3794 | Thymidine-triphosphatase inhibitor | 6 | 0.9989 |
3795 | Thymidylate 5'-phosphatase inhibitor | 5 | 0.8077 |
3796 | Thymidylate synthase inhibitor | 839 | 0.9932 |
3797 | Thymine dioxygenase inhibitor | 14 | 0.9998 |
3798 | Thyroid hormone agonist | 104 | 0.9862 |
3799 | Thyroid hormone alpha 1 agonist | 5 | 1.0000 |
3800 | Thyroid hormone alpha 1 antagonist | 12 | 1.0000 |
3801 | Thyroid hormone alpha agonist | 5 | 1.0000 |
3802 | Thyroid hormone alpha antagonist | 93 | 0.9998 |
3803 | Thyroid hormone antagonist | 261 | 0.9930 |
3804 | Thyroid hormone beta 1 agonist | 5 | 1.0000 |
3805 | Thyroid hormone beta 1 antagonist | 156 | 0.9996 |
3806 | Thyroid hormone beta agonist | 74 | 0.9997 |
3807 | Thyroid hormone beta antagonist | 178 | 0.9996 |
3808 | Thyrotropin releasing hormone agonist | 15 | 0.9999 |
3809 | Thyrotropin releasing hormone antagonist | 6 | 1.0000 |
3810 | Thyroxine 5-deiodinase inhibitor | 7 | 0.9462 |
3811 | TIE antagonist | 749 | 0.9842 |
3812 | TIE-2 agonist | 6 | 1.0000 |
3813 | TIE-2 antagonist | 734 | 0.9842 |
3814 | TNF convertase inhibitor | 1028 | 0.9981 |
3815 | TNF expression inhibitor | 55 | 0.8758 |
3816 | Tocolytic | 141 | 0.9779 |
3817 | Toll-Like receptor 2 antagonist | 10 | 0.9998 |
3818 | Toll-Like receptor 7 agonist | 86 | 0.9979 |
3819 | Toll-Like receptor 8 agonist | 9 | 1.0000 |
3820 | Toll-Like receptor agonist | 88 | 0.9931 |
3821 | Toll-Like receptor antagonist | 16 | 0.8733 |
3822 | Topoisomerase I inhibitor | 478 | 0.9625 |
3823 | Topoisomerase II inhibitor | 726 | 0.9650 |
3824 | Torsades de pointes | 90 | 0.8224 |
3825 | Torticollis | 28 | 0.8350 |
3826 | Toxic | 5112 | 0.8644 |
3827 | Toxic, gastrointestinal | 1362 | 0.8187 |
3828 | Toxic, respiration | 80 | 0.8211 |
3829 | Toxic, respiratory center | 15 | 0.9270 |
3830 | Toxic, vascular | 194 | 0.8349 |
3831 | TP53 expression enhancer | 99 | 0.8227 |
3832 | Tpr proteinase (Porphyromonas gingivalis) inhibitor | 4 | 0.8533 |
3833 | Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase inhibitor | 42 | 0.9582 |
3834 | Trans-2-enoyl-CoA reductase (NAD+) inhibitor | 4 | 0.9885 |
3835 | Trans-acenaphthene-1,2-diol dehydrogenase inhibitor | 5 | 0.8085 |
3836 | Transactivator transcription protein inhibitor | 25 | 0.8505 |
3837 | Transaldolase inhibitor | 5 | 0.9998 |
3838 | Transcortin receptor antagonist | 29 | 0.9997 |
3839 | Transcription factor AP-1 inhibitor | 249 | 0.9711 |
3840 | Transcription factor inhibitor | 1287 | 0.9166 |
3841 | Transcription factor NF kappa A inhibitor | 7 | 0.8406 |
3842 | Transcription factor NF kappa B inhibitor | 534 | 0.9560 |
3843 | Transcription factor NF kappa B stimulant | 7 | 0.8530 |
3844 | Transcription factor rho inhibitor | 7 | 1.0000 |
3845 | Transcription factor STAT inhibitor | 269 | 0.8997 |
3846 | Transcription factor STAT3 inhibitor | 234 | 0.9104 |
3847 | Transcription factor STAT6 inhibitor | 20 | 0.9849 |
3848 | Transcription factor stimulant | 7 | 0.8530 |
3849 | Transforming growth factor antagonist | 241 | 0.9858 |
3850 | Transforming growth factor beta 1 agonist | 3 | 0.8895 |
3851 | Transforming growth factor beta 1 antagonist | 186 | 0.9920 |
3852 | Transforming growth factor beta 3 antagonist | 20 | 0.9999 |
3853 | Transforming growth factor beta antagonist | 227 | 0.9895 |
3854 | Transglutaminase 2 inhibitor | 27 | 0.9730 |
3855 | Transketolase inhibitor | 7 | 0.9168 |
3856 | Translation initiation factor IF-2 antagonist | 5 | 0.9998 |
3857 | Trans-octaprenyltranstransferase inhibitor | 12 | 0.9917 |
3858 | Trans-pentaprenyltranstransferase inhibitor | 5 | 0.9878 |
3859 | Transplant rejection treatment | 694 | 0.9135 |
3860 | Transthyretin amyloid fibril formation inhibitor | 29 | 0.9842 |
3861 | Trehalose-phosphatase inhibitor | 3 | 0.9956 |
3862 | Tremor | 537 | 0.8349 |
3863 | Triacetate-lactonase inhibitor | 3 | 0.9894 |
3864 | Trimerelysin II inhibitor | 7 | 0.9921 |
3865 | Trimethylamine dehydrogenase inhibitor | 9 | 0.9323 |
3866 | Trimethylamine-N-oxide reductase inhibitor | 11 | 0.9902 |
3867 | Trimethylamine-oxide aldolase inhibitor | 5 | 0.8099 |
3868 | Trimethyllysine dioxygenase inhibitor | 7 | 0.9819 |
3869 | Triose-phosphate isomerase inhibitor | 23 | 0.9855 |
3870 | Tripeptide aminopeptidase inhibitor | 23 | 0.9404 |
3871 | Tripeptidyl peptidase II inhibitor | 36 | 0.9993 |
3872 | Tripeptidyl-peptidase I inhibitor | 22 | 0.9634 |
3873 | TRKA antagonist | 146 | 0.9826 |
3874 | TRKB antagonist | 21 | 0.9548 |
3875 | tRNA (adenine-N1-)-methyltransferase inhibitor | 6 | 0.9992 |
3876 | tRNA (cytosine-5-)-methyltransferase inhibitor | 5 | 0.9852 |
3877 | tRNA (guanine-N1-)-methyltransferase inhibitor | 4 | 0.9935 |
3878 | tRNA (guanine-N2-)-methyltransferase inhibitor | 5 | 0.9937 |
3879 | tRNA (guanine-N7-)-methyltransferase inhibitor | 6 | 0.9909 |
3880 | tRNA (uracil-5-)-methyltransferase inhibitor | 10 | 0.9994 |
3881 | tRNA adenylyltransferase inhibitor | 9 | 0.9863 |
3882 | tRNA cytidylyltransferase inhibitor | 15 | 0.9894 |
3883 | tRNA methyltransferase inhibitor | 22 | 0.9950 |
3884 | tRNA nucleotidyltransferase inhibitor | 3 | 0.9918 |
3885 | tRNA-pseudouridine synthase I inhibitor | 3 | 0.9684 |
3886 | Tropinesterase inhibitor | 3 | 0.8568 |
3887 | TRPA1 agonist | 10 | 0.9334 |
3888 | TRPA1 antagonist | 17 | 0.9778 |
3889 | Trypanothione-disulfide reductase inhibitor | 62 | 0.9610 |
3890 | Trypsin inhibitor | 1401 | 0.9889 |
3891 | Tryptase 1 inhibitor | 144 | 0.9995 |
3892 | Tryptase inhibitor | 198 | 0.9860 |
3893 | Tryptophan 2,3-dioxygenase inhibitor | 24 | 0.8809 |
3894 | Tryptophan 2-monooxygenase inhibitor | 20 | 0.9620 |
3895 | Tryptophan 5 hydroxylase inhibitor | 25 | 0.9483 |
3896 | Tryptophan alpha,beta-oxidase inhibitor | 4 | 0.9583 |
3897 | Tryptophan dimethylallyltransferase inhibitor | 8 | 0.9733 |
3898 | Tryptophan hydroxylase 1 inhibitor | 16 | 0.9999 |
3899 | Tryptophan synthase inhibitor | 14 | 0.9953 |
3900 | Tryptophan transaminase inhibitor | 4 | 0.9877 |
3901 | Tryptophanamidase inhibitor | 5 | 0.9851 |
3902 | Tryptophan-tRNA ligase inhibitor | 38 | 0.9898 |
3903 | Tryptophanyl aminopeptidase inhibitor | 3 | 0.9901 |
3904 | TTK protein kinase inhibitor | 6 | 0.9631 |
3905 | Tubulin agonist | 26 | 0.9999 |
3906 | Tubulin antagonist | 1164 | 0.9725 |
3907 | Tubulin GTPase inhibitor | 6 | 0.9967 |
3908 | Tubulin-tyrosine ligase inhibitor | 17 | 0.9871 |
3909 | Tubulinyl-Tyr carboxypeptidase inhibitor | 6 | 0.9983 |
3910 | Tumour necrosis factor alpha antagonist | 688 | 0.9470 |
3911 | Tumour necrosis factor alpha release inhibitor | 2422 | 0.9445 |
3912 | Tumour necrosis factor antagonist | 781 | 0.9372 |
3913 | Twitching | 7 | 0.8119 |
3914 | Tyrosine 2,3-aminomutase inhibitor | 6 | 0.9944 |
3915 | Tyrosine 3 hydroxylase inhibitor | 12 | 0.8836 |
3916 | Tyrosine 3 hydroxylase stimulant | 3 | 1.0000 |
3917 | Tyrosine kinase inhibitor | 6059 | 0.9491 |
3918 | Tyrosine kinase stimulant | 3 | 0.9559 |
3919 | Tyrosine phenol-lyase inhibitor | 20 | 0.9981 |
3920 | Tyrosine transaminase inhibitor | 34 | 0.9855 |
3921 | Tyrosine-ester sulfotransferase inhibitor | 24 | 0.9873 |
3922 | Tyrosine-protein kinase EMT inhibitor | 199 | 0.9894 |
3923 | Tyrosine-protein kinase receptor antagonist | 161 | 0.9831 |
3924 | Tyrosine-protein kinase receptor FLT3 inhibitor | 388 | 0.9821 |
3925 | Tyrosine-protein kinase TYRO 10 inhibitor | 8 | 0.9205 |
3926 | Ubiquinol-cytochrome-c reductase inhibitor | 10 | 0.8164 |
3927 | Ubiquitin thiolesterase inhibitor | 7 | 0.9596 |
3928 | Ubiquitin-protein ligase inhibitor | 27 | 0.9710 |
3929 | UDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitor | 60 | 0.9990 |
3930 | UDP-glucose 4-epimerase inhibitor | 28 | 0.9721 |
3931 | UDP-glucose 6-dehydrogenase inhibitor | 8 | 0.9509 |
3932 | UDP-glucose-hexose-1-phosphate uridylyltransferase inhibitor | 18 | 0.9755 |
3933 | UDP-glucuronate 4-epimerase inhibitor | 13 | 0.9998 |
3934 | UDP-glucuronate 5'-epimerase inhibitor | 3 | 0.9997 |
3935 | UDP-glucuronate decarboxylase inhibitor | 12 | 0.9954 |
3936 | UDP-glucuronosyltransferase substrate | 817 | 0.9303 |
3937 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 20 | 0.9900 |
3938 | UDP-N-acetylglucosamine 2-epimerase inhibitor | 7 | 0.9915 |
3939 | UDP-N-acetylglucosamine 4-epimerase inhibitor | 3 | 0.9015 |
3940 | UDP-N-acetylglucosamine diphosphorylase inhibitor | 8 | 0.9931 |
3941 | UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase inhibitor | 11 | 0.9808 |
3942 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase inhibitor | 9 | 0.9966 |
3943 | UDP-N-acetylmuramate dehydrogenase inhibitor | 20 | 0.9880 |
3944 | UDP-N-acetylmuramate-L-alanine ligase inhibitor | 18 | 0.9760 |
3945 | UDP-N-acetylmuramoylalanine-D-glutamate ligase inhibitor | 18 | 0.9877 |
3946 | UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase inhibitor | 8 | 0.9997 |
3947 | UDP-sugar diphosphatase inhibitor | 4 | 0.9956 |
3948 | UGT1A substrate | 313 | 0.9305 |
3949 | UGT1A1 substrate | 113 | 0.9443 |
3950 | UGT1A10 substrate | 99 | 0.9457 |
3951 | UGT1A3 substrate | 118 | 0.9426 |
3952 | UGT1A4 substrate | 128 | 0.9451 |
3953 | UGT1A5 substrate | 16 | 0.9413 |
3954 | UGT1A6 substrate | 85 | 0.9291 |
3955 | UGT1A7 substrate | 61 | 0.9443 |
3956 | UGT1A8 substrate | 99 | 0.9543 |
3957 | UGT1A9 substrate | 92 | 0.8929 |
3958 | UGT2B substrate | 259 | 0.9537 |
3959 | UGT2B1 substrate | 99 | 0.9609 |
3960 | UGT2B10 substrate | 20 | 0.9092 |
3961 | UGT2B11 substrate | 37 | 0.9553 |
3962 | UGT2B12 substrate | 4 | 0.8678 |
3963 | UGT2B15 substrate | 84 | 0.9549 |
3964 | UGT2B17 substrate | 15 | 0.9269 |
3965 | UGT2B18 substrate | 6 | 0.9698 |
3966 | UGT2B19 substrate | 5 | 0.9921 |
3967 | UGT2B20 substrate | 19 | 0.9958 |
3968 | UGT2B23 substrate | 5 | 0.9921 |
3969 | UGT2B28 substrate | 8 | 0.9620 |
3970 | UGT2B30 substrate | 5 | 0.9921 |
3971 | UGT2B4 substrate | 35 | 0.9100 |
3972 | UGT2B4D substrate | 5 | 0.9921 |
3973 | UGT2B4E substrate | 5 | 0.9921 |
3974 | UGT2B7 substrate | 138 | 0.9520 |
3975 | UGT2B7H substrate | 28 | 0.9793 |
3976 | UGT2B7Y substrate | 28 | 0.9793 |
3977 | UGT2B9 substrate | 39 | 0.9508 |
3978 | Ulcer, aphthous | 9 | 0.8311 |
3979 | Ulcer, gastric | 27 | 0.9072 |
3980 | Ulcer, peptic | 34 | 0.8848 |
3981 | Ulceration | 53 | 0.9074 |
3982 | Ulcerative colitis treatment | 3 | 0.9999 |
3983 | Undecaprenyl-diphosphatase inhibitor | 5 | 0.9828 |
3984 | Undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase inhibitor | 3 | 0.9560 |
3985 | Undecaprenyl-phosphate galactose phosphotransferase inhibitor | 6 | 0.9997 |
3986 | Undecaprenyl-phosphate mannosyltransferase inhibitor | 3 | 0.9480 |
3987 | Uracil phosphoribosyltransferase inhibitor | 14 | 0.9955 |
3988 | Urate transporter 1 inhibitor | 29 | 0.9790 |
3989 | Urate-ribonucleotide phosphorylase inhibitor | 12 | 0.9232 |
3990 | Urease inhibitor | 18 | 0.9250 |
3991 | Urethanase inhibitor | 10 | 0.8744 |
3992 | Uric acid excretion stimulant | 122 | 0.9431 |
3993 | Uridine kinase inhibitor | 7 | 0.9931 |
3994 | Uridine nucleosidase inhibitor | 15 | 0.9913 |
3995 | Uridine phosphorylase inhibitor | 106 | 0.9979 |
3996 | Urinary incontinence treatment | 1959 | 0.9539 |
3997 | Urinary retention | 181 | 0.8040 |
3998 | Urine discoloration | 9 | 0.9539 |
3999 | Urocanate hydratase inhibitor | 16 | 0.9940 |
4000 | Urokinase inhibitor | 304 | 0.9906 |
4001 | Urolithiasis treatment | 6 | 0.9001 |
4002 | Urologic disorders treatment | 2025 | 0.9433 |
4003 | Uroporphyrinogen decarboxylase inhibitor | 30 | 0.9908 |
4004 | Uroporphyrinogen-III synthase inhibitor | 9 | 0.9397 |
4005 | Urotensin II agonist | 26 | 0.9999 |
4006 | Urotensin II antagonist | 45 | 0.9967 |
4007 | Urticaria treatment | 8 | 0.9538 |
4008 | Uterine relaxant | 43 | 0.8611 |
4009 | Uterine rupture | 3 | 0.9998 |
4010 | Uterine stimulant | 33 | 0.9474 |
4011 | UTP-glucose-1-phosphate uridylyltransferase inhibitor | 10 | 0.9998 |
4012 | Valine decarboxylase inhibitor | 4 | 0.9903 |
4013 | Valine dehydrogenase (NADP+) inhibitor | 6 | 0.9949 |
4014 | Valine-pyruvate transaminase inhibitor | 3 | 0.9999 |
4015 | Valine-tRNA ligase inhibitor | 10 | 0.9784 |
4016 | Vanilloid 1 agonist | 14 | 0.8629 |
4017 | Vanilloid 1 antagonist | 248 | 0.9932 |
4018 | Vanilloid 3 antagonist | 6 | 1.0000 |
4019 | Vanilloid 4 agonist | 6 | 1.0000 |
4020 | Vanilloid 4 antagonist | 73 | 0.9793 |
4021 | Vanilloid agonist | 20 | 0.9211 |
4022 | Vanilloid antagonist | 1066 | 0.9925 |
4023 | Vanillyl-alcohol oxidase inhibitor | 7 | 0.9951 |
4024 | Vascular (periferal) disease treatment | 799 | 0.9113 |
4025 | Vascular adhesion protein 1 inhibitor | 11 | 0.9012 |
4026 | Vascular dementia treatment | 10 | 0.8839 |
4027 | Vascular endothelial growth factor 1 antagonist | 593 | 0.9734 |
4028 | Vascular endothelial growth factor 2 antagonist | 3219 | 0.9793 |
4029 | Vascular endothelial growth factor 3 antagonist | 361 | 0.9760 |
4030 | Vascular endothelial growth factor antagonist | 3913 | 0.9709 |
4031 | Vasculitis treatment | 26 | 0.9529 |
4032 | Vasodilator | 1105 | 0.8928 |
4033 | Vasodilator, coronary | 220 | 0.8584 |
4034 | Vasodilator, peripheral | 190 | 0.8519 |
4035 | Vasopressin 1 agonist | 17 | 1.0000 |
4036 | Vasopressin 1 antagonist | 951 | 0.9955 |
4037 | Vasopressin 1A agonist | 9 | 1.0000 |
4038 | Vasopressin 1A antagonist | 847 | 0.9968 |
4039 | Vasopressin 1B agonist | 8 | 1.0000 |
4040 | Vasopressin 1B antagonist | 292 | 0.9976 |
4041 | Vasopressin 2 agonist | 132 | 0.9986 |
4042 | Vasopressin 2 antagonist | 748 | 0.9976 |
4043 | Vasopressor | 124 | 0.8674 |
4044 | Vasoprotector | 22 | 0.8107 |
4045 | VCAM antagonist | 414 | 0.9894 |
4046 | VCAM-1 antagonist | 413 | 0.9894 |
4047 | VCAM1 expression inhibitor | 56 | 0.9502 |
4048 | VEGF expression inhibitor | 38 | 0.9414 |
4049 | VEGFR2 expression inhibitor | 5 | 1.0000 |
4050 | Venom exonuclease inhibitor | 8 | 0.8720 |
4051 | Venombin A inhibitor | 9 | 0.9829 |
4052 | Venombin AB inhibitor | 5 | 0.8818 |
4053 | Vesicant | 6 | 0.9937 |
4054 | Vesicle monoamine transporter 2 inhibitor | 13 | 1.0000 |
4055 | Vesicle monoamine transporter inhibitor | 14 | 0.9955 |
4056 | Vesicular acetylcholine transporter inhibitor | 75 | 0.9984 |
4057 | Vesicular glutamate transport inhibitor | 4 | 1.0000 |
4058 | Vestibular dysfunction | 10 | 0.9202 |
4059 | Vibriolysin inhibitor | 12 | 0.9987 |
4060 | Viral entry inhibitor | 66 | 0.8665 |
4061 | Viral fusion inhibitor | 3 | 1.0000 |
4062 | Visual acuity impairment | 6 | 0.8920 |
4063 | Vitamin | 102 | 0.9817 |
4064 | Vitamin D receptor agonist | 102 | 0.9996 |
4065 | Vitamin D receptor antagonist | 75 | 0.9998 |
4066 | Vitamin D3 hydroxylase inhibitor | 15 | 0.9992 |
4067 | Vitamin D-like | 16 | 0.9995 |
4068 | Vitamin K-like | 19 | 0.9995 |
4069 | Vitamin-K-epoxide reductase (warfarin-insensitive) inhibitor | 7 | 0.9471 |
4070 | Vitronectin receptor antagonist | 1721 | 0.9968 |
4071 | VLA-4 antagonist | 1119 | 0.9958 |
4072 | Vomilenine glucosyltransferase inhibitor | 6 | 0.9833 |
4073 | Weakness | 250 | 0.8054 |
4074 | Wee-1 tyrosine kinase inhibitor | 5 | 0.9985 |
4075 | Weight gain | 25 | 0.8546 |
4076 | Weight loss | 169 | 0.8296 |
4077 | Withdrawal | 13 | 0.8280 |
4078 | Wound healing agent | 282 | 0.9068 |
4079 | Xaa-Pro dipeptidyl-peptidase inhibitor | 11 | 0.9837 |
4080 | Xanthine dehydrogenase inhibitor | 93 | 0.9798 |
4081 | Xanthine oxidase inhibitor | 110 | 0.9576 |
4082 | Xanthine oxidase substrate | 42 | 0.9765 |
4083 | Xanthine phosphoribosyltransferase inhibitor | 39 | 0.9971 |
4084 | Xanthine-like | 23 | 0.9986 |
4085 | Xanthommatin reductase inhibitor | 5 | 0.9853 |
4086 | Xenobiotic-transporting ATPase inhibitor | 13 | 0.9191 |
4087 | Xerostomia | 405 | 0.8001 |
4088 | X-His dipeptidase inhibitor | 22 | 0.9765 |
4089 | X-methyl-His dipeptidase inhibitor | 10 | 0.8782 |
4090 | X-Pro dipeptidase inhibitor | 21 | 0.9855 |
4091 | X-Trp aminopeptidase inhibitor | 7 | 0.9944 |
4092 | Xylan 1,4-beta-xylosidase inhibitor | 14 | 0.9935 |
4093 | Xylan endo-1,3-beta-xylosidase inhibitor | 5 | 0.9716 |
4094 | Xylose isomerase inhibitor | 11 | 0.9872 |
4095 | YAK3 inhibitor | 15 | 0.9999 |
4096 | Yawning | 39 | 0.8661 |
4097 | Yeast ribonuclease inhibitor | 3 | 0.9616 |
4098 | ZAP-70 protein tyrosine kinase inhibitor | 104 | 0.9823 |
4099 | Zinc deficiency | 4 | 0.9747 |